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Introduction
Le matériel génétique, ie la somme des gènes contenus dans la molécule d’ADN d’un
organisme, a deux caractéristiques principales : il est reproduit fidèlement en vue de sa
transmission génération après génération et il transfère de l’information destinée à la
biosynthèse des protéines. Les protéines sont les principales structures cellulaires responsables
des tâches structurelles et enzymatiques. Leurs différentes activités sont déterminées par leurs
différentes structures tridimensionnelles, elles-mêmes dictées par leurs différentes séquences
en acides aminés. C’est ainsi que les gènes déterminent les activités cellulaires car
l’information qu’ils contiennent spécifie la séquence des protéines (Figure 1).
Une autre caractéristique des protéines est leur localisation cellulaire. En effet, la cellule
eucaryotique est organisée en différents compartiments délimités par une membrane (Figure 2 ;
par exemple, le lysosome). Chaque compartiment effectue des fonctions précises (par exemple,
le lysosome dégrade les protéines internalisées par la cellule) et contient pour cela un jeu
spécifique de protéines (le lysosome contient des protéases). Comme la biosynthèse des
protéines est effectuée uniquement dans le cytosol par les ribosomes, chaque protéine doit être
subséquemment délivrée au compartiment où elle effectue son activité. Si ce compartiment est
différent du cytosol, ses protéines doivent donc être transloquées à travers une membrane. Les
protéines secrétées hors de la cellule ou localisées à la membrane plasmique, dans le réticulum
endoplasmique, l’appareil de Golgi ou les lysosomes, généralement définies sous le terme de
« protéines sécrétées », sont toutes adressées à la membrane du réticulum endoplasmique
qu’elles traversent par un pore nommé le translocon. Cet adressage et la translocation à travers
cette membrane se déroulent d’une manière co-traductionelle et sont spécifiés par la présence
d’une séquence « signal » localisée dans la région N-terminale des protéines sécrétées
(Figure 3). Les ribosomes exposant une chaîne naissante contenant une séquence signal sont
spécifiquement reconnus par un facteur cytosolique assurant l’adressage co-traductionel à la
membrane du reticulum endoplasmique : la particule de reconnaissance du signal (signal
recognition particle en anglais, SRP ; Figure 4A). SRP reconnaît spécifiquement la séquence
signal (étape 1), est subséquemment chargé en GTP (étape 2) et adresse le complexe
ribosome-chaîne naissante (ribosome-nascent chain en anglais, RNC) au reticulum
endoplasmique par son interaction dépendante du GTP avec le récepteur à SRP qui est localisé
à  cette  membrane  (étape  3).  Finalement,  le  RNC  est  déposé  sur  le  translocon,  la  chaîne
naissante est transloquée co-traductionellement à travers la membrane, SRP et son récepteur se
sépare après l’hydrolyse du GTP et un nouveau cycle d’adressage peut commencer (étape 4).
Les deux premières étapes du cycle d’adressage mènent à la formation d’un complexe
RNC-SRP apte à l’interaction avec la membrane du réticulum endoplasmique (Figure 4B).
SRP a une faible affinité pour tous les ribosomes engagés dans le processus de traduction. Ils
peuvent donc former un complexe transitoire, appelé le « complexe de sélection » (« sampling
complex » en anglais) dans lequel SRP est en proximité de la chaîne naissante et pourrait ainsi
la «goûter » pour déterminer si elle contient une séquence signal ou non. Si la chaîne naissante
contient une séquence signal, elle est immédiatement reconnue par SRP. Il en résulte une
augmentation de l’affinité de SRP pour le ribosome. Ce nouveau complexe plus stable est celui
qui est adressé à la membrane plasmique par l’interaction de SRP avec son récepteur. Ce
complexe est nommé le « complexe d’adressage » (« targeting complex » en anglais). Il est
caractérisé par un arrêt de l’élongation de la chaîne naissante induit par SRP. En effet, SRP
ralentit la synthèse de la chaîne naissante dès qu’il a reconnu une séquence signal. Cette
activité de SRP est nommé « arrêt d’élongation ». Elle permettrait d’augmenter la fenêtre
temporelle durant laquelle la chaîne naissante demeure dans une conformation compatible ave
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la translocation. In vivo, elle est requise pour un couplage efficace entre les mécanismes de
traduction et de translocation.
Chez les mammifères, SRP est composé d’un ARN de 300 nucléotides, l’ARN SRP, et de six
protéines : SRP9, SRP14, SRP19, SRP54, SRP68 et SRP72 (Figure 5A). SRP a l’allure d’une
tige allongée de 5-6 nm de diamètre et de 23-24 nm de longueur (Figure 5B). SRP est
séparable en deux domaines fonctionnels : le domaine S et le domaine Alu.  Le  domaine  S
comprend la partie centrale de l’ARN SRP et les protéines SRP19, SRP54, SRP68 et SRP72.
Le domaine Alu comprend les extrémités 5’ et 3’ de l’ARN SRP et les protéines SRP9 et
SRP14. La protéine SRP54 est le composant-clé de SRP comme indiqué par sa conservation
durant l’évolution. En effet, elle reconnaît les séquences signal et interagit avec le récepteur de
SRP à la membrane du réticulum endoplasmique. Cependant, tous les composants de SRP sont
requis pour l’adressage co-traductionel efficace des protéines secrétées à cette membrane.
SRP19 est requise pour la liaison de SRP54 à l’ARN SRP. SRP68 et SRP72 jouent un rôle lors
de l’interaction avec la membrane du reticulum endoplasmique.
Le domaine Alu est responsable de l’activité d’arrêt d’élongation de SRP. En effet, une région
conservée et très basique de la protéine SRP14 est spécifiquement requise pour cette activité.
Des particules SRP contenant une protéine SRP14 tronquée de son domaine C-terminal après
le résidu lysine 95 (K95 ; Figure 9) n’arrêtent plus l’élongation des chaînes naissantes
porteuses d’une séquence signal, mais sont toujours aptes à former un « sampling complex », à
reconnaître les séquences signal et à adresser les ribosomes à la membrane du reticulum,
quoique cette dernière activité soit moins efficace dans ce cas, comme attendu (se référer
ci-dessus). Le mécanisme permettant au domaine Alu d’interférer avec l’élongation de la
chaîne naissante n’est pas déterminé. Il est plus que probable que le domaine Alu interagisse
avec un site actif du ribosome. De ce qui précède, le domaine C-terminal de la protéine SRP14
est un bon candidat pour une telle interaction.
Le domaine Alu est aussi requis pour la formation du « sampling complex ». Dans ce cas, rien
n’est connu si ce n’est que des particules SRP ne contenant pas l’hétérodimère SRP9/14 sont
incapables de former des « sampling complexes ». Ceci suggère à nouveau que SRP9/14
pourrait contacter le ribosome dans le « sampling complex ».
La structure du domaine Alu a  été  révélée  récemment.  Les  protéines  SRP9  et  SRP14  sont
structurellement homologues et forment un hétérodimère (SRP9/14) en l’absence de l’ARN
SRP. La structure de l’hétérodimère consiste en un feuillet ? anti-parallèle à six brins alignés
sous quatre hélices ? (Figure 6A). Ces protéines ressemblent au domaine de liaison à l’ARN
double brin (double-stranded RNA-binding domain en anglais, dsRBD ; Figure 6B). Malgré
cette ressemblance, l’hétérodimère ne lie pas l’ARN SRP de la même manière qu’un dsRBD
interagit avec l’ARN double brin (Figure 7C). En effet, SRP9/14 interagisse avec l’ARN SRP
par le feuillet ? anti-parallèle à six brins (Figure 7A). Les séquences de l’ARN SRP
principalement contactées par l’hétérodimère (nommé ARN Alu) consiste en deux courtes
structures tige-boucle (Hélices III et IV) connectées par une région simple brin hautement
conservé (U-turn) d’un côté et par l’hélice centrale de l’ARN SRP (Hélice V) de l’autre côté, et
forment le domaine 5’ de l’ARN Alu (Figure 8B). Les boucles L2 et L1.2 des hélices III et IV,
respectivement (Figure 8A), se contactent par appariements de certaines de leur bases, créant
une structure tridimensionnelle compacte (Figure 7B). Dans un modèle du domaine Alu
complet, la partie 3’ de l’ARN Alu (Hélice V ; Figure 8A) se replie sous le feuillet ?
anti-parallèle à six brins de l’hétérodimère, formant un domaine Alu très compact (Figure 7A).
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Comprendre comment le domaine Alu de SRP peut interférer avec l’élongation des chaînes
naissantes contenant une séquence signal a été le point de départ de mon travail de thèse.
Comme mentionné ci-dessus, le domaine Alu interagit plus que probablement avec un des sites
actifs du ribosome durant la phase d’élongation. Dans ce sens, il a été souvent proposé que le
domaine Alu pourrait interférer avec les fonctions des facteurs d’élongation (elongation factors
en  anglais,  EFs).  Les  EFs  interagissent  avec  le  ribosome  à  un  site  spécifique  localisé  à
l’interface des sous-unités ribosomiques. La liaison du domaine Alu en proximité ou dans le
site de liaison des EFs lorsque SRP54 reconnaît la séquence signal est possible physiquement,
basé sur notre connaissance des dimensions de SRP mentionnées ci-dessus.
Afin de déterminer la localisation du domaine Alu dans le ribosome lorsqu’il interfère avec
l’élongation des chaînes naissantes porteuses d’une séquence signal, je me suis attelé à
déterminer les protéines ribosomiques à proximité de SRP14 dans des complexes fonctionnels
SRP-ribosome par une approche utilisant un réactif chimique formant des liaisons covalentes
entre protéines (réaction dite de « cross-linking » en anglais). Les produits de ces réactions de
cross-linking (dits « cross-link products » en anglais) impliquant la protéine SRP14 ont été
détectés par western blotting avec des anticorps anti-SRP14 purifiés par affinité. J’ai donc
commencé par utiliser cette approche pour déterminer la localisation du domaine Alu dans des
« targeting complexes » et durant la synthèse d’une protéine sécrétée (la préprolactine ;
Résultats  1  et  2).  Cette  analyse  a  démontré  que  le  domaine Alu ne peut être localisé qu’à
proximité du site de liaison des EFs durant l’arrêt d’élongation. Je propose dans la discussion
un mécanisme original pour l’arrêt d’élongation : SRP interfère avec la liaison des EFs au
ribosome après la reconnaissance d’une séquence signal dans la chaîne naissante. J’ai aussi
utilisé l’analyse par cross-linking avec des « sampling complexes » et durant la synthèse d’une
protéine non sécrétée (la cyclin ; Résultats 3). Cette analyse a démontré que le domaine Alu est
déjà en proximité de composants ribosomiques durant l’étape de « sampling », supportant
l’hypothèse d’une interaction directe avec le ribosome comme mentionnée ci-dessus. Plus
précisément, le domaine Alu pourrait déjà être localisé à proximité du site de liaison des EFs.
Cependant, en comparant les deux analyses par cross-linking, j’ai observé un changement
frappant dans l’environnement ribosomique de SRP14 après reconnaissance de la séquence
signal, concomitant avec une stabilisation du domaine Alu dans le ribosome. Ces observations
m’ont permis de proposer un changement dans la position du domaine Alu après
reconnaissance de la séquence signal. Finalement, les deux analyses par cross-linking
supportaient l’idée que le domaine Alu pourrait interagir avec le ribosome. SRP14 est un bon
candidat pour une interaction fonctionnelle, comme son domaine C-terminal est
spécifiquement  requis  pour  l’arrêt  d’élongation.  Dans  un  test  dit  «  ribosome en  pièces  »,  j’ai
testé la capacité de SRP9/14 à interagir avec des fragments de l’ARN ribosomique localisés
dans le site des EFs (Résultats 4). Ces expériences ont démontré une affinité significative de
SRP9/14 pour une grande variété d’ARNs. Cette affinité ne dépendait pas du domaine
C-terminal de SRP14. Dans un test de liaison au ribosome in vitro (Résultats 5), j’ai démontré
que la protéine SRP9/14 interagissait avec le ribosome en proximité d’une protéine de 18 kDa
associée avec la petite sous-unité. A nouveau, cette interaction ne dépendait pas du domaine
C-terminal de SRP14.  Ensemble, ces deux tests m’ont suggéré qu’un autre domaine de
SRP9/14 pourrait être impliqué dans une interaction fonctionnelle avec l’ARN ribosomique. Je
discute la fonctionnalité de cette interaction avec l’apport de données récemment publiées.
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Résultats
1) Pour déterminer la localisation du domaine Alu dans le ribosome durant l’arrêt
d’élongation, des « targeting complexes » ont d’abord été analysés par cross-linking.
L’environnement de SRP14 dans ces complexes a été déterminé en utilisant le réactif chimique
DSS qui réagit avec les groupes amines primaires (principalement, les chaînes latérales des
lysines ; Figure 10A). Le DSS crée une liaison covalente entre deux protéines si celles-ci sont
en proximité (moins de 12 Å). Il en résulte un produit de cross-link. Les produits de cross-link
contenant la protéine SRP14 et une protéine ribosomique ont été détectés par western blotting
avec des anticorps anti-SRP14 purifiés par affinité et sont nommés 14-X. La lettre X est suivi
d’un nombre indiquant la taille apparente (en kDa) de la protéine cross-linkée à SRP14 (Figure
10B). Pour former des « targeting complexes », des complexes Ribosome-Chaîne naissante
(RNC) ont été formés dans du lysat de reticulocyte de lapin par la traduction d’un ARN
messager tronqué codant les 86 premiers acides aminés de la préprolactine, une protéine
sécrétée (Figure 11a). Les RNCs stables ainsi formés exposent la séquence signal de la
préprolactine au site de sortie de la chaîne naissante. Finalement, ces RNCs ont été incubés
dans des conditions de basse concentration en sel ([KOAc] = 50 mM) avec du SRP purifié dans
des conditions natives du pancréas de chien. Les « targeting complexes » ainsi formés ont été
traités avec du DSS et les produits de cross-link contenant SRP14 détectés par western blotting
(Figure 12A, colonne 11). Cinq produits de cross-link SRP14 ont été détectés. Le plus petit
était un produit de cross-link attendu SRP14-SRP9 (14-X9). Les quatre autres produits de
cross-link représentaient probablement des produits de cross-link SRP14 avec des protéines
ribosomiques de 17, 20, 31 et 45 kDa (14-X17, 14-X20, 14-X31 et 14-X45, respectivement).
Ceci a démontré expérimentalement pour la première fois que le domaine Alu est en proximité
de composants ribosomiques dans le « targeting complex ».
Afin de prouver que le cross-link a quatre protéines ribosomiques représentaient la localisation
du domaine Alu dans le « targeting complex », l’analyse par cross-linking a été effectué dans
des conditions de haute concentration en sel ([KOAc] = 500 mM) dans lesquelles seul le
« targeting complex » peut être formé (Figure 13A). Les quatre produits de cross-link avec les
protéines ribosomiques de 17, 20, 31 et 45 kDa ont pu être détectés dans ces conditions,
confirmant que ces produits de cross-link représentent bien la localisation du domaine Alu dans
le « targeting complex ». D’une manière intéressante, ce résultat suggère aussi que le domaine
Alu est fermement maintenu en proximité du ribosome dans le « targeting complex » car la
production des produits de cross-link SRP14 avec le ribosome n’était pas dramatiquement
réduite dans ces conditions stringentes (environ 40% de réduction seulement).
L’analyse par cross-linking dans des conditions de basse concentration en sel a été répétée avec
des RNCs purifiés d’un extrait de germe de blé (Figure 12C). Dans les complexes
SRP-ribosome,  SRP14  était  cross-linkée  à  des  protéines  ribosomiques  de  tailles  similaires  à
celles cross-linkées dans les ribosomes mammifères, indiquant que ces protéines ont été
conservées durant l’évolution.
Afin de prouver que les quatre protéines cross-linkées à SRP14 sont bien des protéines
ribosomiques, les « targeting complexes » traitées au DSS ont été dissociées en sous-unités 40S
et 60S par traitement avec la puromycin et une haute concentration en sel ([KOAc] = 500 mM).
Les sous-unités ont été purifiées par sédimentation sur un gradient de sucrose et analysées par
western blotting avec les anticorps anti-SRP14. Des conditions de cross-linking ont dues être
trouvées pour minimiser la formation de liaisons covalentes entre les sous-unités (Figure 14).
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Dans les « targeting complexes » traités avec DSS, 14-X31 était associé avec la petite
sous-unité ribosomique, alors que 14-X20 et 14-X45 étaient associés avec la grande sous-unité
ribosomique (Figure 15A-D). Cette analyse a prouvé que les protéines cross-linkée à SRP14
sont bien des protéines ribosomiques. De plus, leur association avec les deux sous-unités
ribosomiques a démontrée que le domaine Alu est localisée à l’interface des sous-unités
ribosomiques dans le « targeting complex », la seule localisation permettant d’expliquer des
cross-link de SRP14 aux deux sous-unités.
Afin de démontrer la localisation du domaine Alu à l’interface des sous-unités ribosomiques
dans un test plus fonctionnel (ie lorsque SRP arrête effectivement la traduction de la chaîne
naissante), des traductions actives de préprolactine ont été traitées avec le DSS. Les ribosomes
ont été purifiés de ces traductions et analysées par western blotting avec des anticorps
anti-SRP14 pour détecter la formation des produits de cross-link SRP14 (Figure 16). Cette
analyse a démontrée que SRP14 était spécifiquement cross-linkée à quatre protéines
ribosomiques dans les traductions de préprolactine. Les tailles de ces protéines étaient
identiques à celles des protéines ribosomiques cross-linkées à SRP14 dans le « targeting
complex », démontrant que le domaine Alu est bien localisé à l’interface des sous-unités
ribosomiques durant l’arrêt d’élongation.
Afin de préciser la localisation du domaine Alu durant l’arrêt d’élongation, nous avons tiré
avantage de la caractérisation complète des protéines ribosomiques mammifères. Seules deux
protéines ribosomiques peuvent expliquer le produit de cross-link 14-X45 : les protéines L3 et
L4. Ce sont effectivement les deux seules protéines ribosomiques d’une taille supérieure à
36 kDa et elles sont bien associées avec la grande sous-unités ribosomiques. Par contre, seule
la protéine L3 est localisée prêt de l’interface des sous-unités ribosomiques et donc le
cross-link 14-X45 ne peut s’expliquer que par une liaison covalente entre SRP14 et L3. L3 est
localisée à proximité et interagit avec le motif SRL de l’ARN ribosomique 28S, un composant
majeur du site de liaison des facteurs d’élongation (EFs). Donc, le produit de cross-link
14-X45 positionne le domaine Alu en proximité du site de liaison des EFs (Figure 17). Les
autres produits de cross-link peuvent aussi s’expliquer par des liaisons covalentes à des
protéines ribosomiques localisées en proximité du site de liaison des EFs.
2) Afin de prouver expérimentalement que le domaine Alu est bien localisé en proximité
du site de liaison des facteurs d’élongation (EFs) durant l’arrêt d’élongation, l’identité des
protéines ribosomiques cross-linkées à SRP14 doit être déterminée. Pour cela, des anticorps
ont été produits contre différentes protéines ribosomiques de la grande sous-unité, localisées en
proximité du site de liaison des facteurs d’élongation (EFs) et dont la taille peut expliquer les
produits de cross-link SRP14 observés (Figure 18). En analysant des ribosomes de blé ou de
lapin par western blotting avec ces anticorps (Figure 19), des protéines de taille attendues ont
pu être détectées. Sur la base de leur taille apparente déterminée par cette approche, L23, L12
et L3 sont confirmées comme étant de bons candidats pour les protéines ribosomiques de 17,
20 et 45 kDa, respectivement, cross-linkées à SRP14 durant l’arrêt d’élongation. Sur la base de
sa taille apparente, L9 était trop grande pour expliquer le produit de cross-link 14-X20.
Afin d’améliorer la qualité de ces anticorps (en terme de spécificité et de réduction du bruit de
fond), ils ont été purifiés par affinité, soit sur des colonne couplés au peptide utilisé pour
l’immunisation (L23 / Figure 20 et L3 / Figure 21), soit sur membrane de nitrocellulose
chargée avec de la protéine recombinante (L12 / Figure 22). Ces purifications ont permis
d’augmenter la qualité des anticorps.
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Pour identifier les protéines cross-linkées à SRP14 avec ces anticorps purifiés, des
immunoprécipitations des réactions de cross-link doivent être effectuées. Pour détecter les
produits de cross-link après immunoprécipitation, la protéine SRP14 doit être marquée au 35S.
En effet, des problèmes techniques empêchent l’analyse par western blot après
immunoprécipitation dans notre étude. Pour incorporer de la protéine SRP14 marquée dans
SRP, ce dernier doit être désassemblé, puis reconstitué in vitro en présence d’un hétérodimère
SRP9/14 dont la protéine SRP14 a été synthétisée in vitro en présence de methionine 35S.
Malheureusement, le SRP reconstitué ne permettait pas de détecter les produits de cross-link
SRP14 en présence de ribosome (Figure 23). Ceci est probablement dû à un très faible taux de
formation des complexes SRP-ribosome avec le SRP reconstitué.
3) En parallèle à l’analyse par cross-linking des « targeting complexes », des « sampling
complexes » ont été analysés pour déterminer si le domaine Alu est déjà en proximité de
composants ribosomiques durant l’étape de « sampling ». La formation des « sampling
complexes » a été effectuée comme celle des « targeting complexes », sauf que les RNCs ont
été formés par traduction d’un ARN messager tronqué codant pour les 130 premiers acides
aminés de la cyclin, une protéine ne contenant pas de séquence signal. Quand les « sampling
complexes » ont été traités avec le DSS (Figure 12a, colonne 10), des produits de cross-link
SRP14 avec des protéines ribosomiques ont été détectés, démontrant que le domaine Alu est
déjà en proximité de composants ribosomiques durant l’étape de « sampling ». Plus
précisément, la taille identique des protéines cross-linkées à SRP14 dans les « sampling » et
« targeting complexes » a indiqué que le domaine Alu pourrait déjà être localisé prêt du site de
liaison des facteurs d’élongation (EFs) durant le « sampling ». En accord avec cette
interprétation, la protéine de 20kDa impliqué dans le produit de cross-link 14-X20 était
associée avec la grande sous-unité ribosomique dans les deux complexes (Figure 15C et E).
Afin de comparer plus précisément la localisation du domaine Alu dans les deux complexes, les
produits de cross-link 14-X20, 14-X31 et 14-X45 ont été quantifiés (Figure 12B). L’intensité
de 14-X20 ne changeait pas dans les deux cas. Par contre, les intensités de 14-X31 et 14-X45
augmentait de environ 2,5 fois dans les réactions avec les « targeting complexes », indiquant
une différence notable dans l’environnement du domaine Alu après reconnaissance de la
séquence signal. Pour confirmer cette différence dans un test plus fonctionnelle,
l’environnement du domaine Alu dans le ribosome a été comparé lors de la traduction d’une
protéine sécrétée ou d’une protéine non sécrétée (préprolactine et cycline, respectivement ;
Figure 16). Cette analyse a confirmé que le domaine Alu est proche de composants
ribosomiques durant l’étape de « sampling » et que son environnement change après la
reconnaissance de la séquence signal.
4) Nos analyses par cross-linking sont compatibles avec l’idée que le domaine Alu
interagit avec le ribosome lors des deux premières étapes du cycle d’adressage à la membrane
du reticulum endoplasmique. Comme SRP et le ribosome sont d’anciens complexes
ribonucléoprotéiques, il est probable que leurs interactions fonctionnelles impliquent des
domaines ou des motifs conservés. Ainsi, dans le domaine Alu,  SRP14  est  un  bon  candidat
pour une interaction fonctionnelle avec le ribosome durant l’arrêt d’élongation. En effet, son
domaine C-terminal conservé (Figure 9) est spécifiquement requis pour l’arrêt d’élongation et
pourrait interagir avec l’ARN ribosomique à cause de sa nature extrêmement basique. De plus,
il n’est pas ordonné dans la structure du domaine Alu (Figure 7) et est donc accessible pour des
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interactions. Comme le domaine Alu est localisé à proximité de site de liaison des facteurs
d’élongation (EFs) durant l’arrêt d’élongation, des motifs conservés de l’ARN ribosomique de
ce  site  pourrait  être  contacté  par  le  domaine  C-terminal  de  SRP14.  L’ARN  28S  contient
effectivement deux motifs conservés localisés dans le site de liaison des EFs et requis pour
leurs fonctions : le motif LGAR et le motif SRL (Figure 24). Les deux motifs interagissent
avec les EFs et leur liaison transitoire par le domaine C-terminal de SRP14 durant l’arrêt
d’élongation pourrait empêcher la liaison des EFs au ribosome, interférant ainsi avec
l’élongation de la chaîne naissante. Pour étayer cette hypothèse, la capacité de l’hétérodimère
SRP9/14 de lier des petits ARNs synthétiques représentants les motifs LGAR et SRL a été testé
dans une approche dite « ribosome en pièce ». La formation de complexe a été détectée par
chromatographie par exclusion de taille dans des conditions permettant la détection de
complexes  transitoires  ([KCl]  =  100  mM).  Un  ARN  contrôle  a  été  utilisé,  qui  ne  devrait  pas
lier  SRP9/14.  Ces  conditions  permettaient  la  détection  du  complexe  formé  du  petit  ARN
synthétique LGAR et de la protéine ribosomique qui lui est associé, L12 (Figures 25-27). Cette
analyse a révélé que la protéine SRP9/14 a une affinité significative pour tous les ARNs
synthétiques testés (Figures 28-31). Cette affinité ne dépend pas de la présence du domaine
C-terminal de SRP14 car un hétérodimère contenant une protéine SRP14 tronquée de ce
domaine après le résidu K95 (Figure 9 ; hétérodimère SRP9/14K95) était toujours capable de
lier ces ARNs synthétiques (Figure 32). De même, l’inactivation du domaine de liaison à
l’ARN SRP n’affectait pas la liaison à ces ARNs (Figure 33). En conclusion, la protéine
SRP9/14 semble posséder un autre domaine qui pourrait interagir avec l’ARN.
5) L’analyse par cross-linking des complexes SRP-ribosome lors de l’étape de
« sampling » a révélé que le domaine Alu est en proximité de composants ribosomiques. Ceci
suggère que le domaine Alu pourrait contacter le ribosome. Afin de tester cette possibilité, une
particule ribonucléoprotéique (RNP) mimant le domaine Alu de  SRP  (le  RNP Alu151,
comprenant l’ARN Alu151 (Figure 8C) lié à l’hétérodimère SRP9/14) a été testée pour sa
capacité à lier le ribosome. Dans ce test de liaison au ribosome in vitro (Figure  34),  le  RNP
Alu151 ne liait pas le ribosome. L’ARN Alu151 seul ne liait pas plus le ribosome (Figure 35).
Par contre, l’hétérodimère SRP9/14 seul liait le ribosome (Figure 36A-B), ce qui représentait la
première interaction décrite d’un composant du domaine Alu avec le ribosome. Comme
déterminé par une analyse par cross-linking (Figure 37), SRP9/14 lie le ribosome en proximité
d’une protéine de 18 kDa. Cette protéine est associée avec la petite sous-unité ribosomique
(Figure 38). Ce patron de cross-link était différent de celui observé pour les complexes
SRP-ribosome, nous empêchant de conclure que le domaine Alu de SRP et SRP9/14 seule sont
localisés au même site dans le ribosome. En parallèle, l’analyse de la protéine SRP9/14K95
(Figure 36C-D) et de la protéine SRP9/14 dont le domaine de liaison à l’ARN SRP a été
inactivée (Figure 39C-D) a montré que la liaison de SRP9/14 au ribosome ne dépendait pas du
domaine C-terminal de SRP14 ni d’un domaine de liaison à l’ARN SRP actif. En conclusion,
toutes ces observations suggère que SRP9/14 interagit avec le ribosome en proximité d’une
protéine de 18 kDa associée avec la petite sous-unité ribosomique par un domaine qui n’a pas
encore été défini à ce jour. In vivo,  l’interaction  de  SRP9/14  avec  le  ribosome  pourrait  se
produire dans les cellules de primates car elles contiennent un excès de protéine SRP9/14 libre
(non associée avec l’ARN SRP).
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Discussion
1) En analysant les deux premières étapes du cycle d’adressage des protéines sécrétées à la
membrane du reticulum endoplasmique par SRP, de nouveaux aspects du mécanisme utilisé
par SRP pour retarder l’élongation des chaînes naissantes contenant une séquence signal ont pu
être démontrés durant mon travail de thèse. Cet arrêt d’élongation est effectué par le domaine
Alu de SRP. Ce domaine pourrait interagir avec un site du ribosome pour interférer avec le
processus d’élongation. Durant l’élongation, les sites actifs du ribosome sont 1) le site de
liaison des facteurs d’élongation (EFs) ; 2) le centre de décodage de l’ARN messager; 3) le site
A de liaison des ARNs de transfert ; 4) le centre de transpeptidylation et 5) le site E de liaison
des ARNs de transfert. L’interaction de domaine Alu avec un de ces sites pourrait bloquer
l’élongation de la chaîne naissante.
Afin de déterminer le site ribosomique dans lequel le domaine Alu est  localisé  durant  l’arrêt
d’élongation, l’environnement de la protéine SRP14 a été exploré par une analyse de
« cross-linking » avec un réactif chimique durant la synthèse d’une protéine sécrétée (la
préprolactine ; Résultats 1 ; Table I). Cette analyse a démontré que le domaine Alu est localisé
à l’interface des sous-unités ribosomiques durant l’arrêt d’élongation, en accord avec la
localisation  des  différents  sites  actifs  du  ribosome.  Plus  précisément,  le  domaine Alu ne peut
être localisé qu’en proximité du site de liaison des EFs durant l’arrêt d’élongation car SRP14
était cross-linkée à une protéine de 45 kDa associée avec la grande sous-unité ribosomique. La
seule protéine de 45 kDa associée avec cette sous-unité à proximité de l’interface des
sous-unités ribosomiques est L3, une protéine interagissant avec le site de liaison des EFs.
En proximité du site de liaison des EFs, le domaine Alu pourrait interférer avec l’incorporation
des ARNs de transfert dans le ribosome par le facteur d’élongation 1 (EF1), avec la réaction de
transpeptidylation ou avec la réaction de translocation des ARNs de transfert catalysé par EF2.
Comme SRP n’interagit pas avec le ribosome avant la réaction de transpeptidylation, il ne peut
que interférer avec les fonctions des EFs, probablement en les empêchant de se lier au
ribosome. SRP interférerait probablement avec la liaison de EF2, car il peut interagir avec le
ribosome avant la translocation des ARNs de transfert.
En accord avec nos résultats et conclusions, une étude récente par microscopie
cryo-électronique  (Halic et al., 2004) a localisé le domaine Alu dans le site de liaison des EFs
durant l’arrêt d’élongation (Figures 40 et 41).
A notre connaissance, le mécanisme utilisé par SRP pour arrêter l’élongation des chaînes
naissantes (ie reconnaissance d’une séquence spécifique de la chaîne naissante et interférence
avec la fonction des facteurs d’élongation) est original par comparaison avec d’autres
mécanismes de contrôle traductionnel. La plupart de ces mécanismes affectent l’étape
d’initiation de la synthèse protéique. Un mécanisme bloque aussi la liaison de EF2 au
ribosome, mais ceci résulte en un arrêt global de la synthèse protéique. D’autres exemples de
contrôle de l’élongation de protéines spécifiques au niveau de l’étape d’élongation existent
mais diffèrent soit pour le déterminant de la spécificité, soit pour le mécanisme qui bloque
l’élongation. Les micro-RNPs inhibent la synthèse d’ARNs messager spécifiques au niveau de
l’élongation, mais reconnaissent des séquences spécifiques de l’ARN messager. Comment ils
interfèrent ensuite avec l’élongation n’est pas encore déterminé. Des chaînes naissantes
peuvent aussi contrôler leur propre élongation (par exemple, SecM). Elles contiennent des
motifs spécifiques reconnus par le ribosome. Cependant, leur élongation est interrompue au
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niveau de la réaction de transpeptidylation. Finalement, l’ARN messager Hac1 peut aussi
interrompre sa propre traduction au niveau de l’élongation en faisant des appariements de
paires de bases entre ses régions 5’ et 3’ non traduites. Dans ce cas, l’élongation est
interrompue par le piégeage des ribosomes sur l’ARN messager. En conclusion, des
déterminants des chaînes naissantes et des ARNs messager peuvent spécifier un arrêt
d’élongation. L’arrêt peut être effectué de différentes façons. Le mécanisme utilisé par SRP est
donc un exemple original d’un de ces contrôles traductionnels au niveau de l’élongation.
2) L’arrêt d’élongation effectué par SRP n’est enclenché qu’en présence d’une séquence
signal dans la chaîne naissante. Pour « goûter » les chaînes naissantes afin de déterminer si
elles contiennent une séquence signal, SRP peut interagir transitoirement avec tous les
ribosomes engagés dans le processus de traduction. Le domaine Alu est requis pour la
formation de ce complexe transitoire, peut-être pour une interaction avec le ribosome. Cette
hypothèse implique que le domaine Alu doit être en proximité du ribosome dans le complexe
transitoire. L’analyse de la localisation du domaine Alu durant la synthèse d’un protéine non
sécrétée (la cyclin) par cross-linking (Résultats 3 ; Table I) supporte cette hypothèse car SRP14
se trouvait en proximité de composants ribosomiques. Une interaction du domaine Alu avec le
ribosome n’a pas pu être démontrée dans un test de liaison au ribosome in vitro avec  une
particule ribonucléoprotéique mimant le domaine Alu de SRP (Résultats 5), peut-être à cause
des conditions expérimentales. Alternativement, le domaine Alu pourrait ne pas interagir avec
le ribosome. Sa localisation dans le ribosome serait assurée par sa connexion avec le domaine S
qui, lui, interagit avec le ribosome dans le complexe transitoire.
La comparaison de la localisation du domaine Alu dans le ribosome durant la synthèse d’une
protéine sécrétée (la préprolactine) et d’une protéine non sécrétée (la cyclin) a révélé un
changement dans la localisation du domaine Alu après reconnaissance de la séquence signal
(Table I). Alors que SRP14 n’était cross-linkée qu’à une protéine de 20 kDa durant la synthèse
de la cyclin, elle était cross-linkée à quatre protéines durant la synthèse de la préprolactine. Ces
changements pourraient être expliqués par une réorientation du domaine Alu dans le ribosome
après reconnaissance de la séquence signal. En effet, l’analyse de complexes transitoires
SRP-ribosome par cross-linking (Résultats 2) a démontré que le domaine Alu pourrait déjà être
localisé à proximité du site de liaison des EFs.
Pour que la localisation du domaine Alu en proximité du site de liaison des EFs soit changée
après reconnaissance de la séquence signal, un signal doit être transmis depuis le domaine S
qui reconnaît la séquence signal. Ce signal pourrait être transmis via un changement de
l’orientation de deux charnières de la partie centrale de l’ARN SRP (h1 et h2)  après
reconnaissance de la séquence signal, ce qui modifierait la position du domaine Alu par rapport
au ribosome.
3) La localisation du domaine Alu en proximité du site de liaison des facteurs d’élongation
(EFs) durant l’arrêt d’élongation supporte l’idée d’une interaction fonctionnelle avec le
ribosome durant l’arrêt d’élongation. SRP14 est un bon candidat pour une interaction
fonctionnelle, car son domaine C-terminal est spécifiquement requis pour l’arrêt d’élongation.
De plus, il a été conservé durant l’évolution, est accessible pour des interactions dans la
structure du domaine Alu et pourrait interagir avec des motifs conservés de l’ARN ribosomique
dans  le  site  de  liaison  des  EFs.  Deux  motifs  conservés  de  l’ARN  ribosomique  28S  sont
impliqués dans la liaison des EFs au ribosome: le motif LGAR et le motif SRL. Une interaction
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transitoire du domaine C-terminal de SRP14 avec ces motifs pourrait interférer avec la liaison
des EFs au ribosome. Pour tester cette hypothèse, des petits ARNs synthétiques reproduisant
ces motifs de l’ARN ribosomique 28S ont été testés in vitro pour leur interaction avec SRP9/14
dans  un  test  dit  «  ribosome  en  pièces  »  (Résultats  4).  Cette  analyse  a  révélé  une  affinité
significative de SRP pour tous les ARNs synthétiques testés. Cette affinité n’était pas
dépendante du domaine C-terminal de SRP14. Cependant, pour des raisons techniques, une
interaction de ce domaine avec l’ARN ribosomique n’a pas pu être exclue.
Nos deux études de liaison in vitro (Résultats 4 et 5) ont suggéré que l’hétérodimère SRP9/14
pourrait contenir un domaine de liaison à l’ARN non défini jusqu’à ce jour. Ce domaine
pourrait impliquer la surface formée par les hélices ? de SRP9/14 (Figure 6A). De plus, SRP9
et SRP14 ressemblent au domaine dsRBD qui lie les ARNs double brin par ses hélices ?
(Figures 6B et 7C). La surface en hélices ? de SRP9/14 est accessible pour des interactions
dans la structure du domaine Alu (Figure 7A). Elle contient des résidus basiques qui pourraient
interagir avec l’ARN (Figure 6C). Une telle interaction pourrait se produire durant l’arrêt
d’élongation (Figure 42) car, dans le complexe SRP-ribosome, cette surface pourrait être
localisée à proximité de l’ARN ribosomique 18S. Finalement, une interaction de la surface
formée par les hélices ? de SRP9/14 avec une molécule d’ARN a déjà été observée dans la
structure du domaine Alu (Weichenrieder et al., 2000). Dans cette structure, un hétérodimère
SRP9/14 était lié aux boucles L1.2 et L2 de l’ARN Alu par  cette  surface  (Figure  43).  Il  est
possible, finalement, que SRP9/14 dans le complexe SRP9/14-ribosome (Résultats 5) se lie par
sa surface  en hélices ? comme observé dans le complexe SRP-ribosome (Figure 42A). En
effet, le cross-link avec la protéine de 18 kDa associée avec la petite sous-unité ribosomique
dans le complexe SRP9/14-ribosome peut s’expliquer par une liaison covalente à la protéine
S23 (Figure 44), localisée à proximité de SRP9/14 dans le complexe SRP-ribosome.
Pour terminer, un rôle pour l’ARN Alu n’a pas été démontré durant ce travail, bien que
l’accessibilité au solvant des boucles L2 et L1.2 dans la structure du domaine Alu (Figure 7A) a
suggéré qu’elles pourraient jouer un rôle durant l’arrêt d’élongation. Leur taille et leur forme
ne sont pas conservées (Huck et al., 2004). Cette observation  ne supporte pas l’idée qu’elles
interagissent avec le ribosome. Par contre, elles pourraient simplement remplir l’espace entre
les sous-unités ribosomiques durant l’arrêt d’élongation et ainsi prévenir physiquement l’entrée
des facteurs d’élongation dans le ribosome.
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The signal recognition particle (SRP) is a cytoplasmic ribonucleoprotein complex required for
the co-translational targeting of secretory proteins to the endoplasmic reticulum (ER)
membrane.  SRP  consists  of  one  RNA  molecule  (the  SRP  RNA)  bound  to  six  polypeptides
(SRP9, SRP14, SRP19, SRP54, SRP68 and SRP72) and it can be divided into two domains:
the S domain and the Alu domain. During the synthesis of secretory proteins, SRP recognizes a
specific portion of the growing nascent chain: the signal sequence. To do that, SRP interacts
transiently with all translating ribosomes to sample their growing nascent chain. The formation
of the transient complex requires the Alu domain of SRP. As soon as a signal sequence
emerges from the ribosome, it is bound by the S domain and, subsequently, the Alu domain
arrests the elongation of the growing nascent chain. Finally, the elongation-arrested
SRP-ribosome-nascent chain complex is targeted to the ER membrane where the
co-translational translocation of the secretory protein is achieved.
I have been interested in understanding how the Alu domain of SRP arrests the elongation of
the growing nascent chain. The Alu domain of SRP consists of the Alu sequences of the SRP
RNA bound to the SRP9-SRP14 heterodimer (SRP9/14). During elongation arrest, it most
likely  interacts  with  a  functional  site  of  the  ribosome.  To  determine  the  functional  site,  we
probed the ribosomal environment of SRP14 in functional SRP-ribosome complexes by
chemical cross-linking. The results demonstrated that the Alu domain was stably located in
close proximity to the elongation factor-binding site (EF-binding site) during elongation arrest,
supporting the old notion that the Alu domain  might  interact  with  this  site  to  arrest  the
elongation  of  the  growing  nascent  chain.  I  therefore  proposed  a  peculiar  mechanism  for  the
elongation arrest: SRP might interfere with the binding of the EFs to the ribosome upon
recognition of a signal sequence in the growing nascent chain.
Interestingly, the results also indicated that the Alu domain might already be located in close
proximity to the EF-binding site during the sampling of the growing nascent chain. In fact, in
the sampling and targeting complexes, SRP14 was in close proximity of ribosomal proteins
with identical sizes. However, upon signal sequence recognition, we observed a change in the
ribosomal environment of SRP14. Moreover, the Alu domain was stabilized in its ribosomal
location. These observations suggested that the location of the Alu domain in the ribosome is
affected by signal sequence recognition. The location of SRP14 in close proximity to
ribosomal proteins was also the first experimental evidence for an interaction between the Alu
domain and the ribosome during the sampling of nascent chain.
Our cross-linking analyses supported the notion that the Alu domain interacts with the
ribosome. In this hypothesis, the C-terminal domain of SRP14 was a good candidate for a
functional interaction as it is specifically required for elongation arrest. In a “ribosome-in
pieces” assay, the ability of the SRP9/14 heterodimer to form complexes with fragments of the
28S rRNA making up the EF-binding site was assayed. SRP9/14 had a significant affinity for
all  the  assayed  RNAs,  independently  of  the  C-terminal  domain  of  SRP14.  In  an in vitro
ribosome-binding assay, SRP9/14 alone interacted with the ribosome in close proximity to an
18 kDa protein associated with the small ribosomal subunit, revealing for the first time an
interaction between a component of the Alu domain  and  the  ribosome.  As  in  the
“ribosome-in-pieces” assay, the interaction was independent of the C-terminal domain of
SRP14. Both assays suggested that an as yet undefined region of the heterodimer SRP9/14
might interact with the ribosomal RNA. I discussed the functionality of this hypothesis in the
light of recently published data.
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1 From genes to proteins
The genetic material, ie the sum of the genes carried by the DNA molecule of an organism, has
two main characteristics: it can be faithfully reproduced so that it is inherited generation after
generation and it can transfer information for protein biosynthesis (Lewin, 1997).
Proteins are the main cellular structures responsible for enzymatic and structural activities,
although RNAs play important roles, too. Each protein folds into a defined molecular structure
required for its activity. The structure is dictated by the amino acid sequence of the protein.
The information contained in the genes (at the level of its DNA sequence) specifies the amino
acid sequence of the protein. The genes therefore specify the molecular structure of proteins.
Very briefly (Figure 1), how is the genetic information (encoded by DNA) “translated” into a
protein sequence (composed of amino acids)? Genes used for the synthesis of proteins are
transcribed into messenger RNAs (mRNAs). Then the mRNA sequence is translated into a
protein sequence. This translation step is carried out by cellular organelles called ribosomes
that use the genetic code for the biosynthesis of proteins.
Figure 1: Transfer of information for protein biosynthesis from the genetic material (adapted from Lewin, 1997). The
main steps for the biosynthesis of proteins from the genetic material are depicted. Note that the order of events may differ for
different proteins.
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2 Localization of proteins
The  eukaryotic  cell  is  a  very  complex,  well-organized  ultra-structure  (Figure  2).  It  is
circumscribed by the plasma membrane. Its intracellular space is divided into several
compartments (endoplasmic reticulum, cytosol, mitochondria …) carrying out specific cellular
functions. The correct localization of a protein is therefore as important as its structure for its
function. Impairment of the localization of a protein may lead to disorder in the cell machinery
and diseases (Marr et al., 2002).
Each compartment of the cell is soaked in the cytosol and is circumvented by a membrane. The
ribosomes  are  cytosolic  organelles.  Thus  the  biosynthesis  of  a  protein  (e.g.  a  lysosomal
protease) always starts in this compartment. To reach the cognate compartment where it exerts
its function (in this case, the lysosome), the protein has to be translocated across a membrane
(Blobel, 1980). In eukaryotic cells, proteins localized in the endoplasmic reticulum, the Golgi,
the lysosomes, integrated into the plasma membrane or secreted outside of the cell (termed
“secretory proteins”) are translocated across the membrane of the endoplasmic reticulum (ER;
Walter et al., 1984). Once in the lumen of the ER, they are routed to the accurate compartment
via the secretory pathway.
Figure 2: The compartmentalization of a eukaryotic cell (adapted from Alberts et al., 1994). The main sub-cellular compartments
of a typical animal cell are indicated on this cartoon of a thin section.
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3 The co-translational translocation in higher eukaryotes
In higher eukaryotes, the translocation across the ER membrane is a co-translational process,
occurring concomitantly with the biosynthesis of secretory proteins. Secretory proteins possess
a specific N-terminal extension, termed “signal sequence” (Martoglio and Dobberstein, 1998).
Signal  sequences  share  a  common  tripartite  structure  (Figure  3).  Ribosomes  translating  a
secretory protein are co-translationally targeted to the ER membrane as soon as the signal
sequence is exposed at the surface of the ribosome (Figure 4A, steps 1 to 4). At the ER
membrane, they are docked onto the translocon, the protein-conducting channel embedded in
the ER membrane (Figure 4A, step 4; Johnson and van Waes, 1999). At this stage, proteins are
synthesized into the translocon and reached the lumen of the endoplasmic reticulum
(Figure 4A, step 4).
Two factors required for co-translational targeting were isolated through elegant biochemical
experiments (Walter et al., 1984). The signal recognition particle (SRP) is an 11S cytoplasmic
ribonucleoprotein complex (Keenan et al., 2001). SRP recognizes the signal sequence
presented by the ribosome and is subsequently loaded with GTP (Figure 4A, step 2).  This
SRP-Ribosome nascent chain (RNC) complex is then targeted to the ER membrane by a
GTP-dependent interaction with the second factor required for co-translational targeting: the
SRP receptor (SR; step 3). Once the complex is formed, the RNC is docked onto the translocon
(step 4). Finally, SRP and SR hydrolyze GTP in a concerted manner and are free to engage
new targeting cycles.
Figure 3: The tripartite structure of signal sequences (adapted from Martoglio and Dobberstein, 1998). Signal
sequences can be divided into three domains of different length and composition. “n”: Hydrophilic N-terminal region,
containing positive charge, 15-50 amino acids. “c”: Polar C-terminal region, 5-6 amino acids. “h”: Hydrophobic core, 6-12
amino acids (characteristics from Spahn et al., 2004; von Heijne, 1985).
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Figure 4: The SRP targeting cycle. A) A schematic drawing of the complete SRP targeting cycle (adapted from Keenan et al.,
2001). The signal sequence exposed by the ribosome is highlighted in yellow. SRP and SR in their GTP- or GDP-bound state are
indicated as T or D, respectively. See text for details. B) The two first steps of the SRP targeting cycle (1 and 2 in A; adapted
from Powers and Walter, 1996). Ribosome-nascent chain complexes (RNCs) are in yellow. The signal sequence is depicted as a
winding line. The affinities of the SRP-RNC complexes are from Flanagan et al., 2003 and were determined with the following
nascent chains: the first 84 amino acids of globin (sampling complex); the first 86 amino acids of preprolactin (targeting
complex).
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4 The first steps of ER targeting
We have been mainly interested in the first steps of the SRP cycle leading to the formation of a
SRP-RNC complex primed for docking at the membrane (Figure 4B). SRP has a salt-sensitive,
low affinity for all ribosomes engaged in protein synthesis (Bacher et al., 1996; Flanagan et al.,
2003; Powers and Walter, 1996; Walter et al., 1981). They can therefore form a transient
complex, termed the “sampling complex”. In the complex, SRP is in the proximity of the
nascent chain (Hauser et al., 1995). It was therefore proposed that the role of this complex is to
allow SRP to sample the nascent chain for the presence of a signal sequence (Ogg and Walter,
1995). As soon as a signal sequence emerges from the ribosome, it is recognized by SRP
(Jungnickel and Rapoport, 1995; Walter and Blobel, 1981) and the affinity of the SRP-RNC
complex increases remarkably (Bacher et al., 1996; Flanagan et al., 2003; Powers and Walter,
1996; Walter et al., 1981). Finally, this stable complex, termed the “targeting complex”, is
targeted to the ER membrane by the interaction between SRP and its receptor.
Figure 5: The signal recognition particle. A) Schematic structure of mammalian SRP (Wild et al., 2002). SRP RNA is represented by a
dark line. The localization of the SRP proteins are indicated by coloured areas. M and NG indicate the M and NG domains of SRP54,
respectively. “S”: S domain. “Alu”: Alu domain. The dotted line indicates the site of enzymatic cleavage between the Alu and S domains.
B) The Alu domain and SRP54 are located at the opposite extremities of SRP. The structures of the Alu domain (Weichenrieder et al.,
2000) and of the S domain (Wild et al., 2001) were placed in the envelope of an electron microscopy image (top left) obtained from the
mammalian SRP (Andrews et al., 1985). SRP54 is represented by the NG domain of the T. aquaticus homologue (T. aquaticus Ffh NG
domain) and by the M domain of the E.coli homologue bound to helix 8 (E.coli M-domain-helix 8). A putative location for the SRP68/72
heterodimer is indicated, as well as the boundary between the Alu and S domains. Modified from Wild et al., 2002.
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Upon signal sequence recognition, SRP slows down the elongation of the nascent chain (Wolin
and Walter, 1989; Mason et al., 2000). In a heterologous system (an in vitro translation system
based on wheat germ extract supplemented with canine SRP), a complete arrest of elongation
was previously observed (Walter and Blobel, 1981). Hence the targeting complex is an
elongation-arrested complex and this activity of SRP was termed “elongation arrest”.
Elongation arrest was proposed to increase the time window during which the nascent chain
remains in a translocation-competent state (Flanagan et al., 2003; Siegel and Walter, 1988a). In
agreement with this proposal, the lack of elongation arrest decreases the translocation
efficiency in vitro (Mason et al., 2000; Thomas et al., 1997). In vivo, it is required for the tight
coupling of translation and translocation (Mason et al., 2000).
Figure 6: The structure of the SRP9/14 heterodimer. A) Two different views of the free SRP9/14 heterodimer. SRP9 is coloured in red,
SRP14 in green. The N- and C-termini of SRP9 and SRP14 are indicated with the same colour code. These views were prepared with the
Swiss-PdbViewer using the PDB file 1914 (Birse et al., 1997). B) A comparison between the structure of SRP9 (Birse et al., 1997) and the
structure of the second dsRBD of X. laevis RNA-binding protein A (Ryter and Schultz, 1998). The N-terminal and C-terminal ?-helices
are coloured in blue and red, respectively. Modified from Wild et al., 2002. C) The location of basic electrostatic potential on the surface
of the heterodimer SRP9/14. The electrostatic potential of the heterodimer SRP9/14 was calculated using the program GRASP (Birse et
al., 1997). The positive electrostatic potential is coloured in blue. Red: negative electrostatic potential. White: neutral electrostatic
potential. The views represent the ?-sheet surface (left) and the ?-helical surface (right) of the heterodimer. N and C indicate the N- and
C-termini of SRP9 (red) and SRP14 (red).
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5 The mammalian Signal Recognition Particle
The mammalian SRP is composed of a small RNA of 300 nucleotides, SRP RNA, and six
polypeptides named according to their apparent molecular mass (SRP9, SRP14, SRP19,
SRP54, SRP68, SRP72; Figure 5A). It is a rod-shaped particle 5-6 nm wide and 23-24 nm long
(Figure 5B; Andrews et al., 1985) that can adopt different conformations during the SRP cycle
(Andreazzoli and Gerbi, 1991). SRP can be enzymatically divided in two functional domains:
the S domain and the Alu domain  (Gundelfinger  et  al.,  1983).  The  S  domain  comprises  the
central part of SRP RNA (nucleotides 100-250 of canine SRP RNA) and SRP19, SRP54,
SRP68  and  SRP72  proteins.  The  5’  and  3’  ends  of  SRP  RNA,  as  well  as  SRP9  and  SRP14
proteins, are located in the Alu domain. A complete particle is required to mediate the efficient
co-translational translocation of secretory proteins (Siegel and Walter, 1985; Siegel and
Walter, 1986).
5.1 The S domain of SRP
SRP54 is a key component of SRP. Indeed it is universally conserved (Luirink and Sinning,
2004) and is sufficient and necessary for signal sequence binding (Lutcke et al., 1992; Siegel
and Walter, 1988b; Zopf et al., 1993). It binds signal sequence and SRP RNA through its
C-terminal methionine-rich domain (M domain in Figure 5; Lutcke et al., 1992; Lutcke, 1995;
Zopf  et  al.,  1990).  SRP54  is  also  the  GTPase  of  SRP.  Its  N-terminal  and  central  GTPase
domain (NG domain in Figure 5) interacts wit the SR (Keenan et al., 2001; Rapiejko and
Gilmore, 1997). Interestingly, the NG domain might also be implicated in signal sequence
recognition (Cleverley and Gierasch, 2002). In conclusion, SRP54 is responsible for both
signal sequence recognition and targeting activities of SRP (Figure 5A). SRP54 alone interacts
with the ribosome in proximity to the nascent chain exit site, most likely at the L23/L23a
protein (Gu et al., 2003; Pool et al., 2002; Pool, 2003). At this position, it can bind the signal
sequence and discriminate it from a non-signal sequence (Hauser et al., 1995). Finally, a
ribosomal  component  stimulates  GTP  binding  to  SRP54  (Bacher  et  al.,  1996).  However,
SRP54 alone is not sufficient to promote translocation (Hauser et  al.,  1995).  It  has to be in a
complex  with  SRP  RNA-helix  8  (Figure  5B)  to  promote  the  translocation  of
elongation-arrested RNC in a GTP-controlled manner (Hauser et al., 1995). In agreement, both
SRP54 and SRP RNA are necessary and sufficient for the interaction with the SR (Miller et al.,
1993).
However, SRP54 and SRP RNA-helix 8 are not sufficient to promote the efficient
co-translational translocation of secretory proteins (Hauser et al., 1995). In this case, a
complete SRP is required. From this point of view, the other components of the S domain, as
well  as the ones of the Alu domain (see below), are required for the efficient coupling of the
translation and translocation processes. SRP19 is required for the assembly of SRP54 into the
particle (Lutcke, 1995). SRP68/72 functions in the docking process at the membrane (Siegel
and Walter, 1988b). Finally, a complete SRP is required for the formation of sampling complex
(Powers and Walter, 1996).
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5.2 The Alu domain of SRP
SRP9 and SRP14 proteins form a heterodimer in the absence of SRP RNA (termed SRP9/14;
Strub and Walter, 1990). SRP9 and SRP14 are structurally homologous, containing the same
????????? fold. Hence the heterodimer consists of a six-stranded anti-parallel ?-sheet stacked
against four ?-helices (Figure 6A; Birse et al., 1997). SRP9 and SRP14 resemble the double
stranded RNA-binding domain (dsRBD; Ryter and Schultz, 1998), although the connectivity of
the ?-helices and their stacking with ?-strands as well as the organization and orientation of the
loop regions are different are different (Figure 6B). However, the heterodimer does not interact
with the Alu sequences  of  SRP RNA (Figure  8A;  Strub  et  al.,  1991)  as  the  dsRBD interacts
with dsRNA. Indeed, the dsRBD contacts dsRNA by residues of its ?-helical surface (Figure
7C; Ryter and Schultz, 1998), whereas the heterodimer SRP9/14 binds specifically to the Alu
sequences of SRP RNA via its concave ?-sheet surface (Figure 7A; Weichenrieder et al.,
2000), as suggested by the positive electrostatic potential of this surface (Figure 6C; Birse et
al., 1997).
The Alu sequences of SRP RNA consist of two short hairpins (helices III and IV) connected by
a conserved single-stranded region on one side (U-turn) and by the central stem (helix V) on
the other side. The portion of the Alu sequences comprising the regions that become
inaccessible to chemical modification upon SRP9/14 binding (Figure 8A; Strub et al., 1991)
together with the 3’ complementary strand in the central stem is sufficient for high-affinity
binding of the heterodimer (Figure 8B; Weichenrieder et al., 1997). It can be separated into a
5’ domain, comprising the first 47 nucleotides of SRP RNA, and a 3’ domain. The 5’ domain
contains the primary binding site for the protein. It consists of two helical stacks connected by
the  central  U-turn,  a  structural  motif  termed the  ?-junction  (Figure  7B;  Weichenrieder  et  al.,
2000). Base-pairing occurs between the loops of helices III and IV (L2 and L1.2, respectively,
in  Figures  7B  and  8A).  The  heterodimer  SRP9/14  specifically  interacts  with  the  core  of  the
?-junction (the U-turn motif) on the opposite side of the interacting loops (Figure 7B). In a
model for the native Alu domain, the SRP9/14 heterodimer induces the RNA to fold back onto
itself and places the 3’ domain side-by-side with the 5’ domain (Figure 7A).
5.3 The functions of the Alu domain
The Alu domain  of  SRP  is  specifically  required  for  the  elongation  arrest  activity  of  SRP
(Mason et al., 2000; Thomas et al., 1997). The molecular mechanism is not currently
understood (Introduction 5.4). However, the Alu domain most likely contacts the ribosome
upon signal sequence recognition by SRP54. A component of the Alu domain  that  was
proposed to specifically interact with the ribosome during elongation arrest is SRP14. It might
contact the ribosome by its highly conserved, basic C-terminus (Figure 9) that is not ordered in
the crystal structure of the Alu domain (Figure 7A). Indeed SRP particles containing SRP14
truncated after residue 90 (Figure 9) were unable to arrest the elongation of a secretory protein
nascent chain, whereas they remained unaffected for signal sequence recognition, targeting and
sampling  complex  formation  (Mason et  al.,  2000;  Thomas  et  al.,  1997).  The  essential  region
was located between residues M91 and K100. Indeed SRP particles containing the mouse
SRP14 truncated after residue K100 were fully active (Bovia et al., 1994). Complementary
analyses with human SRP14 confirmed these observations and further refined the critical
region to residues K96 to K100 (Figure 9; Huck L., Terzi L. and Strub K., unpublished results).
The heterodimer SRP9/14 is also required for the formation of the sampling complex (Hauser
et al., 1995; Powers and Walter, 1996; Siegel and Walter, 1986).
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Figure 7: The structure of the Alu domain (adapted from Weichenrieder et al., 2000, Huck et al., 2004 and Wild et al., 2002).
A) Two different views of a model Alu RNP in its fully folded, physiological conformation (Weichenrieder et al., 2000). SRP9 is coloured
in red, SRP14 is coloured in green. The N- and C-termini of SRP9 and SRP14 are indicated with the same colour code. Residues after
lysine  95  of  SRP14 (K95;  see  Figure  9)  were  not  ordered  in  the  crystal.  The  5’  and  3’  ends  of  SRP RNA are  indicated,  as  well  as  the
hydroxyl radical footprints of SRP9/14 on SRP RNA in magenta (Strub et al., 1991) and the loops of the helices H3 and H4 (L2 and L1.2,
respectively). Yellow balls indicate cysteines in the heterodimer SRP9/14. B) A close up view of the base-pairing between loops L2 and
L1.2 (right). The structure of the SRP Alu 5’ domain is presented on the left. SRP9 and SRP14 are coloured in grey. The nucleotides from
loops L2 and L1.2 that are involved in tertiary base pairing between the loops are shown as wire frame and are enlarged in a close up view
on the right. Bases G13, G14 and C15 form hydrogen bonds with C37, C34 and G33, respectively. One base from each loop, G16 and
A36, extend the stack formed by the three base pairs. C) The dsRBD interacts with dsRNA through residues located in its ?-helices (Ryter
and Schultz, 1998). The Xlrbpa-2 dsRBD is shown as a ?-carbon trace in purple. The side chains residues interacting with the dsRNA
(Regions 1, 2 and 3) are depicted in grey and green. Red: oxygen atoms; Blue: nitrogen atoms; Yellow: phophorus. The black lines
indicate the hydrogen bonds.
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Figure 8: The secondary structure of the Alu sequences of SRP RNA. The RNA helices (labelled H) are numbered according to Zwieb et
al., 2005. A) The secondary structure of the human SRP RNA in the Alu domain is presented whereas the sequence of the SRP RNA in the
S domain (from nucleotides 101 to 249) was omitted for clarity. The nucleotides that become inaccessible to chemical modification upon
SRP9/14 binding are coloured in red according to Strub et al., 1991. The nucleotides of loops L1.2 and L2 that are involved in tertiary base
pairing between the loops (Figure 7B) are indicated with arrows. B) The secondary structure of the minimal SRP RNA (SA86 RNA)
sufficient for high-affinity binding of the heterodimer SRP9/14 (Weichenrieder et al., 1997). The 5’ and 3’ domains are indicated as well as
their boundary (vertical line). C) The secondary structure of the Alu151 RNA, comprising the whole sequence of the SRP RNA in the Alu
domain closed by a GUAA tetraloop at the junction with the S domain.
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5.4 The mechanism of the elongation arrest
How does the Alu domain effect elongation arrest? SRP is not expected to inhibit the
transpeptidylation reaction (for a review on ribosome functions, see Wilson et al., 2002) since
it does not productively interact with the ribosome at this stage of translation (Ogg and Walter,
1995). To effect elongation arrest, the Alu domain most likely interferes with the function of
the elongation factors (EFs; Andersen et al., 2003). In agreement with this hypothesis, SRP
productively interacts with the ribosome before the translocation of the tRNA from the A-site
to the P-site (Ogg and Walter, 1995). This movement of the tRNA is catalyzed by EF2. Thus,
to interfere with tRNA translocation, the Alu domain might bind close or at the EF-binding site
and could therefore interfere with their binding to the ribosome. In agreement with its size
(Andrews et al., 1985), SRP can physically bridges the nascent chain exit site, where SRP54 is
located (Gu et al., 2003; Pool et al., 2002) and the EF-binding site. The crystal structure of the
Alu domain did not reveal obvious structural similarities between the Alu domain and
elongation factors or tRNA (Weichenrieder et al., 2000) that would suggest a mimicry-based
mechanism for elongation arrest.
Figure 9: Alignment of residues 91 to 110 (Homo sapiens numbering) of the C-terminal sequences of SRP14 from
various species. The residues specifically required for the elongation arrest activity of SRP are highlighted in yellow. The
residues following lysine 95 (K95) were not ordered in the crystal structure of the Alu domain (Figure 7A).The names of the
species  are  as  follow: O. sativa, Oryza sativa (rice) / A. thaliana, Arabidopsis thaliana (Mouse-ear cress) / S. cerevisae,
Saccharomyces cerevisiae (Baker’s yeast) / S. cerevisae, Saccharomyces cerevisiae (Baker’s yeast) / S. pombe,
Schizosaccharomyces pombe (Fission yeast) / C. elegans, Caenorhabditis elegans / D. melanogaster, Drosophila melanogaster
/ H. sapiens, Homo sapiens. The murine sequence between residues M91 and K100 is identical to the human one.
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6 Aim of this work
Although several studies were published recently on the Alu domain structure and function, the
molecular events that lead to the arrest of nascent chain elongation are still not understood. All
existing data converge to the notion that, upon signal sequence recognition by SRP54 at the
exit  site  of  the  nascent  chain,  SRP  might  position  its Alu domain in the EF-binding site. To
validate  this  hypothesis,  we  aimed  at  determining  the  location  of  the Alu domain in the
ribosome during elongation arrest (Results 1 and 2). In parallel experiments, we also probed
the environment of SRP14 in the sampling complex (Results 3). Both cross-linking analyses
supported the notion that the Alu domain might interact with the ribosome. The heterodimer
SRP9/14  was  a  strong  candidate  for  a  functional  interaction  with  the  ribosome  since  the
C-terminal domain of SRP14 is specifically required for elongation arrest. In a
“ribosome-in-pieces” assay, we looked for functional interactions between SRP9/14 and
fragments of the 28S rRNA making up the EF-binding site (Results 4). In an in vitro
ribosome-binding assay, we looked for functional interactions between SRP9/14 and the
ribosome (Results 5). Finally, we discussed the implications of the results on our understanding
of the mechanism and activation of the elongation arrest activity of SRP, together with recently
published data.
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1 The Alu domain location during elongation arrest
1.1 Strategy
The ribosomes synthesizing secretory proteins must be targeted to the endoplasmic reticulum
(ER)  membrane  to  allow  the  co-translational  translocation  of  the  nascent  chain  across  this
membrane. The selectivity of this process is ensured by the presence of a signal sequence in the
nascent chain. This signal sequence is recognized by the signal recognition particle (SRP). The
SRP54 protein specifically binds the signal sequences exposed at the nascent chain exit site of
the ribosome. Upon signal sequence recognition by SRP54, SRP delays the elongation of the
nascent chain, an activity called “elongation arrest”. Finally, the elongation-arrested
SRP-Ribosome-Nascent chain complex, termed the “targeting complex”, is targeted to the ER
membrane. The Alu domain  of  SRP  is  responsible  for  the  elongation  arrest  activity.  How  it
interferes with the elongation of the nascent chain is unknown. We hypothesized that it might
bind close or at the elongation factor-binding site (EF-binding site) during elongation arrest
(Introduction 5.4).
To validate this hypothesis, we decided to determine the location of the Alu domain in the
targeting complex. We probed the environment of SRP14 using DSS, a homo-bifunctional
cross-linker  that  reacts  with  primary  amino  groups  (mainly  the  side  chain  of  lysines).  If  two
lysines  are  in  close  proximity  (less  than  12  Å)  in  the  targeting  complex,  DSS  may  create  a
covalent bond between them. If the two lysines belong to two different proteins, a cross-link
product is formed (Figure 10A). To detect cross-link products involving SRP14 (SRP14-X in
Figure 10A), the cross-linking reactions were analysed by western blotting using
affinity-purified anti-SRP14 antibodies (Figure 10B). The apparent molecular weight of the
protein cross-linked to SRP14 could be deduced from the difference in size between SRP14
and the cross-link product. Cross-link products were named according to the apparent
molecular weight of the protein cross-linked to SRP14 (14-X10 for a protein of 10 kDa).
Figure 10: Formation and detection of cross-link products. A) DSS (red line) is a homo-bifunctional cross-linker. It can react with
primary amino groups (mainly, the side chain of lysines), separated by at most 12 Å, and hence covalently bond these two amino
groups. If they belong to two different proteins (e.g. SRP14 and protein X), a cross-link product is formed (labelled SRP14-X).
B) To detect cross-link products containing SRP14, cross-linking reactions were analysed by western blotting with affinity-purified
anti-SRP14 antibodies (Materials and Methods 1.8).The apparent molecular weight of the cross-link products (e.g. 28 kDa) was
compared to the apparent molecular weight of SRP14 (18 kDa) to deduce the apparent molecular weight of the protein cross-linked to
SRP14 (10 kDa). The cross-link product was named according to the apparent molecular weight of the unidentified cross-linked protein
(14-X10).
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1.2 The formation of targeting complex
In order to form the targeting complex, we produced ribosome-nascent chain complexes
(RNCs) in the rabbit reticulocyte lysate. A truncated mRNA encoding the first 86 amino acids
of preprolactin was translated in this system (Materials and Methods 3.4). Since this mRNA
did not contain a stop codon, its translation resulted in the formation of a stalled RNC exposing
the signal sequence of preprolactin at the nascent chain exit site (pPl86 RNC; Powers and
Walter, 1996). The pPl86 RNCs were purified by sedimentation through a high-salt sucrose
cushion (Powers and Walter, 1996). The pPl86 nascent chain could be detected in the
ribosomal pellet (Figure 11A, lane 2). The absence of shorter translation products demonstrated
that each translated mRNA molecule was associated with only one ribosome. To optimize the
RNC production, the truncated mRNA was titrated in translation reactions in order to saturate
nascent chain synthesis (data not shown; see Materials and Methods 3.4). Finally, to form the
targeting complex, these purified pPl86 RNC were incubated with canine SRP purified under
native conditions (Materials and Methods 4.1). The optimal DSS concentration in the
cross-linking experiments was 800 µM, which is 20 fold higher than the one used in similar
experiments which identified ribosomal proteins cross-linked to SRP54 (Pool et al., 2002). The
requirement for a higher DSS concentration may be explained by the smaller size and/or lower
accessibility of the targets.
Figure 11: Purification of Ribosome-Nascent chain complexes (RNC). A) RNC were produced in the rabbit reticulocyte lysate by
the translation of truncated mRNA encoding either the first 130 amino acids of cyclin (Cyc130, lane 1) or the first 86 amino acids of
preprolactin (pPl86, lane 2) in the presence of 35S-methionine and were purified from the translation reactions through a high-salt,
sucrose cushion. Ribosomal pellets were directly analysed by SDS-PAGE and autoradiography to detect the Cyc130 and pPl86 nascent
chains. B) The 35S-labelled Cyc130 and pPl86 nascent chains from A were quantified by phosphorescence imaging and their relative
yields at maximized translation efficiencies were calculated taking into account that pPl86 and Cyc130 contain four and six
methionines, respectively. The pPl86 intensity was set as 1 (arbitrary unit).
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1.3 The Alu domain is located in close proximity to conserved ribosomal components in
the targeting complex.
When targeting complexes were treated with DSS, five SRP14 cross-link products were
detected (Figure 12A, lane 11). The smallest one (14-X9) had the expected size of an
SRP14-SRP9 cross-link product. In agreement, it was also seen with SRP alone (lane 2) and
was recognized by anti-SRP9 antibodies (data not shown). The other cross-link products
presumably represented SRP14 covalently bonded to ribosomal proteins. The apparent
molecular  weights  of  the  proteins  were  in  the  size  range  of  17  to  45  kDa,  as  expected  for
ribosomal  proteins.  As  indicated  by  the  strong  signal  of  SRP14 in  the  control  reactions  with
pPl86 RNCs (Figure 12A, lanes 5 and 8), rabbit SRP co-purified with the RNCs exposing a
signal sequence as the rabbit reticulocyte lysate contains endogenous, active SRP (Meyer et al.,
1982; Wolin and Walter, 1989). The weak signals of the SRP14 cross-link products in the
absence of canine SRP (lane 8) were therefore likely to result from covalent links between
rabbit SRP14 and ribosomal proteins. In conclusion, the Alu domain is located in close
proximity to ribosomal proteins in the targeting complex.
During the preparation of the pPl86 RNCs, we noted a contamination with ribosomes that do
not expose a nascent chain at the exit site (mock ribosomes; Flanagan et al., 2003). SRP has a
weak,  but  significant,  affinity  for  mock  ribosomes  (Flanagan  et  al.,  2003).  When  SRP-mock
ribosome complexes were treated with DSS in control experiments (Figure 12A, lane 9),
SRP14 was also cross-linked to four ribosomal proteins with sizes identical to those observed
with targeting complexes (lane 11), suggesting that the cross-link products observed with
pPl86 RNC preparations might represent the binding of SRP to contaminating mock
ribosomes. To definitely confirm that the cross-link products represent the location of the Alu
domain in the targeting complex, we performed our cross-linking assay under high salt
conditions ([KOAc] = 500 mM) which disrupt the interaction between SRP and mock
ribosomes (Powers and Walter, 1996). Consistently, we failed to detect SRP14 cross-link
products when SRP-mock ribosome complexes were analysed under high salt conditions
(Figure 13A, lane 4). When targeting complexes were analysed under high salt conditions, we
could detect the four SRP14 cross-link products (Figure 13A, lane 6). These observations
demonstrated that the four cross-link products were specific for the targeting complex. More
importantly, they also revealed that the Alu domain was stably located in the ribosome in the
presence of a signal sequence. Indeed, the yield of cross-link products was only reduced by
approximately 40 % under the high salt conditions (quantifications not shown, compare Figure
13A, lanes 3 and 6), supporting the notion that the Alu domain might interact with the
ribosome.
Finally, we repeated the cross-linking analysis with mock ribosomes and pPl86 RNCs purified
form the wheat germ (WG) extract. SRP14 was cross-linked to the same number of ribosomal
proteins (Figure 12C) and their sizes were similar when compared to cross-linking assays with
mock ribosomes and pPl86 RNCs purified from the rabbit reticulocyte (RR) lysate
(Figure 12A). In conclusion, the proteins in proximity to the Alu domain  appeared  to  be
conserved between mammalian and plant ribosomes. The intensity of 14-X20 was weaker and
the one of 14-X17 stronger than with the mammalian system, which may be explained by
structural differences between the systems. Note, that even under optimised translation
conditions the yield of nascent chains for the same amount of ribosome was significantly lower
with wheat germ lysate than with reticulocyte lysate (Materials and Methods 3.4). Hence the
observed cross-link products might predominantly reflect binding of SRP to vacant ribosomes.
We did not perform this analysis under high salt conditions to validate this hypothesis.
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Figure 12: Cross-linking of SRP14 to ribosomal proteins. A) Western blot analysis of cross-linking reactions with
affinity-purified anti-SRP14 antibodies. The complexes formed between canine SRP (1 pmole) and RNCs (2 pmoles) purified
from the rabbit reticulocyte lysate were treated with 800 µM DSS. N: Ribosomes prepared from mock translations; C: Cyc130
RNCs; P: pPl86 RNCs. Lanes 6-8: RNCs alone, lanes 9-11: RNCs and canine SRP. Control lanes 3-5: RNCs alone without DSS,
lanes 1 and 2: canine SRP alone without and with DSS treatment, respectively. The number following X in the labels indicates the
estimated minimal size of the proteins cross-linked to SRP14 (Figure 10). 14-X9 marks the cross-link between SRP14 and SRP9.
Gel: 12 % acrylamide. MW: Molecular weight standards (in kDa). B) The relative abundance of the SRP14 cross-link products.
The 14-X20, 14-X31 and 14-X45 cross-link products from the reactions with mock ribosomes (lane 9), Cyc130 RNCs (lane 10)
and pPl86 RNCs (lane 11) in A were quantified with a CCD camera-based system. The relative intensities of each cross-link
product in the reactions with mock ribosomes and pPl86 RNCs were calculated by comparison to the intensity of the same
cross-link product in the reactions with Cyc130 RNCs, which was set at 100 % (Materials and Methods 4.1). Note that the
exposure times used for the quantification of 14-X20, 14-X31 and 14-X45 were different. Hence, these quantifications do not
represent the relative abundances of the three cross-link products in a given reaction. C) Western blot analysis of the
cross-linking reactions with SRP and wheat germ RNCs using affinity-purified anti-SRP14 antibodies. Cross-linking reactions
were  done  as  in A. Lanes 1-3: RNCs without DSS; lanes 4-6: RNCs with DSS; lanes 7-9: RNCs with SRP and DSS treatment.
*: a wheat germ ribosomal protein of the small subunit recognized fortuitously by the anti-SRP14 antibodies. Gel: 12 %
acrylamide. MW: Molecular weight standards (in kDa).
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1.4 The Alu domain is located at the interface of ribosomal subunits in the targeting
complex.
To address the question of whether SRP14 was cross-linked to bona fide ribosomal proteins,
we  dissociated  the  RNC  after  the  cross-linking  reaction  with  puromycin  and  high  salt
treatments. The subunits were separated through a sucrose gradient. Fractions were collected
with continuous monitoring of the absorbance at 254 nm and analysed by western blotting with
antibodies against SRP14, S15 and L9 (Materials and Methods 4.2). Monitoring S15, L9 and
the ribosomal RNA allowed me to examine the efficiency of the subunit separation and to
identify the fractions comprising the subunits.
Without adding DSS to Cyc130 RNCs, all RNCs were separated into subunits (Figure 14A). In
contrast, after treatment with DSS at the usual concentration (800 µM), almost all ribosomes
were found in the 80S peak, presumably because most of the ribosomal subunits became
covalently linked through ribosomal proteins (results not shown). To alleviate this problem,
we determined the minimal DSS concentration which still allowed us to detect the SRP14
cross-link products (100 µM). Even at the reduced DSS concentration, a significant fraction of
the ribosomal subunits was cross-linked (Figure 14B, 80 S). As evaluated from the S15 and L9
contents of the 80S fractions, the cross-linked ribosomes represented about 75% (see also
Figure 15B-E). Importantly, based on the RNA and protein profiles, we could clearly identify
the regions in the gradient that comprised the 40S and 60S ribosomal subunits (Figure 14B).
Figure 13: Salt-dependent cross-linking of SRP14 to
ribosomal components. A) Western blot analysis of the
cross-linking reactions under low or high salt
concentrations with affinity-purified anti-SRP14
antibodies. Complexes formed between SRP (1 pmole)
and  rabbit  RNCs (2  pmoles)  were  treated  with  800  µM
DSS and the proteins displayed by 12 % SDS-PAGE. N:
Ribosomes prepared from mock translations; C: Cyc130
RNCs; P: pPl86 RNCs. Lanes 1-3 and 4-6: cross-linking
reactions at 50 mM and 500 mM KOAc, respectively.
MW: Molecular weight standards (in kDa). B)
Quantification of the SRP14 cross-link products. The
SRP14 cross-link products 14-X20, 14-X31 and 14-X45
in  lanes  2,  3  and  6  in A were  quantified  with  a  CCD
camera-based system. The intensities of each cross-link
product in the reactions with pPl86 RNCs at 50 mM and
500 mM KOAc were calculated by comparison to the
intensity of the same cross-link product in the reactions
with  Cyc130  RNCs at  50  mM KOAc,  which  was  set  at
100 %. Finally, these values were corrected to take into
account the difference in the cross-linking efficiency at
50 mM and 500 mM salt (Materials and Methods 4.1).
Hence these quantifications do not represent the relative
abundances of the three cross-link products in a given
reaction.
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Figure 14: Ribosomal subunits separation with and without DSS treatment. A) RNA, S15 and L9 profiles without
DSS treatment. Cyc130 RNCs were treated with puromycin/high salt and the ribosomal subunits resolved on a 10-30 %
sucrose gradient. The absorbance at 254 nm was monitored continuously during fractionation (upper panel). The L9 and
S15 contents of all fractions were determined by western blotting with anti-S15 and anti-L9 antibodies (gel: 12 %
acrylamide). The signals were quantified with a CCD camera-based system (lower panel). B) RNA, S15 and L9 profiles
with DSS treatment (100 µM). Data were collected as described in A.
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Figure 15: SRP14 was cross-linked to both ribosomal subunits in the targeting complex. A) Western blot analysis of the
gradient after ribosomal subunit separation. pPl86 RNCs (21 pmoles) were incubated with canine SRP (17.5 pmoles) and
treated with DSS (100 µM final concentration) at low salt concentration (50 mM potassium acetate and 2.5 mM Mg(OAc)2).
Subsequently, ribosomes were dissociated into subunits by puromycin/high salt treatment and the subunits separated on a
10-30% sucrose gradient. Fractions were collected and pooled to represent 40S (5), Int (6), 60S (7) and 80S (8 and 9) as
established in Figure 14. The top fractions were combined into four equal parts (fractions 1-4). The pooled fractions were
analysed by western blotting with affinity-purified anti-SRP14 (upper panel), anti-L9 (medium panel) and anti-S15 (lower
panel) antibodies. MW: Molecular weight standards (in kDa). Gel: 12 % acrylamide. B-D) Relative  amounts  of  14-X31 (B),
14-X20 (C) and 14-X45 (D) as compared to the amounts of S15 and L9 present in each fraction. E) Quantification of a
gradient western blot analysis of Cyc130 RNCs cross-linked to SRP. Same experimental conditions as in A but the
cross-linking reaction was done with Cyc130 RNCs. At DSS concentrations of 100 µM, only 14-X20 could be quantified and
was compared to S15 and L9.
- 41 -
To assign the SRP14 cross-link products to the 40S or the 60S ribosomal subunits, DSS-treated
targeting complexes were dissociated into subunits and analysed on a gradient run in parallel.
Based on the analysis presented in Figure 14, we used the A254 nm profile recorded during the
fractionation of the gradient to pool the fractions containing the 80S, 60S and 40S subunits
(data not shown; Materials and Methods 4.2). This was necessary to detect the
cross-link products associated with the subunits by western blotting with anti-SRP14
antibodies (Figure 15A). The intermediate region (INT) was separated from the subunits
because it contained small amounts of both L9 and S15 (Figure 14B). The fractions from the
top of the gradient were pooled into four equal parts (Figure 15, fractions 1 to 4). The S15 and
L9 contents of all fractions were determined to verify the assignments (Figure 15A). SRP14
was quantified from a picture taking at a much shorter exposure to monitor the presence of
SRP in the different fractions (not shown). About 72 % of SRP was not cross-linked to
ribosomes and was therefore found on top of the gradient (Figure 15A, lanes 1 to 4; the
presence of SRP was also revealed by the detection of 14-X9). About 16 % of SRP was found
in the 80S fractions whereas only 8% and 4% of SRP was present in the 60S and 40S fractions,
respectively. Notably all the SRP14 cross-link products were present in the 80S fraction and
none was found at the top of the gradient (Figure 15A) confirming unambiguously that SRP14
was cross-linked to bona fide ribosomal proteins.
In the targeting complex, SRP14 was cross-linked to proteins from both ribosomal subunits.
The  31  kDa  protein  was  associated  with  the  small  ribosomal  subunit  as  14-X31  was  clearly
detected in the 40S fraction (Figure 15A-B). In addition, it was more enriched in the 40S
fraction as compared to the adjacent fractions, confirming its association with the small
subunit. Note, the 60S fraction was contaminated with the 80S fraction (Figure 14B) and
therefore also contained S15 and 14-X31 (Figure 15B). The 20 kDa and 45 kDa proteins were
associated with the large ribosomal subunit as 14-X20 and 14-X45 were present in the 60S
fraction and completely absent in the 40S fraction (Figure 15C-D). In conclusion, the
cross-linking of SRP14 to proteins from both ribosomal subunits demonstrated that the Alu
domain is located at the interface of the ribosomal subunit in the targeting complex. The
weakest cross-link product, 14-X17, was just detectable in the 60S fraction. However, its
abundance was lower as compared to 14-X20 and 14-X45 and in the 40S fraction it could not
be detected because of a significant background in the region (Figure 15A). Its subunit
association could therefore not be determined unambiguously.
1.5 The Alu domain is located at the interface of ribosomal subunits during elongation
arrest.
In the previous experiments, we could demonstrate that the Alu domain of SRP is located at the
interface of the ribosomal subunits in the targeting complex. However, we could not
demonstrate the functionality of this location because it was determined with arrested RNC,
which are artificially arrested in elongation. We therefore decided to confirm the location of
the Alu domain at the interface of the ribosomal subunits in actively translating ribosomes. SRP
has been shown to mediate a transient elongation arrest of preprolactin synthesis in the rabbit
reticulocyte lysate (Wolin and Walter, 1989). Hence the full-length preprolactin mRNA was
translated in this in vitro system and the translations were reacted with DSS after 15 minutes.
Preprolactin could be detected at this time point (Figure 16A). After cross-linking, the
ribosomes were purified through a high-salt sucrose cushion and analysed for the presence of
SRP14 adducts as before (Figure 16C, upper part). To confirm that the same amount of
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ribosomes was analysed in each sample, we performed immunobloting with anti-S15
antibodies on the same membrane (Figure 16C, lower part).
Figure 16: Cross-linking of SRP14 to ribosomal components in ongoing translations. A) Cyclin and preprolactin synthesis in the
rabbit reticulocyte lysate. Full-length cyclin and preprolactin mRNAs were titrated individually into reticulocyte translation reactions in
the presence of 35S-methionine and translated for 15 minutes before analysis of the reactions by SDS-PAGE and autoradiography.
Gel: 5-20 % acrylamide (gradient gel). B) The quantification of cyclin and preprolactin yields by phosphorescence imaging. The relative
yields in A were calculated taking into account that cyclin and preprolactin contain sixteen and eight methionine residues, respectively. In
lanes 1 and 7, equivalent molar amounts of the full-length proteins were present in the reactions and these conditions were used for the
cross-linking experiments. C) The SRP14 cross-link products formed during the synthesis of cyclin and preprolactin. Cross-linking was
performed as described in Material and Methods 4.3 in the rabbit reticulocyte lysate under the conditions determined in B. The ribosomes
were purified through high-salt sucrose cushions after cross-linking and the ribosomal pellets were analyzed by western blotting with
affinity-purified anti-SRP14 antibodies (upper panel). To confirm that the same amount of ribosomes were analysed in each sample, the
same blot was subsequently analyzed with anti-S15 antibodies (lower panel). Lanes 4-6 contained exogenous canine SRP (4 pmoles).
N: mock translation; C: Cyclin translation; P: preprolactin translation. MW: Molecular weight standards (in kDa). Gel: 12 % acrylamide.
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During preprolactin synthesis, SRP14 was unambiguously cross-linked to four ribosomal
proteins (Figure 16C, lanes 3). In this experiment, the ribosomal proteins were cross-linked to
the endogenous rabbit SRP (Wolin and Walter, 1989). The yield of 14-X17 was very low.
However it was unambiguously detected when we supplemented the translations with
exogenous canine SRP (lane 6). In the absence of translation (lane 1), these cross-link products
were not detected, demonstrating that the four cross-link products defined the location of the
Alu domain during preprolactin translation. The sizes of the SRP14 cross-link products were
identical to those observed with purified pPl86 RNCs (Figure 12A, lane 11), demonstrating
that the Alu domain location was the same in the targeting complex and during preprolactin
synthesis. In conclusion, this analysis demonstrated that the Alu domain is located at the
interface of the ribosomal subunit during elongation arrest.
The weak signal 14-X20 in mock translation supplemented with canine SRP (lane 4) most
likely represents the location of the Alu domain in the absence of elongation arrest. The lower
SRP concentrations in ribosomal pellets form mock translations (lanes 1 and 4), as reflected by
the  SRP9-SRP14  signals,  were  explained  by  the  fact  that  SRP-ribosome  complexes  are  only
stable to high salt treatment in the presence of a signal sequence in the nascent chain (Powers
and Walter, 1996). SRP was therefore removed from vacant ribosomes in the high salt
purification step, unless one of its proteins was covalently linked to a ribosomal protein. Our
cross-linking assay in ongoing translations confirmed that the Alu domain  was  located  at  the
interface of the ribosomal subunits during elongation arrest.
1.6 The Alu domain of SRP is located in the close proximity to the elongation
factor-binding site during elongation arrest.
In order to locate more precisely the Alu domain in the ribosome, we took advantage of the
complete characterization of the mammalian ribosomal proteins (Wool et al., 1995; ribosomal
proteins from all kingdoms are listed on the Swiss-Prot Protein knowledgebase,
www.expasy.ch/cgi-bin/lists?ribosomp.txt). Since the apparent molecular size of a cross-link
product defines the minimal size of the cross-linked protein, only L3 and L4 may account for
the X45 protein as they are the only mammalian ribosomal proteins with a size larger than 36
kDa. In agreement L3, L4 and 14-X45 are associated with the large ribosomal subunit. On the
basis  of  structural  and  biochemical  studies  on  archaeal  and  eukaryotic  ribosomes  (Ban et  al.,
2000; Nygard and Nika, 1982; Spahn et al., 2001; Yusupov et al., 2001), only L3 is located at
the interface of the ribosomal subunits. In conclusion, these observations designated L3 as the
only candidate for the X45 protein based on the size and subunit association of 14-X45.
Alternatively, 14-X45 may represent a cross-link between SRP14 and two ribosomal proteins.
We cannot completely exclude this possibility, but it seems rather unlikely for at least two
reasons. Since the cross-linking efficiency is very low in our experiments, simultaneous
linkage of three proteins is statistically a very rare event and 14-X45 would therefore be
expected to be much less abundant. In addition, we never observed different cross-linked
products of smaller sizes by changing the experimental conditions (e.g. DSS concentration, salt
concentration, RNC-SRP ratio).
L3 is in close proximity to and directly interacts with the sarcin-ricin loop (SRL), a critical site
of interaction for the EFs in the ribosomal 23S RNA (Figure 18; Ban et al., 2000; Uchiumi et
al., 1999; Yusupov et al., 2001). Thus, the cross-linking of SRP14 to L3 places the Alu domain
in close proximity to the EF-binding site during elongation arrest (Figure 17). The location of
the Alu domain in close proximity to the EF-binding site is in agreement with several
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observations. First, to be covalently bonded to proteins of both ribosomal subunits, SRP14
would have to span the intersubunit space. Based on the crystal structure of the SA50 Alu RNP
(Weichenrieder et al., 2000), the two most distant, solvent-accessible lysine residues (K74 and
K95) are separated by about 47 Å. Adding twice the size of the cross-linker increases the
maximal distance between two proteins cross-linked to SRP14 to about 74 Å which is
sufficient to bridge the inter-subunit space, with each extremity of SRP14 pointing towards one
of the ribosomal subunits. In addition, to position the Alu domain at the subunit interface, SRP
has to span the distance between the interface and the nascent chain exit site, where SRP54 is
located in proximity of L23a and L35 (Pool et al., 2002). According to its size (23-24 nm),
SRP is sufficiently extended to contact the two positions simultaneously as previously
described (Andrews et al., 1985). Finally, the sizes of the other cross-link products can be
explained by cross-linking of SRP14 to ribosomal proteins neighbouring L3 in the large and
small ribosomal subunit (Figure 17; Results 2).
1.7 Summary
The Alu domain  of  SRP  is  specifically  required  for  elongation  arrest.  We  determined  the
location of the Alu domain during elongation arrest to understand how it interferes with the
elongation of the nascent chain. Our cross-linking assays with targeting complexes and during
the synthesis of a secretory protein demonstrated that, during elongation arrest, the Alu domain
was located at the interface of the ribosomal subunit. Indeed, SRP14 was cross-linked to four
conserved proteins belonging to both ribosomal subunits. Their size and subunit association
indicated that the Alu domain was located close to the EF-binding site, supporting the notion
that SRP interferes with the binding of the EFs to the ribosome during elongation arrest.  The
detection of the SRP14 cross-link products under high salt conditions demonstrated that the Alu
domain is stably located in the ribosome during elongation arrest, supporting the notion that the
Alu domain might interact with the ribosome.
Figure 17: A schematic model of the Alu domain location within the targeting complex. Complete ribosomes are
represented schematically as viewed from the solvent side of the 40S subunit. Ribosomal proteins are positioned in
agreement with the cryo-EM reconstructions of yeast ribosomes (Spahn et al., 2001). The Alu domain is represented at
scale by the SA50 Alu RNP structure (Weichenrieder et al., 2001). Its orientation was chosen randomly. The
“*” represents the two most distant lysine residues of SRP14. The grey arrow indicates a possible pathway for the SRP
RNA helix 5 linking the Alu and the S domain (Figure 8). Candidate ribosomal proteins for the different cross-link
products are shown (see also Figure 18). The ribosomal A and E sites are indicated to help the orientation.
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2 Identification of the ribosomal proteins cross-linked to SRP14
2.1 Strategy
The cross-linking assays demonstrated that the Alu domain  of  SRP  was  located  in  close
proximity to the elongation factor-binding site (EF-binding site) during elongation arrest
(Results 1). To confirm experimentally the location of the Alu domain, we decided to identify
the ribosomal proteins cross-linked to SRP14 using the method described in Pool et al., 2002.
Briefly the authors determined the location of SRP54 in the targeting complex (SRP bound to
pPl86 RNC). SRP54 was cross-linked to two ribosomal proteins of the large ribosomal
subunits (cross-link products SRP54-X12 and SRP54-X17). Based on the size and the subunit
association of the cross-linked products, candidates for the X12 and X17 proteins were chosen
and antibodies were raised against them. Antibodies against ribosomal proteins L23a and L35
specifically immunoprecipitated the cross-link products SRP54-X17 and SRP54-X12,
respectively, confirming that SRP54 was located in proximity to the nascent chain exit site in
the targeting complex. To facilitate the analysis, the authors used a 35S-labelled SRP54 in their
cross-linking assay. Their immunoprecipitations could therefore be analysed by SDS-PAGE
and autoradiography instead of western blotting. When we tried to analyse our
immunoprecipitations by western blotting, we always detected the heavy and light chains of
the antibodies from the immunoprecipitation even if the antibodies were covalently coupled to
beads (data not shown). The antibodies chains migrating at the same size ranges as the SRP14
cross-link products in SDS-PAGE, their strong signals covered the other signals, preventing
the detection of our low-abundant SRP14 cross-link products. It is therefore imperative to use
35S-labelled SRP14 in our cross-linking assay when these reactions are going to be
immunoprecipitated.
Figure 18: Candidates for the proteins of large ribosomal subunit proteins cross-linked to SRP14. The location of the four
candidates for the X17, X20 and X45 proteins cross-linked to SRP14 is indicated on this view of the Thermus termophilus 70S ribosome
(Yusupov et al., 2001). The putative location of the Alu domain in the ribosome is shown as a red dot. The SRL and LGAR motifs of the
23S rRNA are also indicated. The sizes of the mouse homologues (from the Swiss-Prot Protein knowledgebase, www.expasy.org/sprot)
are 14.8 kDa (L23), 17.8 kDa (L12), 21.8 kDa (L9) and 46 kDa (L3). The homology between mouse (Mm) and Thermus thermophilus
(Tt) proteins (based on sequence similarities and indexed at the Swiss-Prot Protein Knowledgebase, www.expasy.ch/cgi-
bin/lists?ribosomp.txt) is as follow: Mm L23 - Tt L14; Mm L12 - Tt L11; Mm L9 - Tt L6; Mm L3 - Tt L3. The ribosomal protein S3
(Mm S3 - Tt S3) is also indicated (size = 26.7 kDa).
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2.2 Candidate ribosomal proteins cross-linked to SRP14 in the targeting complex
In the targeting complex, SRP14 was cross-linked to four proteins from both ribosomal
subunits  (Results  1).  14-X31 was  associated  with  the  small  subunit,  whereas  the  other  cross-
link products were on the large subunit. As discussed (Results 1.6), 14-X45 could only be
explained by the cross-linking of SRP14 to ribosomal protein L3, thus locating the Alu domain
in the close proximity to the EF-binding site. We focused our analysis on the cross-link
products associated with the large ribosomal subunit. In proximity to L3, one strong candidate
for the X17 protein was L23 (Figure 18). L23 has an appropriate molecular weight (14.8 kDa)
and is also in close proximity to the EF-binding site as indicated by its cross-linking to EF2
(Nygard et al., 1987). According to their molecular weights, two ribosomal proteins may
account for the X20 protein: L12 and L9. L9 interacted with the A-chain of ricin, an
N-glycosidase that removes a specific adenine in the sarcin-ricin loop (SRL), a critical site of
interaction for both EFs in the ribosomal 23S RNA (Results 1.6). This modification prevents
the binding of EF2 and therefore abrogates protein synthesis (Brigotti et al., 1989; Endo et al.,
1987; Vater et al., 1995). L12 is an essential component of the EF-binding site and it interacts
with the LGAR motif of the 28S rRNA (Figure 18; Results 4.1). In agreement, both proteins
were located close or at the subunits interface of the ribosome (Figure 18). In conclusion, all
the cross-link products associated with the large subunit could be explained by the covalent
linkage of SRP14 to ribosomal proteins located at the EF-binding site.
Figure 19: Test of anti-L23, anti-L12,
anti-L9 and anti-L3 sera in western
blotting experiments. Anti-L23: Purified
wheat germ ribosomes (1 pmole/lane) were
analysed by western blotting with anti-L23
serum (n° 4942). Each lane was incubated
with a different bleed of the serum. Lane 1:
bleed 1; lane 2: bleed 2; lane 3: bleed 3; lane
4: bleed 4. MW: Molecular weight standards
(in kDa). Gel: 15% acrylamide. Anti-L12:
Different amounts of purified rabbit
reticulocyte ribosomes were analysed by
western blotting with anti-L12 serum
(n° 4688, bleed 1). Amounts of ribosomes:
2 pmoles (lane 1); 0.2 pmoles (lane 2);
0.02 pmoles (lane 3). MW: Molecular weight
standards (in kDa). Gel: 15% acrylamide.
Anti-L3: 2 pmoles of purified rabbit
reticulocyte ribosomes were analysed by
western blotting with anti-L3 serum
(n° 3021, bleed 1). MW: Molecular Weight
standards (in kDa). Gel: 10% acrylamide.
Anti-L9: Different amounts of purified rabbit
reticulocyte Cyc130 RNC were analysed by
western blotting with anti-L9 serum (n° 3019,
Final bleed). Ribosomes amounts: 1 pmole
(lane 1); 0.1 pmoles (lane 2); 0.01 pmoles
(lane 3). MW: Molecular weight standards (in
kDa). Gel: 15 % acrylamide.
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2.3 The production of antibodies and their purification
We raised  antibodies  against  these  four  ribosomal  proteins  (Materials  and  Methods  1.7).  We
assayed  their  ability  to  specifically  detect  a  protein  from the  rabbit  reticulocyte  and/or  wheat
germ ribosomes with the expected molecular weight by western blotting (Figure 19). The L23,
L12 and L3 proteins were confirmed as good candidates for the X17, X20 and X45 proteins.
Indeed, the sera against L23, L12 and L3 detected a protein of 17 kDa, 20 kDa and 45 kDa,
respectively, in good agreement with the theoretical molecular weight of these proteins
(L23: 14.8 kDa; L12: 17.8 kDa; L3: 46 kDa; MWs from the Swiss-Prot Protein
knowledgebase, www.expasy.org/sprot). The slower migration observed for L23 and L12 was
most likely due to their basic nature (pI = 10.95, 9.88 and 10.38, respectively; Wool et al.,
1995). Based on its apparent molecular weight, L9 could be excluded as a candidate protein for
the X20 adduct. Indeed, the sera against L9 detected a protein of 25 kDa.
The sensitivity and specificity of the different sera was highly variable (Figure 19). Anti-L12
was highly specific towards rabbit L12 and easily detected reasonable amounts of this protein
(0.02 pmoles). Anti-L23 was reasonably specific. However, the signals were weak. Anti-L3
was neither very specific, nor very sensitive. To improve the specificity of our antibodies, we
purified them by affinity.
To purify the L23-specific and L3-specific antibodies, the L23 and L3 peptides used for the
immunization of the rabbits were separately coupled to sepharose and the respective sera were
applied to the columns. The antibodies specifically bound to the columns were eluted with a
low pH buffer and tested by western blotting (Materials and Methods 1.8).
The affinity purification of anti-L23 antibodies increased their specificity. Most of the
unspecific antibodies were not retained on the column (Figure 20, compare Input and Flow
through). Hence, the affinity-purified antibodies were highly specific for the rabbit L23
(Figure 20, Fractions of elution 3 and 4). Moreover, no signals were detected around 31 kDa,
the region where 14-X17 was detected.
Figure 20: Affinity purification of anti-L23 antibodies on a peptide
column. The detection of 1 pmole of L23 from rabbit reticulocyte (RR)
ribosomes by western blotting using the fractions from the affinity
purification of anti-L23 antibodies on a L23-peptide column is presented.
The anti-L23 serum (n° 4942; bleed 4, 2 ml) was prepared as described in
Materials and Methods 1.9 and applied to a sepharose column coupled to
the L23 peptide used for the serum production. The flow through
(unbound fraction) was collected. Bound antibodies were eluted with a
low pH buffer and collected in fractions of 300 µl. Input: 1/1000e of the
serum before loading. Flow through: 1/1000e of the flow through.
Fractions of elution: 1/30e of each fraction from the elution step. MW:
Molecular weight standards (in kDa). Gel: 5-20 % acrylamide (gradient
gel).
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The affinity-purification of anti-L3 antibodies did not solve the problem of specificity.
Contaminating antibodies co-purified with L3-specific antibodies on the column (Figure 21,
compare Input and Fraction of elution 4). Alternatively L3-specific antibodies might
cross-react with other ribosomal proteins. Nevertheless the purification increased the specific
signal for L3 compared to the other detected proteins (compare Input and Fractions of elution 3
and 4). For example, the protein below 36 kDa gave the most intense signal before purification
whereas the L3-specific signal became the most intense one after purification. Importantly the
L3-specific antibodies did not recognize another ribosomal protein larger than 36 kDa. Thus
the immunoprecipitation of 14-X45 by these antibodies could only be explained by
cross-linking of SRP14 to L3. Finally, no signals were detected around 60 kDa, the region
where 14-X45 was detected.
The L12-specific antibodies were affinity-purified on human L12 immobilized on
nitrocellulose membrane (Materials and Methods 1.8). The purification significantly decreased
the detection of other ribosomal proteins (compare Figure 22, lane 1, and Figure 19, Anti-L12
panel, lane 1).
Figure 21: Affinity purification of anti-L3 antibodies on a peptide
column. The detection of 1 pmole of L3 from rabbit reticulocyte (RR)
ribosomes by western blotting using the fractions from the affinity
purification of anti-L3 antibodies on a L3-peptide column is presented. The
anti-L3 serum (n°2021, bleed 1, 2 ml) was prepared as described in
Materials and Methods 1.9 and applied to a sepharose column coupled with
the L3 peptide used for the serum production. The flow through (unbound
fraction) was collected. Bound antibodies were eluted with a low pH buffer
and collected in fractions of 300 µl. Input: 1/100e of the serum before
loading. Flow through: 1/100e of the flow through. Fractions of elution:
1/15e of each fraction from the elution step. MW: Molecular weight
standards (in kDa). Gel: 5-20 % acrylamide (gradient gel).
Figure 22: Affinity purification of anti-L12 antibodies on membrane. The
detection of different amounts of L12 from rabbit reticulocyte (RR)
Cyc130 RNCs by western blotting using affinity-purified anti-L12 antibodies is
presented. The anti-L12 antibodies were purified as described in Bovia et al., 1995
from serum 4688, bleed 1 (Materials and Methods 1.9). Amounts of Cyc130
RNCs: 2 pmoles (lane 1), 0.2 pmoles (lane 2), 0.02 pmoles (lane 3), 0.002 pmoles
(lane 4). MW: Molecular weight standards (in kDa). Gel: 12 % acrylamide.
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2.4 Reconstituted SRP cannot be used in our cross-linking assay.
We planned to use the affinity-purified antibodies described above for the immunoprecipitation
of the SRP14 cross-link products. To be able to detect the cross-link products after
immunoprecipitation, they had to be labelled as described in Pool et al., 2002 (Results 2.1).
Labelled SRP14 could be easily produced by in vitro translation in the presence of
35S-methionine. A functional heterodimer could be formed if the translation was supplemented
with recombinant, purified SRP9 (data not shown, see Huck et al., 2004). Finally, this labelled
heterodimer had to be incorporated into a functional SRP particle. This reconstitution of SRP
could be performed in vitro from the different components of SRP (SRP RNA and the 6 SRP
proteins; Materials and Methods 3.3; Walter and Blobel, 1983). Observations from our
laboratory indicated that these reconstituted particles were less active in functional assays than
the native, canine SRP: 100 nM of reconstituted SRP were as active as 10-20 nM of native,
canine SRP (see below). Thus we first tested whether the SRP14 cross-link products were
detected when the reconstituted SRP was used in the cross-linking assay.
Figure 23: Cross-linking assays with reconstituted SRP. The western blotting analysis with affinity-purified anti-SRP14 antibodies
of a cross-linking reaction using reconstituted SRP is presented. SRP was reconstituted as described in Materials and Methods 3.3. The
human SRP9/14 heterodimer was used in the reconstitution. Reconstituted SRP (1 pmole) was incubated with wheat germ pPl86 RNC
(3 pmoles) under low salt conditions ([KOAc] = 50 mM) and reacted with DSS as indicated. Reactions were analysed by western
blotting with affinity-purified anti-SRP14 antibodies. MW: molecular weight standards (in kDa). Gel: 5-20% acrylamide (gradient gel).
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The SRP reconstitution was performed as described in Materials and Methods 3.3. Notably, we
used the recombinant, purified, human SRP9/14 heterodimer in these assays. It was not
labelled with 35S-methionine. Thus the cross-linking assays were analysed by western blotting
with affinity-purified anti-SRP14 antibodies as before (Results 1.3). Reconstituted SRP was
incubated with wheat germ pPl86 RNC and reacted with DSS. We could not detect any of the
SRP14 cross-link products (Figure 23, lane 5). This discrepancy may be explained by a low
yield of targeting complexes. Targeting complexes were obtained with the wheat germ pPl86
RNCs and native canine SRP (Figure 12C). It designated the reconstituted SRP as the weak
link in the formation of targeting complexes. Several observations supported this notion. We
observed that 100 nM of the SRP reconstitutions were as active as 10-20 nM of native canine
SRP in  elongation  arrest  assay.  This  observation  is  most  likely  explained  by  the  presence  of
partially assembled SRP in our reconstitutions. Indeed a fraction of the RNA was not able to
interact with the complete set of SRP proteins, most likely due to folding defects in the
S domain (A. Scherrer and K. Strub, personal communications). Partially assembled particles
are not functional (Hauser et al., 1995, Powers and Walter, 1996) and therefore are not
expected to participate in the formation of complexes with ribosome. Based on the relative
activity  of  the  SRP  reconstitutions  in  elongation  arrest  assay,  only  10%  of  SRP  in  our
reconstitutions might be fully assembled and therefore functional. Thus, the yield of targeting
complexes with reconstituted SRP might be low. Under the optimal conditions for the
formation of targeting complexes with native canine SRP, SRP14 cross-link products were
already not abundant (Results 1.3) and their yield in cross-linking reactions with reconstituted
SRP might be therefore too low to allow their detection. To circumvent these limitations, we
tried  to  improve  the  yield  of  functional  SRP  in  the  reconstitution.  This  was  achieved  by  the
modifications  of  the  5’  and  3’  ends  of  the  SRP  RNA  (A.  Scherrer  and  K.  Strub,  personal
communications). We have not yet tested reconstituted SRP containing the modified RNA in
our cross-linking assay.
2.5 Summary
To confirm that the Alu domain of SRP was located in proximity to the EF-binding site during
elongation arrest, we tried to identify the proteins cross-linked to SRP14 by the
immunoprecipitating SRP14 cross-link products with antibodies against several ribosomal
proteins. We produced and purified antibodies against proteins from the large ribosomal
subunit that are located at or close to the EF-binding site. As determined by western blotting
with the purified antibodies, the apparent molecular weight of ribosomal proteins L23, L12 and
L3 was consistent with the size of the X17, X20 and X45 proteins, respectively. We would like
to use these antibodies for the immunoprecipitation of the SRP14 cross-link products.
Unfortunately, this method requires the use of reconstituted SRP particles. The yield of
functional SRP was low in our reconstitutions. Subsequently, the yield of targeting complexes
with  reconstituted  SRP  was  not  sufficient  to  allow  the  detection  of  the  SRP14  cross-link
products. We could increase the yield of functional particles in the reconstitutions by using a
SRP RNA modified at its 5’ and 3’ ends. We have not yet tested reconstituted SRP containing
the modified RNA in our cross-linking assay.
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3 The Alu domain location in the sampling complex
3.1 Strategy
SRP has a low affinity for all ribosomes engaged in protein synthesis (Flanagan et al., 2003;
Powers and Walter, 1996; Walter et al., 1981). In the resulting complex, SRP54 is in close
proximity to the nascent chain (Hauser et al., 1995). This complex was termed the sampling
complex. Indeed it  might allow SRP to sample the nascent chain for the presence of a signal
sequence (Ogg and Walter, 1995). The Alu domain of SRP, and in particular the SRP9/14
heterodimer, are required for the formation of the sampling complex (Powers and Walter,
1996), suggesting that it might interact with the ribosome during sampling of the nascent chain.
This hypothesis implies that the Alu domain must be in close proximity to ribosomal
components in the sampling complex. To test this prediction, we probed the environment of
SRP14 in  the  sampling  complex  with  DSS,  a  homo-bifunctional  cross-linker  that  reacts  with
primary amino groups. SRP14 cross-link products were detected with affinity-purified
anti-SRP14 antibodies (see Results 1.1 for more details).
3.2 The formation of sampling complex
In order to form a sampling complex, we proceeded as described in Results 1.2, but RNCs
were produced by the translation of a truncated mRNA encoding the first 130 amino acids of
cyclin in the rabbit reticulocyte lysate. Cyc130 RNCs do not contain a signal sequence in the
exposed nascent chain (Thomas et al., 1997). The Cyc130 nascent chain could be detected in
the ribosomal pellet (Figure 11A, lane 2). The absence of shorter translation products
demonstrated that each translated mRNA molecule was associated with only one ribosome.
3.3 The location of the Alu domain is similar in sampling and targeting complexes.
When sampling complexes were treated with DSS, three SRP14 cross-link products involving
ribosomal proteins were detected (Figure 12A, lane 10), demonstrating that the Alu domain is
in close proximity to ribosomal components. This is the first experimental evidence
corroborating the idea that the Alu domain of SRP interacts with the ribosome during nascent
chain sampling. More importantly, the apparent sizes of the proteins cross-linked to SRP14
were identical to the ones of the proteins cross-linked to SRP14 during elongation arrest
(Figure 12A, lane 11; see Results 1). It was fully consistent with cross-linking to the same
proteins in the sampling and targeting complexes even if 14-X17 was undetectable in the
sampling  complex  (see  Results  3.3).   In  conclusion,  our  cross-linking  analysis  with  the
sampling complex suggested that the Alu domain  is  already  in  close  proximity  to  the
EF-binding site during nascent chain sampling. The confirmation of this observation will
require the precise location of the Alu domain in the sampling complex. For reasons discussed
elsewhere (Results 2), we have not been able to identify the ribosomal protein cross-linked to
SRP14 in the sampling complex.
The Alu domain was not stably located in close proximity to the EF-binding site in the
sampling complex. When we performed our cross-linking assay under high salt conditions with
targeting complexes, we could unambiguously detect the four SRP14 cross-link products
(Figure 13A, lane 6), indicating that the Alu domain was stably located in the ribosome during
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elongation  arrest  (Results  1).  At  the  contrary,  we  could  not  observe  the  formation  of  SRP14
cross-link products within sampling complexes under high salt conditions (Figure 13A, lane 5),
in agreement with previous studies (Flanagan et al., 2003; Powers and Walter, 1996).
To support the notion that the Alu domain was in close proximity to the same proteins in the
sampling and targeting complexes, we decided to determine the subunit association of the
SRP14 cross-link products in the sampling complex. We dissociated DSS-treated sampling
complexes with puromycin and high salt treatments and separated the ribosomal subunits by
sedimentation  through  a  sucrose  gradient  (for  more  details,  see  Results  1.4).  The  subunit
association of 14-X20 in the sampling complex was consistent with the cross-linking of SRP14
to the same protein in the sampling and targeting complex. Indeed, as in the targeting complex,
it was clearly detectable in the 80S fraction and in the 60S fraction, but was completely absent
from the 40S fraction (Figure 15E; compare with Figure 15C). The other cross-link products
were detectable in the 80S fraction, but were almost undetectable in the subunit fractions. We
therefore could not assign their subunit association (data not shown).
3.4 The orientation of the Alu domain in the ribosome changes upon signal sequence
recognition.
The detection of the same SRP14 cross-link products in the sampling and targeting complexes
suggested that the Alu domain is already located in close proximity to the EF-binding site
during nascent chain sampling. In order to compare more precisely the location of the Alu
domain  in  the  sampling  and  targeting  complexes,  we  quantified  the  intensities  of  the  SRP14
cross-link products from the reactions presented in Figure 12A. This quantification revealed a
noticeable change in the environment of the Alu domain upon signal sequence recognition.
Indeed, whereas 14-X20 was present at equal intensities in all reactions, the other cross-link
products became more abundant upon signal recognition (Figure 12B). In fact, the 14-X45 and
14-X31 signals were reproducibly 2.5-fold higher in reactions with pPl86 RNCs than with
Cyc130 RNCs. Similarly, 14-X17 was only detected with pPl86 RNCs.
Several observations were consistent with the interpretation that the change in the environment
of the Alu domain was triggered by signal sequence recognition. In this case, it should reach a
maximum, once all SRP was bound to ribosomes bearing pPl86 nascent chains (subsequently
called pPl86 ribosomes to avoid confusion with pPl86 RNC preparations which also comprise
vacant ribosomes). This hypothesis was tested experimentally by varying the ratio between
SRP and the number of pPl86 ribosomes in the cross-linking reactions. SRP is expected to bind
preferentially to pPl86 ribosomes because of its two orders of magnitude higher affinity
(Flanagan et al., 2003). To increase the number of pPl86 ribosomes, we raised the total amount
of ribosomes. Specifically, cross-linking reactions with Cyc130 and pPl86 RNCs were done at
ribosome-SRP ratios of 2:1 and 3:1. We found that in both cases 14-X45 and 14-X31 were 2.5
fold more abundant in cross-linking reactions with pPl86 RNCs than with Cyc130 RNCs
confirming that the increase was limited and that the maximum was already reached at the
lower  ribosome-SRP  ratio.  To  decrease  the  number  of  pPl86  ribosomes,  we  lowered  the
ribosome occupancy by adding less preprolactin and cyclin mRNAs while keeping the
ribosome-SRP  ratio  at  3:1.  At  2.5  fold  lower  ribosome  occupancy  as  in  the  previous
experiments, 14-X45 and 14-X31 were only 1.6 fold more abundant (results not shown).
Presumably, pPl86 ribosomes now become limiting and SRP was also bound to vacant
ribosomes thereby reducing the increase of 14-X45 and 14-X31.
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To confirm the change in the environment of the Alu domain upon signal sequence recognition
in a more functional assay, we performed the cross-linking assay in ongoing translations of
cyclin in rabbit reticulocyte lysate (see Results 1.6 for more details). For this experiment,
translations reactions were programmed with an mRNA encoding the full-length cyclin. To
allow a direct comparison with preprolactin translations, we chose concentrations of cyclin and
preprolactin mRNA that yielded comparable translation efficiencies for both proteins (Figure
16A-B). We could unambiguously detect the change in the environment of the Alu domain
upon signal sequence recognition in ongoing translations. Indeed, during cyclin synthesis, only
14-X20 was detected (Figure 16C, lanes 2 and 5), whereas the four SRP14 cross-link products
were detected during preprolactin synthesis (lanes 3 and 6). In addition, this analysis also
confirmed that the Alu domain was in close proximity to ribosomal components during nascent
chain sampling as SRP14 was cross-linked to the 20 kDa ribosomal protein in ongoing
translations of cyclin.
It is worth noting that 14-X20 was less abundant in cyclin translation (lane 2) than in
preprolactin translation (lane 3). It was even absent in mock translation (lane 1). These changes
in the 14-X20 signals appeared to parallel the expected relative affinities of SRP for the
different ribosomes as characterized for wheat germ ribosomes and canine SRP (Flanagan et
al., 2003). They were plausibly rationalized by assuming that other translation factors and/or
chaperones may compete with SRP binding to ribosomes in ongoing translation but not in the
experiments with artificially arrested, purified RNCs (Powers and Walter, 1996; Thulasiraman
et al., 1999). Importantly, this observation does not weaken our conclusion that the
environment of the Alu domain in the ribosome changes upon signal sequence recognition.
Indeed, when exogenous canine SRP was added to the rabbit reticulocyte lysate to increase the
formation of the SRP14 cross-link products during cyclin synthesis (lane 5, compare with
lane 2), the 14-X20 signal became almost 2-fold more intense as compared to the 14-X20
signal during preprolactin synthesis in the absence of exogenous SRP (lane 3). However, the
other SRP14 cross-link products were still undetectable during cyclin synthesis (lane 5),
confirming that the functionality of the change in the environment of SRP14 upon signal
sequence recognition.
3.6 Summary
The Alu domain  of  SRP is  required  for  the  formation  of  the  sampling  complex  (Powers  and
Walter, 1996), suggesting that it interacts with ribosomal components during sampling of the
nascent chain by SRP54. Our cross-linking assays with the sampling complex and in ongoing
translations of cyclin revealed that the Alu domain is already in close proximity to ribosomal
components during nascent chain sampling. They provided the first experimental evidence for
an interaction between the Alu domain and the ribosome during sampling of the nascent chain.
Our cross-linking analysis of the sampling complex also suggested the Alu domain is already
located in the EF-binding site during nascent chain sampling as SRP14 was cross-linked to
identical ribosomal proteins during sampling and elongation arrest (Results 1). However, upon
signal sequence recognition, we observed a change in the ribosomal environment of the Alu
domain.
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4 The Alu domain-ribosome interactions
- Episode 1 -
4.1 Strategy
The Alu domain  of  SRP is  specifically  required  for  the  elongation  arrest  activity  of  SRP.  To
perform its function, it might interact with the ribosome upon signal sequence recognition by
SRP54. Our cross-linking analyses were consistent with this model. Indeed, they demonstrated
that the Alu domain is stabilized in the ribosome upon signal sequence recognition (Results 1).
Moreover, its environment changes upon signal sequence recognition (Results 3). These
observations were consistent with the formation of functional interactions between the Alu
domain and the ribosome during elongation arrest. We were interested in defining such
functional interactions.
SRP and ribosomes are both very ancient ribonucleoprotein particles and are therefore likely to
interact through highly conserved motifs. From this point of view, SRP14 is a strong candidate
for a functional interaction with the ribosome during elongation arrest. Indeed, its highly
conserved C-terminal domain contains the five critical residues specifically required for the
elongation arrest activity of SRP (Figure 9). Since it is not ordered in the structure of the Alu
domain (Figure 7; Weichenrieder et al., 2000), it might be available for an interaction with the
ribosome, most likely with conserved motifs of the ribosomal RNA (rRNA) as it is highly
basic (9 out of 17 residues are lysines or arginines).
Figure 24: Putative secondary structures of human LGAR and SRL RNA. The structures were taken from Gorski et al., 1987 and
Holmberg et al., 1994, respectively. The stem-loop structures of the LGAR RNA were labelled according to E.coli (A1067 in E. coli
corresponds to G1960 in human and A1095 to A1987; both bases are bolded and colored in red) using the human 28S rRNA sequence
(Gonzalez et al., 1985).
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During elongation arrest, the Alu domain is located in close proximity to the elongation
factor-binding site (EF-binding site; Results 1). Interestingly, the EF-binding site contains two
highly conserved RNA motifs of the 28S rRNA, which are both essential for the function of the
EFs: the GTPase-associated region (LGAR) and the sarcin-ricin loop (SRL)(Hausner et al.,
1987; Holmberg et al., 1994; Moazed et al., 1988; Munishkin and Wool, 1997). Both motifs
interact with the EFs (Spahn et al., 2004; Valle et al., 2003)He et al., 2002). We therefore
hypothesised that, during elongation arrest, a transient interaction of the C-terminal domain of
SRP14 with one of these conserved RNA motifs might interfere with the binding of the EFs to
the ribosome. To support this hypothesis, we decided to test the ability of the heterodimer
SRP9/14 to form complexes with small synthetic RNAs corresponding to the SRL and LGAR
motifs of the 28S rRNA. This approach, termed “ribosome-in-pieces”, has been successfully
used  to  dissect  the  interaction  of  the  EFs  with  the  ribosome (He et  al.,  2002;  Munishkin  and
Wool, 1997)
Size exclusion chromatography (SEC) was used to detect interactions of these RNAs with the
heterodimer SRP9/14 (Materials and Methods 4.4). We did not expect a strong interaction
since the interactions occurring during elongation arrest must be transient. Our binding
conditions were therefore non-stringent (100 mM KCl). Based on preliminary experiments
(data not shown), we also used a low concentration of magnesium (0.5 mM). It was required to
detect interactions between SRP9/14 and the RNA fragments.
Figure 25: The formation of the LGAR-L12
complex under our in vitro conditions. A) The
elution profile of LGAR RNA on Superdex 200
in the absence (blue) or in the presence (green)
of  recombinant  human  L12.  The  LGAR  RNA,
alone (110 pmoles at 550 nM) or in the presence
of recombinant human L12 (110 pmoles of
LGAR RNA at 550 nM and 126 pmoles of L12
at 630 nM), was prepared as described in
Materials and Methods 4.4 and analysed by SEC
on a Superdex 200 column equilibrated with 100
mM KCl and 0.5 mM MgCl2. The elutions were
analysed by on-line spectrophotometry at 254
nm. B) The elution profile of recombinant
human L12 protein on Superdex 200 in the
absence (dark) or presence (green) of LGAR
RNA. The recombinant L12, alone (45 pmoles
at  225  nM)  or  in  the  presence  of  LGAR  RNA
(126 pmoles of L12 at 630 nM and 110 pmoles
of  LGAR  RNA  at  550  nM),  was  prepared  as
described in Materials and Methods 4.4 and
analysed by SEC on a Superdex 200 column
equilibrated with 100 mM KCl and 0.5 mM
MgCl2. Fractions (800 µl) were collected after
on-line spectrophotometry as shown in A. The
fraction 1 contained the elution volumes
between 5.6 ml and 6.4 ml, the fraction 2 the
elution volumes between 6.4 and 7.2 ml, etc.
The fractions were analysed by western blotting
with affinity-purified anti-L12 antibodies.
Western blots were quantified using a CCD
camera-based system (GeneGnome). The L12
content in each fraction is given as a percentage
of the sum of the signals in fractions 1 to 20.
These western blots were not set up to be
quantitative. In both panels, a small excess of
L12 upon LGAR RNA was used to ensure the
complete binding of LGAR RNA.
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The synthetic LGAR RNA comprised nucleotides 1923-2015 of human 28S rRNA (Figure 24;
Gonzalez  et  al.,  1985).  It  was  identical  to  the  one  used  in  He  et  al.,  2002.  We  also  purified
recombinant human L12 (Materials and Methods 1.6) to form the LGAR-L12 complex as the
LGAR motif binds ribosomal protein L12 (Figure 18). The synthetic SRL RNA comprised the
4552-4578 region of human 28S rRNA (Figure 24). As a negative control, we also analysed a
non-ribosomal RNA: the 4.5S RNA (Bovia and Strub, 1996). The 4.5S RNA did not bind to
the heterodimer SRP9/14 (Bovia et al., 1997). It is a small RNA (94 nucleotides) conserved in
all rodent species (Schoeniger and Jelinek, 1986). It is related to the Alu sequences  of  SRP
RNA although the typical Alu RNA secondary structure has not been conserved (Labuda and
Zietkiewicz, 1994). The synthetic 4.5S RNA was described in Bovia et al., 1997. The different
RNAs were produced and purified as described in Materials and Methods 2.2. We used the
recombinant human heterodimer SRP9/14 for these experiments. It was purified as described in
Materials and Methods 1.1.
Figure 26: Modifications of the set up for the analysis of the LGAR-L12 complex. A) The elution profile of LGAR RNA on Superdex
200 in the absence (blue) or in the presence (green) of recombinant human L12. The LGAR RNA alone (114 pmoles at 570 nM) or in the
presence of recombinant human L12 (114 pmoles of LGAR RNA at 557 nM and 144 pmoles of L12 at 720 nM) was prepared as
described in Materials and Methods 4.4 and analysed by SEC on a Superdex 200 column equilibrated with 100 mM KCl and 0.5 mM
MgCl2.  A 32P-labelled LGAR RNA (0.2 pmoles) was added to the cold LGAR RNA as a tracer. The elutions were fractionated and their
radioactivity content was determined by scintillation counting and converted to pmoles of RNA as described in Materials and
Methods 4.4. B) The elution profile of recombinant human L12 protein on Superdex 200 in presence of LGAR RNA. The fractions of the
experiment described in A were analysed by slot blotting and immunodetection with affinity-purified anti-L12 antibodies as described in
Materials and Methods 1.12. The immunoblot was quantified using a CCD camera-based system (GeneGnome). The L12 content in each
fraction is given as a percentage of the sum of the signals in fractions 1 to 20. An excess of L12 upon LGAR RNA was used to ensure the
binding of all LGAR RNA. The peak of free L12 is indicated by an arrow.
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4.2 The synthetic LGAR RNA forms a complex with ribosomal protein L12 in our in vitro
assay.
The formation of the LGAR-L12 complex was first assayed to validate our experimental
conditions.  L12 and LGAR RNA were incubated together as described in Materials and
Methods  4.4  and  complex  formation  was  analysed  by  SEC.  The  RNA content  of  the  column
elution was monitored continuously by measuring the optical density at 254 nm. To determine
the protein content of the column elution, 20 fractions were collected during chromatography
and analysed by western blotting with anti-L12 antibodies (Materials and Methods 1.11). We
unambiguously detected the LGAR-L12 complex under our experimental conditions (Figure
25).  Indeed,  the  LGAR  RNA  was  shifted  to  a  smaller  elution  volume  in  the  presence  of
recombinant human L12 (Figure 25A) as expected upon the formation of a larger complex. A
similar shift of the L12 peak was also detected in the presence of LGAR RNA (Figure 25B).
The protein and the RNA migrated precisely in the same fractions upon complex formation
(compare the green curves in panels A and B).
In  the  following  experiments,  we  modified  our  experimental  set  up.  First,  the  RNA  was
quantitatively detected in the fractions form the column elution by using a 32P-labelled LGAR
RNA as tracer (Materials and Methods 2.5). This modification allowed us to directly compare
the protein and RNA content of the fractions. Then, to fasten the detection of the protein in a
more quantitative way than western blotting, the fractions were analysed by slot blotting
followed by immunodetection (Materials and Method 1.13). The formation of the LGAR-L12
complex was confirmed with this new set up (Figure 26). To ensure that each LGAR RNA
molecule was bound by L12, we used an excess of the protein over the RNA, explaining the
detection of free L12 in fraction 13 (Figure 26B, green arrow).
Finally, the L12 footprint pattern on the LGAR RNA in the LGAR-L12 complex was
determined to definitely validate our experimental conditions. The LGAR RNA was
phosphorylated at its 5’ end with 32P and incubated in the presence of an excess of recombinant
L12 under our experimental conditions. The complexes were treated with hydroxyl radicals
(Materials and Methods 4.7; Tullius et al., 1987). The RNA fragments produced by the
cleavage of the hydroxyl radicals were visualized by Urea-PAGE and autoradiography (Figure
27). This analysis confirmed the formation of a bona fide LGAR-L12 complex under our
experimental conditions. Indeed, our protection pattern precisely overlapped with the one
previously determined using different chemicals with rat L12 bound to the 28S rRNA (Figure
27C; Uchiumi and Kominami, 1997). The G1959 stem loop of the LGAR RNA was highly
protected against hydroxyl radicals cleavage in the presence of L12 (Figure 27, A and B).
Compared to the previous study, we observed an additive protection in loops 1959 and 1987
(Figure 27B-C). These loops are base-paired in the L12-LGAR complex (Wimberly et al.,
1999). Under our experimental conditions (low concentration of magnesium), base-pairing
requires the binding of L12 (Uchiumi and Kominami, 1994), explaining our additive protection
in these loops upon L12 binding. In agreement, under the conditions used in the previous study
(higher concentration of magnesium), base-paring was stabilized even in the absence of L12,
explaining the lack of additive protection in these loops upon L12 binding.
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Figure 27: Footprinting analysis of the LGAR-L12 complex. A) The hydroxyl radical cleavage pattern of the LGAR RNA in the
absence or presence of recombinant, purified L12 is presented. The 5’ end-labelled LGAR RNA (less than 1 pmole) was incubated with
L12 (lanes 3 and 4, 3 and 15 pmoles, respectively), BSA (lane 2, 15 pmoles) or in the absence of proteins (lane 1) under the same
conditions used for the SEC analysis (Material and Methods 4.7). After treatment with hydroxyl radicals, the cleavage products were
separated by Urea-PAGE (8 % acrylamide) on a sequencing gel and detected by autoradiography. Sequencing reactions of the 5’
end-labelled LGAR RNA with T1 (lane G), U2 (lane A), PhyM (lane AU) and B. cereus (lane UC) RNAses were analysed in parallel,
together with a LGAR RNA ladder, to map the 3’ end of the cleavage products. B) The sites of protection against (filled arrowheads) or
enhancement of (open arrowhead) hydroxyl radicals cleavage in the presence of L12 are shown on the secondary structure of the
human LGAR RNA. The large and small arrowheads indicate the sites of strong or weak cleavage, respectively. C) The sites protected
(filled symbols) or made accessible (open symbols) by the binding of rat L12 on the rat LGAR RNA were previously published
(Uchiumi and Kominami, 1997). Arrowheads: phosphates affected by the protein binding. Circles: bases affected by the protein
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4.3 SRP9/14 has a significant affinity for a variety of RNAs.
The formation of the LGAR-L12 complex validated the experimental conditions. I therefore
tested the ability of the recombinant human heterodimer SRP9/14 to interact with the
LGAR-L12 complex (Figure 28), the LGAR RNA alone (Figure 29), the SRL RNA
(Figure 30) or the 4.5S RNA (Figure 31).
The SRP9/14 heterodimer interacted with the LGAR-L12 complex (Figure 28). It was clearly
shifted to fractions 9-10 in the presence of the complex (Figure 28C, compare the black and red
curves), co-migrating precisely with the complex (Figure 28A and B, respectively, red curve).
As expected, the LGAR-L12 complex was shifted in the presence of the heterodimer SRP9/14
(Figure 28, A and B, compare the green and red curves) although the shift was small. SRP9/14
most likely interacted with the LGAR RNA in the LGAR-L12 complex. Indeed it was also able
to interact with the LGAR RNA alone (Figure 29). An interaction between SRP9/14 and the
Figure 28: The interaction of the heterodimer
SRP9/14 with the LGAR-L12 complex.
A) The elution profile of LGAR RNA bound to
recombinant L12 on Superdex 200 in the absence
(green) or in the presence (red) of recombinant
SRP9/14. The LGAR RNP (114 pmoles of LGAR
RNA at 570 nM and 149 pmoles of L12 at 745 nM)
was prepared as described in Materials and
Methods 4.4. The LGAR RNP alone or in the
presence of the recombinant SRP9/14 (300 pmoles at
1.5 µM) was analysed by SEC on a Superdex 200
column equilibrated with 100 mM KCl and 0.5 mM
MgCl2.  A 32P-labelled LGAR RNA (0.2 pmoles) was
added  to  the  cold  LGAR  RNA  as  a  tracer.  The
elutions were fractionated and their radioactivity
content was determined by scintillation counting and
converted to pmoles of RNA as described in Materials
and Methods 4.4. B) The elution profile of
recombinant human L12 protein from the experiments
described in A. The fractions of the experiments
described in A were analysed by slot blotting and
immunodetection with affinity-purified anti-L12
antibodies as described in Materials and
Methods 1.12. The immunoblots were quantified
using a CCD camera-based system (GeneGnome).
The L12 content in each fraction is given as a
percentage of the sum of the signals in fractions 1 to
35. The free L12 in excess over the LGAR RNA was
detected in fraction 13 as described in Figure 26. C)
The elution profile of recombinant SRP9/14 in the
absence (black) or presence (red) of the LGAR RNP.
The heterodimer SRP9/14 alone (300 pmoles at 1.5
µM) or in the presence of the LGAR RNP (the same
experiment described in A and B) was analysed by
SEC on a Superdex 200 column equilibrated with 100
mM KCl and 0.5 mM MgCl2. The elutions were
fractionated and analysed by slot blotting and
immunodetection with affinity-purified anti-SRP14
antibodies as described in Materials and
Methods 1.12. The immunoblots were quantified
using a CCD camera-based system (GeneGnome).
The SRP14 content in each fraction is given as a
percentage of the sum of the signals in fractions 1 to
35. The free SRP9/14 (used in excess over the LGAR
RNP) was detected after fraction 18 as expected
(compare the red curve with the black one).
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SRL RNA was also detected (Figure 30). Due to the small size of the complex, the shifts were
small for both components, but again irrefutable. Finally, SRP9/14 also interacted with the
4.5S RNA (Figure 31). The unexpected interaction with the 4.5S RNA might be explained by
the low salt conditions of our assay ([KCl] = 100 mM). Indeed, the heterodimer SPR9/14 was
not able to interact with the 4.5S RNA under high salt conditions ([KOAc] = 350 mM). By
lowering the salt concentration, we might have revealed a weak, specific interaction between
these two macromolecules. In conclusion, the heterodimer SRP9/14 has a significant affinity
for a variety of RNAs under our binding conditions. It might be a characteristic of this protein
as L12 did not exhibit such an affinity (data not shown).
Figure 29: The interaction of the heterodimer SRP9/14 with the LGAR RNA. A) The  elution  profile  of  LGAR  RNA  on
Superdex 200 in the absence (blue) or in the presence (green) of recombinant SRP9/14. The LGAR RNA (100 pmoles at 500 nM)
was prepared as described in Materials and Methods 4.4. The LGAR RNA alone or in the presence of the recombinant SRP9/14 (100
pmoles  at  500  nM)  was  analysed  by  SEC on  a  Superdex  200  column equilibrated  with  100  mM KCl  and  0.5  mM MgCl2.  A 32P-
labelled LGAR RNA (0.2 pmoles) was added to the cold LGAR RNA as a tracer. The elutions were fractionated and their
radioactivity content was determined by scintillation counting and converted to pmoles of RNA as described in Materials and
Methods 4.4. B) The elution profile of recombinant SRP9/14 in the absence (black) or presence (green) of the LGAR RNA. The
heterodimer SRP9/14 alone (300 pmoles at 1.5 µM) or in the presence of the LGAR RNA (the same experiment described in A) was
analysed by SEC on a Superdex 200 column equilibrated with 100 mM KCl and 0.5 mM MgCl2. The elutions were fractionated and
analysed by slot blotting and immunodetection with affinity-purified anti-SRP14 antibodies as described in Materials and Methods
1.12. The immunoblots were quantified using a CCD camera-based system (GeneGnome). The SRP14 content in each fraction is
given as a percentage of the sum of the signals in fractions 1 to 35.
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Figure 30: The interaction of the heterodimer
SRP9/14 with the SRL RNA. A) The elution profile
of SRL RNA on Superdex 200 in the absence (blue)
or in the presence (green) of recombinant SRP9/14.
The  SRL  RNA  alone  (150  pmoles  at  750  nM)  or  in
the presence of recombinant SRP9/14 (780 pmoles at
3.9  µM)  was  prepared  as  described  in  Materials  and
Methods 4.4 and analysed by SEC on a Superdex 200
column equilibrated with 100 mM KCl and 0.5 mM
MgCl2. The elutions were analysed by on-line
spectrophotometry at 254 nm. B) The elution profile
of recombinant SRP9/14 on Superdex 200 in the
absence (dark) or presence (green) of SRL RNA. The
recombinant SRP9/14, alone (780 pmoles at 3.9 µM)
or in the presence of SRL RNA (the same experiment
described in A), was prepared as described in
Materials and Methods 4.4 and analysed by SEC on a
Superdex 200 column equilibrated with 100 mM KCl
and 0.5 mM MgCl2. Fractions (800 µl) were collected
after on-line spectrophotometry as shown in A. The
fraction 1 contained the elution volumes between 5.6
ml and 6.4 ml, the fraction 2 the elution volumes
between 6.4 and 7.2 ml, etc. The fractions were
analysed by western blotting with affinity-purified
anti-SRP14 antibodies (Materials and Methods 1.11).
Western blots were quantified using a CCD
camera-based system (GeneGnome). The SRP14
content in each fraction is given as a percentage of the
sum of the signals in fractions 1 to 20. These western
blots were not set up to be quantitative. The free
SRP9/14 (used in excess over the SRL RNA) was
detected in fractions 15 and after as expected
(compare the black and green curves).
Figure 31: The interaction of the heterodimer
SRP9/14 with the 4.5S RNA. A) The elution profile
of the 4.5S RNA on Superdex 200 in the absence
(blue) or in the presence (green) of recombinant
SRP9/14. The 4.5S RNA (100 pmoles at 500 nM) was
prepared as described in Materials and Methods 4.4
and analysed, alone or in the presence of the
recombinant SRP9/14 (100 pmoles at 500 nM) by
SEC on a Superdex 200 column equilibrated with 100
mM  KCl  and  0.5  mM  MgCl2.  A 32P-labelled 4.5S
RNA (0.2 pmoles) was added to the cold 4.5S RNA
as a tracer. The elutions were fractionated and their
radioactivity content was determined by scintillation
counting and converted to pmoles of RNA as
described in Materials and Methods 4.4. B) The
elution profile of recombinant SRP9/14 in the absence
(black)  or  presence  (green)  of  the  4.5S  RNA.  The
heterodimer SRP9/14 alone (300 pmoles at 1.5 µM)
or in the presence of the 4.5S RNA (the same
experiment described in A) was analysed by SEC on a
Superdex 200 column equilibrated with 100 mM KCl
and 0.5 mM MgCl2. The elutions were fractionated
and analysed by slot blotting and immunodetection
with affinity-purified anti-SRP14 antibodies as
described in Materials and Methods 1.12. The
immunoblots were quantified using a CCD
camera-based system (GeneGnome). The SRP14
content in each fraction is given as a percentage of the
sum of the signals in fractions 1 to 35.
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4.4 The C-terminal domain of SRP14 is not required for the observed interactions.
To address the question of the functionality of the observed interactions, we determined
whether the C-terminal domain of SRP14 was required. Indeed, it is specifically required for
elongation arrest and might directly contact a conserved motif of the rRNA as discussed
before.
We repeated our experiments with the heterodimer SRP9/14K95 instead of SRP9/14. The
SRP14K95 protein is truncated after lysine 95 and therefore lacks the region of SRP14
specifically required for elongation arrest (Figure 9). Our experiments with SRP9/14K95
indicated that the C-terminal domain of SRP14 is not required for the observed interactions
with the synthetic RNAs. Indeed, as shown in Figure 32, SRP9/14K95 could interact with the
LGAR  RNA  alone  (A),  the  LGAR-L12  complex  (B),  the  SRL  RNA  (C)  and  the  4.5S  RNA
(D). As expected due to the smaller size of SRP9/14K95, the shifts were smaller, but
irrefutable. In conclusion, we could not determine a functional interaction between SRP9/14
and one of the synthetic RNA.
Figure 32: The interactions of the SRP9/14K95 heterodimer with the synthetic RNAs. A) The elution profile of LGAR RNA on
Superdex 200 in the absence (blue) or in the presence (green) of recombinant SRP9/14K95. The LGAR RNA was prepared as
described in Materials and Methods 4.4 and analysed, alone (114 pmoles at 570 nM) or in the presence of the recombinant
SRP9/14K95 (100 pmoles of LGAR RNA at 500 nM and 150 pmoles of SRP9/14K95 at 750 nM), by SEC on a Superdex 200
column equilibrated with 100 mM KCl and 0.5 mM MgCl2.  A 32P-labelled LGAR RNA (0.2 pmoles) was added to the cold LGAR
RNA as a tracer. The elutions were fractionated and their radioactivity content was determined by scintillation counting and
converted to pmoles of RNA as described in Materials and Methods 4.4. B) The elution profile of LGAR RNA bound to
recombinant L12 on Superdex 200 in the absence (green) or in the presence (red) of recombinant SRP9/14K95. The LGAR RNP
(114 pmoles of LGAR RNA at 570 nM and 149 pmoles of L12 at 745 nM) was prepared as described in Materials and Methods 4.4.
The LGAR RNP, alone or in the presence of the recombinant SRP9/14K95 (300 pmoles at 1.5 µM) was analysed by SEC on a
Superdex 200 column equilibrated with 100 mM KCl and 0.5 mM MgCl2. A 32P-labelled LGAR RNA (0.2 pmoles) was added to the
cold LGAR RNA as a tracer. The elutions were fractionated and their radioactivity content was determined by scintillation counting
and converted to pmoles of RNA as described in Materials and Methods 4.4. C) The elution profile of SRL RNA on Superdex 200 in
the absence (blue) or in the presence (green) of recombinant SRP9/14K95. The SRL RNA, alone (150 pmoles at 750 nM) or in the
presence of recombinant SRP9/14 (756 pmoles at 3.78 µM), was prepared as described in Materials and Methods 4.4 and analysed
by SEC on a Superdex 200 column equilibrated with 100 mM KCl and 0.5 mM MgCl2. The elutions were analysed by on-line
spectrophotometry at 254 nm. D) The elution profile of the 4.5S RNA on Superdex 200 in the absence (blue) or in the presence
(green) of recombinant SRP9/14K95. The 4.5S RNA (100 pmoles at 500 nM) was prepared as described in Materials and
Methods 4.4 and analysed, alone or in the presence of the recombinant SRP9/14K95 (100 pmoles at 500 nM) by SEC on a Superdex
200 column equilibrated with 100 mM KCl and 0.5 mM MgCl2.  A 32P-labelled 4.5S RNA (0.2 pmoles) was added to the cold 4.5S
RNA as a tracer. The elutions were fractionated and their radioactivity content was determined by scintillation counting and
converted to pmoles of RNA as described in Materials and Methods 4.4.
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Figure 33: The interactions of the SRP9/14-NEM heterodimer with the synthetic RNAs. A) NEM treatment inactivates the
Alu RNA-binding domain of SRP9/14. The Alu151 RNA (see Figure 8; 5 pmoles) was biotinylated, immobilized on streptavidin beads
and incubated with 1 pmoles of SRP9/14 (left) or SRP9/14-NEM (right). Bound proteins (lane B) were recovered and detected by western
blotting with affinity-purified anti-SRP14 antibodies. Unbound proteins were detected in parallel (lane U). I: input (1 pmoles of the
analysed heterodimer). Gel: 5-20% acrylamide (gradient gel). M: Molecular weight standards (in kDa). B) The elution profile of LGAR
RNA on Superdex 200 in the absence (blue) or in the presence (green) of recombinant SRP9/14NEM. The LGAR RNA was prepared as
described in Materials and Methods 4.4 and analysed, alone (114 pmoles at 570 nM) or in the presence of the recombinant SRP9/14NEM
(100 pmoles of both at 500 nM), by SEC on a Superdex 200 column equilibrated with 100 mM KCl and 0.5 mM MgCl2.  A 32P-labelled
LGAR RNA (0.2 pmoles) was added to the cold LGAR RNA as a tracer. The elutions were fractionated and their radioactivity content
was determined by scintillation counting and converted to pmoles of RNA as described in Materials and Methods 4.4. C) The elution
profile of LGAR RNA bound to recombinant L12 on Superdex 200 in the absence (green) or in the presence (red) of recombinant
SRP9/14NEM. The LGAR RNP (was prepared as described in Materials and Methods 4.4 and analysed, alone (114 pmoles of LGAR
RNA at 570 nM and 144 pmoles of L12 at 720 nM) or in the presence of the recombinant SRP9/14 (100 pmoles of LGAR RNA at 520
nM, 144 pmoles of L12 at 720 nM and 143 pmoles of SRP9/14NEM at 715 nM), by SEC on a Superdex 200 column equilibrated with
100 mM KCl and 0.5 mM MgCl2.  A 32P-labelled LGAR RNA (0.2 pmoles) was added to the cold LGAR RNA as a tracer. The elutions
were fractionated and their radioactivity content was determined by scintillation counting and converted to pmoles of RNA as described in
Materials and Methods 4.4. D) The elution profile of the 4.5S RNA on Superdex 200 in the absence (blue) or in the presence (green) of
recombinant SRP9/14Delta12-NEM (see Results 4.6 for details). The 4.5S RNA (100 pmoles at 500 nM) was prepared as described in
Materials and Methods 4.4 and analysed, alone or in the presence of the recombinant SRP9/14Delta12-NEM (100 pmoles at 500 nM) by
SEC on a Superdex 200 column equilibrated with 100 mM KCl and 0.5 mM MgCl2. A 32P-labelled 4.5S RNA (0.2 pmoles) was added to
the cold 4.5S RNA as a tracer. The elutions were fractionated and their radioactivity content was determined by scintillation counting and
converted to pmoles of RNA as described in Materials and Methods 4.4. E) The elution profile of LGAR RNA bound to recombinant L12
on Superdex 200 in the absence (green) or in the presence (red) of recombinant SRP9/14Delta12-NEM (see Results 4.6 for details). The
same experiment described in C was performed, but the heterodimer SRP9/14Delta12-NEM (200 pmoles at 1 µM) was used instead of
SRP9/14-NEM.
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4.5 A functional Alu RNA-binding domain is not required for the observed interactions.
Another domain of the heterodimer SRP9/14 that might participate in the observed interactions
is the six-stranded anti-parallel ?-sheet that contacts the Alu sequences of SRP RNA (Alu RNA
herein; see Introduction 5.2). We assayed the requirement for a functional Alu RNA-binding
domain with NEM-treated SRP9/14 (SRP9/14-NEM).  SRP9/14-NEM was unable to interact
with SRP RNA (Siegel and Walter, 1988b) and with Alu RNA (Figure 33A) demonstrating that
its Alu RNA-binding domain was inactivated.
SRP9/14-NEM interacted with the LGAR RNA alone (Figure 33B), the LGAR-L12 complex
(Figure 33, C and E) and the 4.5S RNA (Figure 33D), indicating that a functional Alu
RNA-binding domain is not required for the observed interactions.
4.6 An undefined region of the heterodimer might interact with RNA.
Preliminary experiments with the heterodimer SRP9/14 suggested that more than one SRP9/14
might be bound to each RNA molecule in our experiments (data not shown). Indeed, when an
equimolar amount of both synthetic RNA and SRP9/14 was used (e.g. Figure 29), all of the
protein was bound whereas a fraction of the RNA was not. By increasing the amount of
SRP9/14 in the assay, the synthetic RNA was completely bound and larger complexes were
detected (data not shown). For example, from the analysis of several experiments, three to four
SRP9/14 heterodimers were predicted to interact with the LGAR RNA (data not shown). This
possibility prevented us to conclude that the C-terminal domain of SRP14 is not required for
the observed interactions. Indeed, in the complexes containing several SRP9/14, we cannot
exclude that one heterodimer interacts with the RNA via the C-terminal domain of SRP14,
another via a functional Alu RNA-binding domain, etc. Thus SRP9/14K95 might still interact
with RNA via its functional Alu RNA-binding domain. Conversely, SRP9/14-NEM might still
interact with RNA via the C-terminal domain of SRP14.
To test these hypotheses, I analysed the SRP9/14Delta12-NEM heterodimer in our assay.
SRP14Delta12 was internally deleted for residues K96 to K107 and therefore specifically
defective in elongation arrest (Mary C. and Strub K., unpublished data). Although its Alu
RNA-binding domain was inactivated, SRP9/14Delta12-NEM was still able to bind the 4.5S
RNA and the LGAR RNP (Figure 33, D and E), corroborating the conclusions of our previous
experiments. Taken together, all our binding experiments suggested that an undefined region of
the heterodimer outside the C-terminal domain of SRP14 might interact with RNA in our in
vitro assay.
4.7 Remarks and perspectives
The results of our “ribosome-in-pieces” analysis remain puzzling. Pejorative factors prevented
us to demonstrate or refute the notion that the C-terminal domain of SRP14 interacts with
conserved motifs of the rRNA during elongation arrest. As discussed (Results 4.6), the
interpretation of our results was hampered by the binding of several heterodimers to each RNA
molecule in our assays. We could also not exclude that the Alu RNA-binding domain does not
contact  RNA  in  our  assay.  Indeed,  its  inactivation  with  NEM  might  be  very  specific  for  the
interaction with Alu RNA. Thus, non-related RNAs might still contact this highly basic
surface.   In  order  to  validate  the  conclusions  of  our  experiments,  we  have  to  find  conditions
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under which our complexes would contain only one heterodimer and one RNA. For that
purpose, the method of analysis must be changed because SEC is not suitable if different
binding conditions have to be tested since it is time-consuming and does not allow the analysis
of multiple samples in parallel. Moreover, we lately observed that SRP9/14 has an unexpected
affinity for the column (e.g. Figure 28C, dark curve). Such an affinity hampered the
quantitative interpretation of our results.
4.8 Summary
We were interested in defining functional interactions between the Alu domain and the
ribosome. The C-terminal domain of SRP14 which is specifically required for elongation arrest
and conserved RNA motifs of the 28S rRNA making up the EF-binding site (the LGAR and
SRL motifs)  were  strong  candidates  for  a  functional  interaction  during  elongation  arrest.  We
tested the ability of the heterodimer SRP9/14 to form complexes with different synthetic
RNAs, including the LGAR and SRL motifs, by size exclusion chromatography. Our
experimental conditions were validated by the interaction between the LGAR RNA and its
associated ribosomal protein L12. However, we have not yet been able detect a functional
interaction as the heterodimer SRP9/14 exhibited a significant affinity for a variety of RNAs
under our binding conditions. These interactions were not abolished in the absence of the
C-terminal domain of SRP14 together with the inactivation of the Alu RNA-binding domain,
suggesting that another domain of the heterodimer outside the C-terminal domain of SRP14
might interact with RNA.
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5 The Alu domain-ribosome interactions
- Episode 2 -
5.1 Strategy
Our cross-linking assays with the sampling complex and in ongoing translations of a
non-secretory protein demonstrated that the Alu domain of SRP is already in close proximity to
ribosomal  components  when  SRP54  samples  the  nascent  chain  for  the  presence  of  a  signal
sequence (Results 3). They supported the notion that the Alu domain might interact with the
ribosome in the sampling complex. The SRP9/14 heterodimer is a strong candidate for such a
functional interaction since its presence in SRP is required for the formation of the sampling
complex (Powers and Walter, 1996). To support a functional interaction between the Alu
domain and ribosomal components during nascent chain sampling, the ability of an Alu domain
mimic to interact with the ribosome was assayed in an in vitro ribosome-binding assay.
Figure 34: In vitro ribosome-binding assay with the Alu151 RNP. The Alu151 RNP (6 pmoles at 200 nM) was incubated in low salt
conditions ([KOAc] = 50 mM) in the absence (“-“) or in the presence (“+”) of mock ribosomes (6 pmoles at 200 nM) purified either
from from the rabbit reticulocyte lysate (RR ribosomes; A to C) or form the wheat germ extract (WG ribosomes; D to F). The samples
were laid on sucrose cushions and the ribosomes were pelleted by centrifugation. To detect the Alu151 RNA (A and D), SRP9/14 (B
and E) and the ribosomes (C and F) after centrifugation, 1/6e of the cushions (“S”) and the ribosomal pellets (“P”) was analysed as
described in Materials and Methods 4.6. “I”: Input (1/6e of the amount of each component used in the assay). A and D) Detection of
the Alu151 RNA by scintillation counting. To facilitate the detection of the Alu151 RNA, a small amount of 32P-labelled Alu151 RNA
was used during the Alu151 RNP reconstitution (see Materials and Methods 3.1). The amount of Alu151  RNA  in  the  “S”  and  “P”
fractions  was  expressed  as  a  percentage  of  the  input,  which  was  set  at  100%. B and E) Detection of the heterodimer SRP9/14 by
western blotting with affinity-purified anti-SRP14 antibodies. C and F) Detection of the ribosomes by western blotting with anti-L9
antibodies. Gel: 15 % acrylamide. M: Molecular weight standards (in kDa).
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5.2 The Alu domain of SRP does not interact with the ribosome.
The components of the Alu domain are the Alu sequences  of  SRP RNA and the  heterodimer
SRP9/14 (Introduction 5.2). For the in vitro ribosome-binding assay with the Alu domain of
SRP,  we used  the Alu151 RNP as  a  SRP Alu domain mimic. This RNP was reconstituted in
vitro with recombinant human SRP9/14 heterodimer and in vitro transcribed Alu151 RNA
(Materials and Methods 3.1). The Alu151 RNA was constructed by closing the Alu sequences
of SRP RNA at the junctions with the S domain by a GUAA tetraloop (Figure 8). The Alu151
RNP therefore comprises all the components of the Alu domain  of  SRP.  If  the Alu domain
interacts with the ribosome, this interaction might be recapitulated with the Alu151 RNP.
To assay the ability of the Alu151 RNP to interact with the ribosome, we adapted a previously
described in vitro ribosome-binding assay (Powers and Walter, 1996; Thomas et al., 1997).
The Alu151 RNP was incubated under low salt conditions ([KOAc] = 50 mM) with mock
ribosomes (that did not expose a nascent chain at the ribosomal exit site; Results 1.3) purified
either from the wheat germ extract (WG ribosomes) or from the rabbit reticulocyte lysate (RR
ribosomes). To fractionate the free and ribosome-bound Alu151 RNP, the samples were laid on
sucrose cushions and the ribosomes were pelleted by centrifugation. After centrifugation, the
cushions contained the free Alu151 RNP (“S” fraction; e.g. Figure 34A-B, “- RR ribosomes”)
and the ribosomal pellets (“P” fraction) would contain the ribosome-bound Alu151 RNP
provided that it interacted with the ribosome. To detect the Alu151 RNP in the “S” and “P”
fractions, a tracer amount of 32P-labelled Alu151 RNA was added during the reconstitution of
the Alu151 RNP. It allowed the detection of the RNA by scintillation counting (see Materials
and Methods 3.1 and 4.6). The SRP9/14 heterodimer was detected by western blotting with
affinity-purified anti-SRP14 antibodies. The efficiency of ribosomes sedimentation was
assayed by western blotting with anti-L9 antibodies (e.g. Figure 34C, “+ RR ribosomes”).
Figure 35: In vitro ribosome-binding assay with the Alu151 RNA. The Alu151 RNA (6 pmoles at 200 nM) was incubated in low salt
conditions ([KOAc] = 50 mM) in the absence (“-“) or in the presence (“+”) of mock ribosomes (6 pmoles at 200 nM) purified from either
the rabbit reticulocyte lysate (RR ribosomes) or the wheat germ extract (WG ribosomes). The samples were laid on sucrose cushions and
the ribosomes were pelleted by centrifugation. To detect the Alu151 RNA (A and B) and the ribosomes (C and D) after centrifugation,
1/6e of the cushion (“S”) and the ribosomal pellet (“P”) was analysed as described in Materials and Methods 4.6. “I”: Input (1/6e of the
amount of each component used in the assay). A and B) Detection of the Alu151 RNA by scintillation counting. To facilitate the detection
of the Alu151 RNA, a small amount of 32P-labelled Alu151 RNA was used as a tracer (see Materials and Methods 2.5). The amount of
Alu151 RNA in the “S” and “P” fractions was expressed as a percentage of the input, which was set at 100%. C and D) Detection of the
ribosomes by western blotting with anti-L9 antibodies. Gel: 15 % acrylamide. M: Molecular weight standards (in kDa).
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We could not detect an interaction between the Alu151 RNP and the ribosome in our in vitro
ribosome-binding assay (Figure 34). Indeed, the Alu151 RNA (A and D) or the SRP9/14
heterodimer (B and E) were only detected in the cushions, as in the absence of ribosomes. The
ribosomes were properly pelleted (C and F). However, we could not exclude that, under our
experimental conditions, this interaction could not occur. First, the central stem of the
Alu151 RNA (nucleotides 64 to 282; Figure 8) which is not required for the high-affinity
binding of the heterodimer SRP9/14 (Weichenrieder et al., 1997), might interfere with the
interaction of another region of the Alu domain with the ribosome if not properly folded. In
agreement, we could not detect an interaction between the ribosome and the Alu151 RNA
(Figure 35). We are currently testing an Alu RNP containing a smaller Alu RNA (SA86 RNA;
Figure 8). In addition, the use of RNCs might be required to detect an interaction between the
Alu domain and the ribosome. Indeed the mammalian SRP can sense the translational state of
the ribosome as it has an increased affinity for RNCs over mock ribosomes caused by a change
in ribosome conformation at the SRP-binding site (Flanagan et al., 2003). It is feasible that the
Alu domain participates in this SRP activity. Indeed, the bacterial SRP, that lacks an Alu
domain,  was  unable  to  sense  the  translational  state  of  the  ribosome  (Raine  et  al.,  2004.  The
interaction of the Alu domain  with  the  ribosome  would  therefore  be  restricted  to  ribosomes
engaged in translation. To answer this question, we are currently assaying Cyc130 RNCs in our
in vitro ribosome-binding assay.
Figure 36: The interaction of the heterodimer SRP9/14 and SRP9/14K95 with the ribosome. The recombinant heterodimers SRP9/14
and SRP9/14K95 (1 pmole at 33.3 nM) were separately incubated in low salt conditions ([KOAc] = 50 mM) in the absence (“-“) or in the
presence (“+”) of mock ribosomes (2 pmoles at 66.6 nM) purified from either the rabbit reticulocyte lysate (RR ribosomes) or the wheat
germ extract (WG ribosomes). The samples were laid on sucrose cushions and the ribosomes pelleted by centrifugation. To detect the
heterodimers (A and C) and the ribosomes (B  and D) after centrifugation, all of the cushion (“S”) and the ribosomal pellet (“P”) was
analysed as described in Materials and Methods 4.6. A) Detection of the SRP9/14 heterodimer by western blotting with affinity-purified
anti-SRP14 antibodies. B) Detection of the ribosomes by western blotting with anti-L9 antibodies. C) Detection of the SRP9/14K95
heterodimer by western blotting with affinity-purified anti-SRP14 antibodies. D) Detection of the ribosomes by western blotting with
anti-L9 antibodies. Gels: 5-20 % acrylamide (gradient gels). M: Molecular weight standards (in kDa).
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5.3 The SRP9/14 heterodimer alone interacts with the ribosome in proximity to an
18 kDa protein associated with the small ribosomal subunit.
As previously mentioned, the SRP9/14 heterodimer is a strong candidate for a functional
interaction with the ribosome since it is required for the formation of the sampling complex. In
agreement with this notion, we observed that the heterodimer SRP9/14 alone interacted with
the ribosome (Figure 36). Indeed, nearly all of the heterodimer was bound to the WG or RR
ribosomes in our ribosome-binding assay, as determined by the detection of SRP14 in the
ribosomal pellets (Figure 36A). This is the first experimental observation that a component of
the Alu domain interacts with the ribosome.
To address the question of the functionality of the interaction, we determined the environment
of SRP14 in the SRP9/14-ribosome complex using DSS, a homo-bifunctional cross-linker (see
Results  1.1  for  more  details).  If  the  location  of  SRP9/14  was  identical  to  the  one  of  the Alu
domain of SRP in SRP-ribosome complexes (Figure 12A), we expected to detect the same
SRP14 cross-link products in all complexes. The cross-link product between SRP14 and
ribosomal proteins in SRP9/14-ribosome complexes were detected by western blotting with
affinity-purified anti-SRP14 antibodies. When SRP9/14-ribosome complexes where reacted
with DSS, only one major SRP14 cross-link product involving a ribosomal protein of 18 kDa
was detected (Figure 37, lane 4). A few other signals were detected, especially a cross-link
product with a protein of 15 kDa. This observation demonstrated that SRP14 cross-link
patterns were different in SRP-ribosome and SRP9/14-ribosome complex. Indeed four
cross-link products with ribosomal proteins of 17, 20, 31 and 45 kDa were detected in the
Figure 37: Cross-linking analysis of the SRP9/14-ribosome complex. Western blotting analysis with affinity-purified anti-SRP14
antibodies of SRP9/14-pPl86 RNC complexes reacted with DSS as indicated. SRP9/14 (3 pmoles at 100 nM) was incubated under low
salt conditions ([KOAc] = 50 mM) with pPl86 RNC (10 pmoles at 333 nM) purified from the wheat germ extract. The samples were
reacted with DSS (100 µM final concentration). The SRP14 cross-link products are labelled as described in Results 1.1. Arrowheads
indicate other SRP14 cross-link products involving ribosomal proteins (see Results 5.6). The white dot indicates a putative SRP14-SRP14
cross-link product (see Results 5.6). The star indicates a ribosomal protein fortuitously recognized by the anti-SRP14 antibodies. Gel:
12 % acrylamide. M: Molecular weight standards (in kDa).
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SRP-ribosome complexes (Figure 12A). Thus we could not conclude that the interaction of
SRP9/14 with the ribosome is functional. We could also not exclude this possibility. Indeed
SRP9/14  might  interact  with  the  ribosome  in  the  same  location  as  the Alu domain, but in a
different orientation, explaining the difference in the SRP14 cross-link patterns. Indeed, in the
SRP-ribosome complexes, the location and the orientation of the Alu domain might be
precisely  constrained  by  the  orientation  of  the  central  stem  of  the  SRP  RNA  (Discussion  2).
The heterodimer SRP9/14 alone might therefore have fewer constraints on its orientation when
bound to the ribosome. To support the notion that SRP9/14 is bound in the same position as the
one occupied by the Alu domain, but in a different orientation, we will have to identify the 18
kDa protein cross-linked to SRP14.
Figure 38: The subunit association of the ribosomal protein cross-linked to SRP14 in the SRP9/14-ribosome complex.  SRP9/14
(3 pmoles at 100 nM) was incubated under low salt conditions ([KOAc] = 50 mM) with pPl86 RNC (10 pmoles at 333 nM) purified from
the wheat germ extract. The complexes were treated with DSS (100 µM final concentration) prior to dissociation into subunits as
described in Materials and Methods 4.2. The ribosomal subunits were purified by sedimentation through a sucrose gradient. A) The
ribosomal RNA content of the gradient was determined by on-line spectrophotometry at 254 nm during fractions collection (20 fractions
of 600 µl). The fractions containing the small (40S) and large (60S) ribosomal subunits, as well as non-dissociated ribosomes (80S), are
indicated. The top and the bottom of the gradient are indicated. B) Western blotting analysis with affinity-purified anti-SRP14 of the
fractions collected in A. The fractions corresponding to the small (40S) and large (60S) subunits, as well as non-dissociated ribosomes
(80S) are indicated as determined in A. The SRP14 cross-link products are labelled as described in Results 1.1 *: a ribosomal protein of
the small subunit fortuitously recognized by the anti-SRP14 antibodies. Gel: 12 % acrylamide. M: Molecular weight standards (in kDa).
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To locate more precisely the SRP9/14-binding site, we determined the subunit association of
14-X18. DSS-treated SRP9/14-pPl86 RNC complexes were dissociated into 40S and 60S
subunits and the subunits purified by sedimentation through a sucrose gradient as described in
Materials and Methods 4.2. The gradient was fractionated as described in Results 1.4 and the
fractions analysed by western blotting with affinity-purified anti-SRP14 antibodies
(Figure 38B). This analysis demonstrated that 14-X18 was associated with the small ribosomal
subunit.  Indeed,  it  was  present  in  the  40S  fractions  (fractions  11  to  13),  but  was  completely
absent  from the  60S fractions  (fractions  16  and  17).  As  expected,  it  was  also  detected  in  the
80S fraction (fraction 19) containing non-dissociated ribosomal complexes. In conclusion,
SRP14 is cross-linked to an 18 kDa protein of the small subunit in the SRP9/14-ribosome
complex.
5.4 The heterodimer SRP9/14 did not interact with the ribosome via the C-terminus of
SRP14.
To demonstrate the functionality of the SRP9/14 interaction with the ribosome, we determined
whether the C-terminal domain of SRP14 was required for the interaction. Indeed the highly
conserved C-terminal domain of SRP14 is a strong candidate for a functional interaction with
the ribosome (see Results 4). It contains the five critical residues specifically required for the
elongation arrest activity of SRP (Figure 9). Since it is not ordered in the structure of the Alu
domain (Figure 7; Weichenrieder et al., 2000), it is most likely available for an interaction with
the ribosome, presumably with conserved motifs of the ribosomal RNA (rRNA) as it is highly
basic (9 out of 17 residues are lysines or arginines).
To determine whether the C-terminal domain of SRP14 was required for the interaction, we
used the SRP9/14K95 heterodimer in our in vitro ribosome-binding assay.  The SRP14K95
protein is truncated after lysine 95 and therefore lacks the region of SRP14 specifically
required for elongation arrest (Figure 9). SRP9/14K95 interacted with both WG and RR
ribosomes (Figure 36C), indicating that the C-terminus of SRP14 was not required for
ribosome-binding.
5.5 A functional Alu RNA-binding domain is not required for the interaction with the
ribosome.
Another domain of the heterodimer SRP9/14 that might participate in the observed interactions
is the six-stranded anti-parallel ?-sheet that contacts the Alu sequences of SRP RNA (Alu RNA
herein; Introduction 5.2). We assayed the requirement for a functional Alu RNA-binding
domain with NEM-treated SRP9/14 (SRP9/14-NEM).  SRP9/14-NEM was unable to interact
with SRP RNA (Siegel and Walter, 1988b) and with Alu RNA (Figure 33A) demonstrating that
its Alu RNA-binding domain was inactivated.
To assay the binding of the heterodimer SRP9/14-NEM to the ribosome, we used size
exclusion chromatography (SEC). Instead of separating free and ribosome-bound heterodimer
by sedimentation through sucrose cushions, the samples were loaded on a Superdex 200
column (Materials and Methods 4.6). Fractions were collected and their content in ribosomes
and heterodimers was determined by western blotting with anti-L9 and affinity-purified
anti-SRP14 antibodies, respectively. SRP9/14-NEM was able to interact with both the WG and
RR ribosomes (Figure 39C). It was exclusively found in the ribosome fraction (fraction 2) in
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the  presence  of  WG  ribosomes  (compare  the  anti-SRP14  and  anti-L9  panels).  Similarly,  the
interaction between the heterodimer SRP9/14 and WG ribosomes was also detected by SEC
(Figure  39A).  As  expected  from  previous  results  (Results  4.6),  in  the  absence  of  ribosomes
(Figure 39B and D), both heterodimers were not restricted to the ribosome fraction, but were
detected through all of the elution. Thus this analysis indicated that a functional
Alu RNA-binding domain was not required for ribosome-binding.
Figure 39: The interaction of the heterodimer SRP9/14 and SRP9/14-NEM with the ribosome. The recombinant heterodimers
SRP9/14 (A and B) and SRP9/14-NEM (C and D) were separately incubated under low salt conditions ([KOAc] = 50 mM) in the absence
(“-“) or in the presence (“+”) of mock ribosomes purified from the wheat germ extract (WG ribosomes). The samples were separately
fractionated by size exclusion chromatography as described in Materials and Methods 4.6. Ten fractions were collected. To detect the
SRP9/14 heterodimers and the ribosomes, 25 % of each fraction were analysed by western blotting, first with affinity-purified anti-SRP14
antibodies, then with anti-L9 antibodies if ribosomes were present in the samples. The SRP9/14 heterodimers were used at 33.3 nM (1
pmole). The WG ribosomes were used at 66.6 nM (2 pmoles). Gels: 5-20 % acrylamide (Gradient gels).  M: Molecular weight standards
(in kDa).
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5.6 Remarks and perspectives
The functional domains of the SRP9/14 heterodimer (the C-terminal domain of SRP14 and the
Alu RNA-binding domain) were not required for the interaction with the ribosome. Indeed, the
heterodimers SRP9/14K95 (lacking the C-terminal domain of SRP14) and SRP9/14-NEM
(containing an inactive Alu RNA-binding  domain)  were  able  to  interact  with  the  ribosome.
However, the interpretation of our data was hampered by the possibility that at least two
heterodimers might be bound to each ribosome in our experiments (data not shown). This
observation was corroborated by the detection of several weak cross-link products when
SRP9/14-ribosome complexes were treated with DSS (Figure 37, lane 4, arrowheads),
suggesting that SRP9/14 has a weak affinity for several sites on the ribosome. If it is the case,
we cannot conclude that neither the C-terminal domain of SRP14 nor a functional Alu
RNA-binding domain is required for the interaction. Indeed, SRP9/14K95 might interact with
the ribosome through its Alu RNA-binding domain at one ribosomal site, whereas the
SRP9/14-NEM heterodimer could interact via the C-terminal domain of SRP14 at another
ribosomal site. This question might be addressed by analysing the SRP14 cross-linking pattern
in SRP9/14K95-ribosome and (SRP9/14-NEM)-ribosome complexes. If one of these
heterodimers  is  no  more  able  to  interact  in  the  proximity  to  the  18  kDa  protein  as  SRP9/14
does, we should be unable to detect 14-X18. Alternatively, SRP9/14 could interact with the
ribosome in the proximity to the 18 kDa protein as a dimer of heterodimer, explaining why two
heterodimers could bind to each ribosome in our assay. This possibility was suggested by the
detection of a SRP14-SRP14 cross-link product under our experimental conditions (Figure 37,
lane 2, white dot). In this case, the binding of SRP9/14 to the ribosome might be independent
of  the  C-terminal  domain  of  SRP14  and  of  a  functional Alu RNA-binding domain. It would
therefore suggest that another undefined region of the heterodimer might contact the ribosome,
as suggested for the interactions with the synthetic RNAs (Results 4.6).
What would be the physiological significance of the SRP9/14-ribosome interaction? In primate
cells, the SRP9/14 heterodimer is present in more than 20-fold excess over SRP and exists
primarily free in the cytoplasm (Bovia et al., 1995). Thus the free heterodimer might contact
the ribosome in vivo. In agreement, the free heterodimer is expected to be 2-fold more
abundant than the ribosome (Walter and Johnson, 1994). These observations suggest that
SRP9/14 might play a role during translation in primate cells. To support this notion, in vivo
cross-linking of SRP9/14 to ribosome might be performed in culture of primate cells. Rodent
cells may be used as a control to monitor the in vivo cross-linking of SRP14 to the ribosome in
SRP-ribosome complexes. Indeed, in these cells, all SRP9/14 is assembled in SRP and free
heterodimers are not detected (Bovia et al., 1995).
5.6 Summary
The close proximity between SRP14 and ribosomal components during nascent chain sampling
(Results 3) supported the hypothesis that the Alu domain of SRP might interact with the
ribosome. However this hypothesis was not supported by our in vitro ribosome-binding assay
with the Alu151 RNP, an Alu domain mimic. Indeed, we have not been able to detect its
binding to the ribosome. Interestingly, binding of the heterodimer SRP9/14 alone to the
ribosome was detected. This is the first experimental observation of an interaction between a
component of the Alu domain and the ribosome. SRP9/14 interacted with the ribosome in the
proximity of an 18 kDa protein from the small ribosomal subunit, suggesting that it occupies a
different location in the ribosome when compared to the Alu domain  of  SRP.  Moreover,  the
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functional domains of the heterodimer SRP9/14 (the C-terminal domain of SRP14 and the Alu
RNA-binding domain) were not required for ribosome binding, suggesting that an undefined
region of SRP9/14 might interact with the ribosome. Unfortunately, these observations did not
allow us to demonstrate the functionality of this interaction. However, it might be
physiologically relevant in primate cells, in which the SRP9/14 is found in excess over SRP
- 75 -
Discussion
- 76 -
1 The peculiar mechanism of the elongation arrest activity of SRP
During this work, we have been mainly interested in the first two steps of the SRP cycle
leading to the formation of a SRP-ribosome complex primed for docking at the ER membrane.
The formation of this “targeting complex” requires the recognition and the binding of the
signal sequence exposed at the nascent chain exit site by SRP. Upon signal sequence
recognition, SRP arrests the elongation of the growing nascent chain. The Alu domain of SRP
is specifically required for the elongation arrest  activity of SRP. Our goal was to reveal how
the Alu domain of SRP interferes with the elongation of the nascent chain.
To perform its function, the Alu domain most likely interacts with an active site in the
ribosome. The active sites of ribosome during the elongation cycle are 1) the elongation
factor-binding site (EF-binding site), where the EFs interact with the ribosome to perform their
tasks (amino acyl-tRNA delivering to the A site for EF1A and translocation of the tRNAs after
transpeptidylation for EF2; Andersen et al., 2003); 2) the decoding center, where the
codon-anticodon interaction is controlled to ensure translation fidelity (Ogle and
Ramakrishnan, 2004); 3) the A site, where the amino acyl-tRNA is located before
transpeptidylation (Wilson et al., 2002); 3) the peptidyltransferase center, where
transpeptidylation (ie the incorporation of the amino acids one by one to the growing
polypeptide chain) occurs (Bashan et al., 2003); 4) the E site, where the deacylated-tRNA exits
the ribosome (Blaha and Nierhaus, 2001). The interaction of the Alu domain with one of these
sites might block the elongation cycle of the ribosome.
To determine the ribosomal site at which the Alu domain interferes with the elongation of the
growing polypeptide chain, we probed the ribosomal environment of SRP14 in the targeting
complex and during the synthesis of a secretory protein (preprolactin) by using a chemical
cross-linker (Results 1). We could demonstrate that the Alu domain  of  SRP is  located  at  the
interface of the ribosomal subunits during elongation arrest. SRP14 was indeed cross-linked to
four ribosomal proteins associated with both ribosomal subunits (Table I). This location was
consistent with the notion that the Alu domain might interfere with one of the active sites of the
ribosome listed above because they are all located at the interface of the ribosomal subunits.
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However, the cross-linking of SRP14 to a 45 kDa protein associated with the large subunit
positioned the Alu domain in close proximity to the EF-binding site only (Results 1.6). At this
position, the Alu domain might interfere with the delivery of the amino acyl-tRNA to the A site
by  EF1A,  with  the  activity  of  the  peptidyltransferase  center  or  with  the  translocation  of  the
tRNAs by EF2. The Alu domain most likely interferes with the function of the EFs because it
has been shown that SRP cannot interact productively with the ribosome before the
transpeptidylation reaction (Ogg and Walter, 1995). It is therefore not likely that the Alu
domain interferes with this reaction to arrest the elongation of the growing polypeptide. Most
likely, the Alu domain  interferes  with  the  functions  of  the  EFs.  The  simplest  model  for
elongation arrest would predict that the Alu domain physically prevents the binding of the EFs
to  the  ribosome.  It  implies  that  the Alu domain is stably located in the ribosome to compete
with  the  entry  of  the  EFs.  In  fact,  we  observed  such  a  stabilization  of  the Alu domain in the
ribosome during elongation arrest (Figure 13). The stabilization might be triggered by the
formation of specific contacts between the Alu domain and the ribosome upon signal sequence
recognition (Discussion 3).
We have not determined experimentally whether the Alu domain interferes with the binding of
EF1A, EF2 or both. It is most likely that the Alu domain prevents the binding of only one of
the  EFs  because  the  EFs  act  sequentially  on  the  ribosome  which  oscillates  between  two
conformations, one recognized by EF1A, the other recognized by EF2 (Mesters et al., 1994). It
is more likely that the Alu domain recognizes only one of the two ribosomal conformations.
Indeed SRP cannot interact with the ribosome at every steps of translation. It can productively
interact with the ribosome before the translocation of the tRNAs, the step catalyzed by EF2,
but not before transpeptidylation (Ogg and Walter, 1995). This observation suggests that the
Alu domain might interfere with the binding of EF2.
Figure 40: The cryo-EM structure of the targeting complex at 12.0 Å (adapted from Halic et al., 2004). The location of the Alu
domain and its connections (C5 and C6) with ribosomal domains in the targeting complex are depicted. RNC were produced in the wheat
germ extract by translation of a truncated mRNA encoding the first 90 amino acids of type II membrane protein  dipeptidylpeptidase B
(DPAP-B) from yeast with haemagglutinin and histidine tags. Stalled RNCs were affinity purified and used for reconstitution with excess
amount of purified canine SRP. The complexes were analysed by cryo-electron microscopy and a three-dimensional map was
reconstructed. The densities of the map were assigned as follow: yellow for the 40S subunit; blue for the 60S subunit; green for the P-site
tRNA; red for SRP. The location of the Alu domain is indicated (Alu domain) as well as its two connections with the ribosome (C5 and
C6). The stalk base (SB, see text) is indicated to facilitate the orientation. h1 and h2: hinges of the SRP RNA backbone (see Halic et al.,
2004).
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Soon after the publication of our results (Terzi et al., 2004), a structure of the targeting
complex at a resolution of 10 Å was determined by cryo-electron microscopy (Figure 40; Halic
et al., 2004). In agreement with our results and conclusions, the Alu domain was located in the
EF-binding site. Indeed, connections between the Alu domain and the ribosome (Figure 40, C5
and C6) involved similar ribosomal regions as the ones involved in the connections with the
EFs (Figure 41; see Discussion 3).
Figure 41: The location of the Alu domain in the EF-binding site (adapted from Halic et al., 2004 and Stark et al., 2002). The
eukaryotic EF2 and the prokaryotic ternary complex (EF1A bound to tRNA and GTP) contact the ribosome at the same sites as the Alu
domain. The cryo-EM maps of the 80S RNC-SRP complex, of the 80S ribosome-eEF-2 complex (Spahn et al., 2004) and of the the 70S
ribosome bound to the ternary complex (Stark et al., 2002) are compared in similar orientations. The subunits of the Alu domain (9/14:
SRP9/14; L1.2: Loop 1.2 in Figure 7; H2: helix 2 in Figure 8), the domains of eEF-2 (domains I, II, V) and the domains of the ternary
complex  (domains  I  and  V  of  EF1A  and  the  T  arm  (T)  of  the  tRNA)  involved  in  the  similar  contacts  are  indicated.  The  ribosomal
components contacting the Alu domain, EF2 and the ternary complex are indicated below the image and were described in Halic et al.,
2004, Spahn et al., 2004 and Valle et al., 2003, respectively. The ribosomal components in green contacted the Alu domain, eEF2 and the
ternary complex. The ribosomal component in blue contacted the Alu domain and EF2. The 40S and 60S subunits of the eukaryotic
ribosome and the 30S and 50S of the prokaryotic ribosome are indicated.
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To our knowledge, the mechanism used by SRP to control the elongation of the nascent
polypeptide (ie recognition of a specific feature of the nascent chain and interference with the
function of the EFs) is unique. The majority of the mechanism controlling translation targets
initiation steps (Gebauer and Hentze, 2004). A few mechanisms act at the level of elongation.
One mechanism also involved ribonucleoprotein complexes. Each of these complexes contains
one small RNA molecule of ~ 22 nucleotides, the microRNA (miRNA; Murchison and
Hannon, 2004), such as the lin-4 miRNA (Olsen and Ambros, 1999). As for SRP, the effect of
the lin-4 miRNA is transient (Seggerson et al., 2002). However, instead of recognizing a
specific feature of the growing nascent chain as SRP, lin-4 represses the translation of lin-14
and lin-28 mRNAs by incomplete base-pairing to the 3’-UTRs of the mRNAs. The 3’-UTR is
usually  the  site  of  action  of  mechanisms  controlling  translation  at  the  level  of  initiation.
However, the association of the lin-4 miRNA and the repressed lin14 mRNA within
polyribosomes suggested that lin-4 miRNA interferes with protein synthesis at a point after the
initiation of translation (Olsen and Ambros, 1999). The molecular mechanism of translational
repression by lin-4 miRNA has not been determined yet.
Another mechanism represses translation by preventing the interaction of EF2 with the
ribosome  as  might  be  the  case  for  SRP.  It  involves  the  phosphorylation  of  EF2  by  the  EF2
kinase. EF2 phosphorylation is induced by a large variety of stimuli (Browne and Proud, 2002)
and it inhibits EF2 activity in protein synthesis by preventing its binding to the ribosome
(Carlberg et al., 1990). However, this mechanism does not involve a cytosolic factor that might
interact with the EF-binding site. Moreover, it does not selectively interfere with translation of
a subset of proteins as the secretory proteins for SRP.
Interestingly, some polypeptides can control their translation by themselves, instead of being
recognized by a specific factor, such as SRP (Rospert, 2004). A well-characterized example of
such a polypeptide is the prokaryotic SecM (Nakatogawa et al., 2004). SecM contains an active
C-terminal sequence (n-FXXXXWIXXXXGIRAGP-c) which interacts with the exit tunnel of
the ribosome thereby causing elongation arrest of SecM (Nakatogawa and Ito, 2002). The exit
tunnel was therefore proposed to function as a discriminating gate. Its gating activity involves
the prokaryotic ribosomal protein L22 (L17 in eukaryotes; Wool et al., 1995). The elongation
arrest of SecM is transient and is released when the Ribosome-SecM nascent chain complex is
targeted to the translocon of the bacterial inner membrane to allow SecM secretion into the
periplasm (Nakatogawa and Ito, 2001), suggesting that the translocon can open the gate in the
exit tunnel once loaded with the arrested complex. Interestingly, such a cross-talk between the
ribosome and the translocon has also been demonstrated in eukaryotes. Transmembrane
segments (TMS) of membrane proteins are handled in a specific way by the translocon in the
ER membrane during their incorporation in the lipid bilayer (Schnell and Hebert, 2003). The
ribosome can signal the presence of a TMS to the translocon when TMS is still located in the
exit tunnel in close proximity to the peptidyltransferase center (Woolhead et al., 2004). This
cross-talk also involves the eukaryotic ribosomal protein L17, suggesting a role for the gating
activity  of  the  exit  tunnel  in  the  integration  of  TMS  into  the  lipid  bilayer.  Moreover,  in
eukaryotes, the gating activity might be also used to arrest the elongation of polypeptide
containing active sequences, such as the fungal arginines attenuator peptide (Fang et al., 2004).
Finally, an example of an mRNA interfering with its own translation during elongation has
been described in the unfolding protein response (UPR). In eukaryotic cells, UPR adapts the
protein-folding capacity of the ER under various stress conditions, when its capacity is
exceeded (Schroder and Kaufman, 2005). The expression of the UPR-specific translation factor
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Hac1p is induced at the translational level during UPR by an unconventional splicing
mechanism which removes an intron from the 3’ UTR of the cytosolic HAC1 mRNA
(Kawahara  et  al.,  1997;  Sidrauski  and  Walter,  1997).  In  the  absence  of  UPR,  the  intron
represses translation of HAC1 mRNA by base-pairing with the 5’ UTR of the mRNA
(Ruegsegger et al., 2001). Since the HAC1 mRNA is associated in polyribosomes in the
absence of UPR, the repression of Hac1p synthesis by the intron clearly involves a post-
initiation mechanism. It was proposed that the base-pairing stalls and traps the ribosomes that
are engaged in the translation of the HAC1 mRNA in the absence of UPR (Ruegsegger et al.,
2001).
In conclusion, the control of translation at the level of elongation involves a wide diversity of
mechanism. Both the nascent polypeptide and the mRNA can be recognized by different
factors triggering the elongation arrest (SRP, miRNP) or can by themselves induce their own
elongation arrest (the active sequences, Hac1 mRNA). The elongation arrest activity of SRP is
a peculiar example. Indeed, the other mechanisms lead to a complete block of elongation
whereas SRP only slows down the elongation (Mason et al., 2000; Wolin and Walter, 1989).
The weaker effect of SRP on elongation might be related to specific needs for targeting of
secretory proteins to the ER membrane.
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2 The activation of elongation arrest
The targeting complex is the functional complex that is targeted to the endoplasmic reticulum
(ER) membrane to allow the co-translational translocation of secretory proteins. The formation
of  the  targeting  complex  is  triggered  by  the  emergence  of  a  signal  sequence  in  the  growing
polypeptide at the nascent chain exit site. The signal sequence is recognized by SRP54. In
order to allow SRP54 to sample the nascent chain for the presence of a signal sequence, SRP
can transiently interact with all translating ribosomes. Indeed SRP is less abundant than
ribosomes in the cell and must therefore rapidly cycle on and off the ribosome to sample every
nascent chain (Walter and Johnson, 1994). In the “sampling complex”, SRP54 is located in the
proximity to the nascent chain exit site (Gu et al., 2003; Pool et al., 2002; Pool, 2003). The
formation  of  the  sampling  complex  requires  a  complete  SRP  (Powers  and  Walter,  1996).  In
conditions under which the formation of the sampling complex is impaired, co-translational
translocation is impaired (Hauser et al., 1995), supporting the physiological significance of this
complex.
The Alu domain of SRP is required for the formation of the sampling complex, suggesting that
the Alu domain might interact with the ribosome during sampling of the nascent chain by
SRP54. This hypothesis implies that the Alu domain must be located in close proximity to
ribosomal components in the sampling complex. To confirm this prediction, we probed the
environment of SRP14 in the sampling complex and in ongoing translations of a cytosolic
protein (cyclin) by chemical cross-linking (Results 3). The cross-linking assays revealed that
the Alu domain is already in close proximity to ribosomal components during sampling of the
nascent chain (Table I) and therefore might interact with the ribosome. We set up an in vitro
ribosome-binding assay to detect an interaction between the ribosome and an Alu domain
mimic, the Alu151 RNP, comprising all the components of the Alu domain  of  SRP
(Results 5.2). If the Alu domain  of  SRP  interacts  with  the  ribosome,  the Alu15 RNP should
recapitulate this interaction. We have not yet observed an interaction between the Alu151 RNP
and the ribosome (Results 5.2). As discussed elsewhere, under our experimental conditions,
this interaction might not occur (Results 5.2). On the other hand, it is feasible that the Alu
domain does not interact with the ribosome in the sampling complex. Indeed, the S domain
interacts with the ribosome in the proximity of the nascent chain exit site via its SRP54 subunit
(Gu et al., 2003; Pool et al., 2002; Pool, 2003). If the central stem of the SRP RNA adopts a
rigid conformation in the sampling complex as in the targeting complex (Halic et al., 2004), it
might force the Alu domain in the EF-binding site. In this model, the heterodimer SRP9/14
would be indirectly required for the formation of the sampling complex.
Our cross-linking analysis of the sampling complex also revealed a change in the environment
of the Alu domain upon signal sequence recognition by the S domain. Indeed, whereas SRP14
was cross-linked to four proteins from both ribosomal subunits during elongation arrest, it was
only cross-linked to one protein from the large ribosomal subunit during nascent chain
sampling (Table 1). Concomitantly with this change, the Alu domain  was  stabilized  in  close
proximity to the EF-binding site (Results 1). These differences may be explained by a change
in the orientation of the Alu domain relative to the ribosome upon signal sequence recognition.
Indeed, the Alu domain might already be located in close proximity to EF-binding site during
sampling since SRP14 was cross-linked to identical ribosomal proteins during sampling and
elongation arrest (Table I). The confirmation of this model will require the precise
determination of the Alu domain location in the sampling complex.
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How could signal sequence recognition at the nascent chain exit site induce a reorientation of
the Alu domain at the EF-binding site? The Alu and S domains of SRP are connected by the
central stem of SRP RNA (Figure 6). In the targeting complex, the S domain is docked in the
proximity of the nascent chain exit site via its SRP54 subunit (Gu et al., 2003; Pool et al.,
2002; Pool, 2003). Two hinges of the central stem (h1 and h2) precisely determine its
orientation relative to the ribosome and therefore the orientation of the Alu domain in the
ribosome (Halic et al., 2004). Possibly, the modification and/or the stabilization of h1 or h2
upon signal sequence recognition might modify the orientation of the Alu domain relative to
the ribosome. The SRP68/72 heterodimer might modify the conformation of h1 upon signal
sequence recognition as it was predicted to cover this region of SRP RNA (Halic et al., 2004).
This hypothesis is in agreement with SRP68/72 requirement for elongation arrest Siegel and
Walter, 1985).
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3 The Alu domain-ribosome interactions
- Episode 3 -
The heterodimer SRP9/14 is a good candidate for a functional interaction with the ribosome.
Indeed, the C-terminal domain of SRP14 is specifically required for the elongation arrest
activity  of  SRP (Introduction  5.3).  Since  it  is  not  ordered  in  the  structure  of  the Alu domain
(Figure 7; Weichenrieder et al., 2000), it might be available for an interaction with the
ribosome, most likely with conserved motifs of the ribosomal RNA (rRNA) as it is highly
basic (9 out of 17 residues are lysines or arginines; Results 1 and 3). Thus two conserved
motifs of the 28S rRNA making up the EF-binding site (LGAR and SRL RNAs; Results 1.3)
are good candidates for an interaction with the C-terminal domain of SRP14. Indeed, they are
both  essential  for  the  function  of  the  EFs  as  they  interact  with  the  EFs  (Spahn  et  al.,  2004;
Valle et al., 2003; He et al., 2002). We therefore hypothesised that, during elongation arrest, a
transient interaction of the C-terminal domain of SRP14 with one of these conserved RNA
motifs might interfere with the binding of the EFs to the ribosome.
To support this hypothesis, the ability of the heterodimer to functionally interact with synthetic
RNAs comprising the SRL and LGAR motifs was assayed. We observed that the heterodimer
has a significant affinity for a variety of RNAs under our binding conditions preventing us to
demonstrate  a  functional  interaction  of  the  C-terminal  domain  of  SRP14  with  the  conserved
RNA motifs of the 28S rRNA. Moreover, the interpretation of the data was hampered by
several other factors as discussed (Results 4.7). In the structure of the targeting complex
(Figure 40; Halic et al., 2004), a functional interaction of the C-terminal domain of SRP14
could not been observed when the structure of the Alu domain (Figure 7; Weichenrieder et al.,
2000) was modelled in the electron densities. Indeed, the C-terminal domain of SRP14 (after
lysine K95) was not resolved in the structure of the Alu domain used for modelling. The
definitive characterization of a functional interaction of the C-terminal domain of SRP14 will
require the direct analysis of targeting complexes. It will be interesting to modify the
C-terminus of SRP14 (e.g. with the specific incorporation of a zero-length cross-linker (Gu et
al., 2003) at different positions after lysine 95) in order to probe its immediate environment in
the ribosome.
Together with previously published observations, our binding studies (Results 4 and 5)
strongly suggested that the heterodimer SRP9/14 might interact with the ribosome through its
?-helical surface during elongation arrest (Figure 7A). Indeed, SRP9 and SRP14 resemble the
double stranded RNA-binding domain (dsRBD; Ryter and Schultz, 1998) although the
connectivity of the ?-helices and their stacking with ?-strands as well as the organization and
orientation of the loop regions are different (Figure 7C). The dsRBD contacts dsRNA through
residues of its ?-helical surface (Figure 7C). The ?-helical surface of SRP9/14 is
solvent-accessible in the Alu domain structure as SRP9/14 interacts with the Alu sequences of
SRP RNA primarily via its concave ?-sheet surface (Figure 7A; Weichenrieder et al., 2000). It
is therefore feasible that a functional interaction between the Alu domain and the ribosome
involved the ?-helical surface of the heterodimer.
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Several observations support this hypothesis. First, the dsRBD is highly specific for dsRNA.
Moreover the binding of dsRBD appeared to be independent of RNA sequence (see references
in Ryter and Schultz, 1998). These two characteristics of the dsRBD were reproduced by the
SRP9/14 heterodimer in our “ribosome-in-pieces” assay (Results 4): the synthetics RNAs were
highly double-stranded and they could all interact with the heterodimer SRP9/14 whereas their
sequences were unrelated. Moreover, the binding of the heterodimer was independent of a
functional Alu RNA-binding domain and of the C-terminal domain of SRP14. Outside these
two functional domains of the heterodimer, its ?-helical surface, paved with basic residues
(Figure 6C), is an interesting candidate for an interaction with our synthetic RNAs and, in the
ribosome, with the ribosomal RNA. In agreement, the heterodimer SRP9/14 might contact the
ribosomal RNA through its ?-helical surface during elongation arrest. Indeed, in the cryo-EM
structure of the targeting complex (Halic et al., 2004), the C6 contacts between the Alu domain
and the ribosome is likely to involve the SRP9/14 heterodimer. Based on molecular modelling,
SRP14 and SRP9 were in the close proximity to helices 5, 14 and 15 of the 18S rRNA and
might contact these RNA motifs via the C-terminal ?-helices of SRP9 and SRP14
(Figure 42A). In this model, each heterodimer would therefore participate in the formation of a
ribosomal RNA-binding domain, in agreement with the positive electrostatic potential of the
?-helical surface of SRP9/14 (Figure 6C). Finally, it is worth noting that an interaction of the
?-helical surface of SRP9/14 with RNA has previously been observed. In the structure of the
Alu domain of SRP (Weichenrieder et al., 2000), an additional SRP9/14 heterodimer was
non-specifically bound to the RNA (Figure 43). It interacted on the side of the RNA where the
L2 and L1.2 loops are located, on the opposite side of the U-turn motif, its specific primary
binding site (Weichenrieder et al., 2000. The RNA was bound at the interface between the
C-terminal helices of SRP9 and SRP14, where the positive electrostatic potential of the surface
is concentrated (Figure 6C).
Figure 42: Ribosomal components involved in the C5 and C6 contacts with the Alu domain of SRP (adapted from Halic et al.,
2004).  A  model  for  the  structure  of  the  mammalian Alu domain (Weichenrieder et al., 2000) was fitted in the electron densities
attributed to the Alu domain. A molecular model of the yeast ribosome (Spahn et al., 2001) was fitted in the electron densities of the
wheat germ RNC. The components proposed to participate in contacts C5 and C6, described in Figure 41, are indicated. A) The C6
contact. B) The C5 contact. In both cases, SRP9 is coloured in cyan, SRP14 in dark blue, the 5’ domain of the Alu part of SRP RNA
(Alu-5’) in red, the 3’ domain (Alu-3’) in dark yellow. Ribosomal proteins (rp) are coloured in gold, the 25S rRNA in light blue and the
18S rRNA in pale yellow. Helices 5 (h5), 14 (h14) and 15 (h15) of 18S rRNA, as well as helices 43 (H43) and 44 (H44) of 25S rRNA,
are indicated. L1.2 and L2: the loops L1.2 and L2, respectively, of the 5’ domain of the Alu RNA. rpL12: ribosomal protein L12. rpL9:
ribosomal protein L9. SRL: the universally conserved ?-sarcin-ricin loop.
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In the mean time, it is feasible that we observed such an interaction between the heterodimer
SRP9/14 alone and the ribosome (Results 5). Indeed, the formation of the SRP9/14-ribosome
complex did not require a functional Alu RNA-binding domain or the C-terminal domain of
SRP14. Interestingly, in the complex, SRP14 was cross-linked to an 18 kDa protein from the
small ribosomal subunit, suggesting that the heterodimer alone might interact with the
ribosome in the EF-binding site. Indeed, the helices 5, 14 and 15 of the 18S rRNA are located
in the close proximity to SRP9/14 in the targeting complex (Figure 42A). The ribosomal
protein S23, a 16 kDa protein from the small subunit, is also located in the close proximity to
helices 5, 14 and 15 (Figure 44A and B). Thus, cross-linking of SRP14 to an 18 kDa protein
may be explained by binding of the heterodimer to helices 5, 14 and 15 in the
SRP9/14-ribosome complex. The identification of the 18 kDa protein will be required to
support this model.
In conclusion, the ?-helical surface of the heterodimer might participate in a functional
interaction between the Alu domain and the ribosome. It would be interesting to mutagenize the
basic residues in the C-terminal helix of SRP9 and SRP14 in order to assay their requirement
for  the  elongation  arrest  activity  of  SRP  and  to  probe  their  immediate  environment  in  the
targeting complex by the specific incorporation of a zero-length cross-linker (Gu et al., 2003)
at different positions in the C-terminal helix of SRP9 and SRP14.
Figure 43: The ?-helical surface of the heterodimer SRP9/14 can interact with the RNA. Two views (related by a rotation of ~ 90°
along the vertical axis) of the heterodimer SRP9/14 bound to loops L2 and L1.2 of the Alu sequences of SRP RNA. SRP14 is coloured in
green, SRP9 in red. Their N- and C-termini are indicated with the same colour code. The loop L2 (nucleotides G11 to G16; Figure 8) is
coloured in orange, the loop L1.2 (A32 to C39) in light blue. The primary binding site of the SRP9/14 heterodimer (U-turn motif) is
coloured in yellow. The arrows points at the C-terminal ?-helices of SRP9 (red) and SRP14 (green). These structures were prepared with
the Swiss-PdbViewer using the pdb file 1E8O (Weichenrieder et al., 2000).
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The loops L2 and L1.2 of the Alu sequences of SRP RNA (Alu RNA) form a structural motif of
the Alu domain that might be accessible for a functional interaction with the ribosome (Figure
Weichenrieder et al., 2000). Indeed, they are solvent-accessible in the Alu domain structure
(Figure 7A-B). However they are less interesting candidates than the SRP9/14 heterodimer as
they are not conserved in size and shape (Huck et al., 2004). They are therefore less likely to
interact with the ribosome. They might simply fill the intersubunit space at the EF-binding site,
therefore preventing physically the entry of the EFs in the ribosome. In agreement, yeast SRP
has  elongation  arrest  activity  (Van Nues  and  Brown,  2004).  However,  it  has  a  specific  RNA
structure lacking the structural motif involving loops L2 and L1.2 (Strub et al., 1999(Van Nues
and Brown, 2004). In this case, the “filling” activity might be performed by another
yeast-specific RNA structure (Van Nues and Brown, 2004). This hypothesis suggests that the
interaction of the SRP9/14 heterodimer with the ribosome might be important to position the
Alu RNA in the intersubunit space. This hypothesis is supported by preliminary experiments
with our “ribosome-in-pieces” assay (Results 4) as we could not detect an interaction between
the Alu domain of SRP (ie the human heterodimer SRP9/14 bound to the SA86 RNA; Figure 8)
and  the  synthetic  RNAs  mentioned  above  (data  not  shown).  In  disagreement  with  this
hypothesis, the modelling of the Alu domain structure (Weichenrieder et al., 2000) in the
electron densities attributed to the Alu domain in the targeting complex (Halic et al., 2004)
suggested that loop L1.2 might contact the LGAR motifs of the 28S rRNA (Figure 42B, H43
and H44). The putative interaction might be due to the heterogeneous nature of the targeting
complex analysed (canine SRP bound to wheat germ ribosome). Indeed canine SRP induces a
complete elongation arrest of preprolactin translation in the wheat germ extract (Walter et al.,
1981), whereas it only slows down the elongation of the same protein in homologous systems
(Mason et al., 2000; Wolin and Walter, 1989). Thus, additional contacts as the one described in
the structure of the targeting complex might explain the stronger effect of SRP on elongation.
Figure 44: The ribosomal protein S23 is in proximity to helices h5, h14 and h15 of the 18S rRNA. A) The location of the ribosomal
protein S23 in the 30S subunit of the Thermus thermophilus ribosome (modified from Brodersen et al., 2002). The 30S subunit is seen
from the subunits interface. The proteins are coloured and the 16S rRNA is in grey. S23 is indicated (the homologue of human S23 is S12
in Thermus thermophilus). The location of helices h5, h14 and h15 of the 16S rRNA is indicated in yellow. B) A close up view of the S23
binding site, showing the close proximity between S23 and helices h5 and h15 that are contacted by SRP14 in the SRP-RNC complex
(Halic et al., 2004).
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Materials and Methods
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1 Production, purification and analysis of proteins
1.1 SRP9/14 purification
Human SRP9 and SRP14 were overexpressed in BL21 LysS E. coli cells transformed with the
plasmid pEth9 and pEth14, respectively (Bovia et al., 1997). Human SRP14K95 was
overexpressed in TunerÔ (DE3) pLacI competent cells (Novagen) transformed with the
plasmid pBH14K95. SRP9 and the various SRP14s bacterial pellets were separately lysed in a
French® pressure cell press (Sim Amincon®) and the SRP9 and SRP14 lysates were combined
and incubated 30 minutes at 4 °C to allow heterodimerisation. Each heterodimer (SRP9/14,
SRP9/14K95) was purified sequentially by chromatography on HiTrap Heparin Sepharose
(Amersham Biosciences), Hydroxyapatite (BioRad Laboratories), Bio-Scale S (BioRad
Laboratories) and Superdex 200 HR (Amersham Biosciences) columns. The purified
heterodimer was concentrated with a Microcon Centrifugal Device YM-3 (Millipore) and
stored at –80 °C in 20 mM HEPES pH 7.5, 500 mM KOAc pH 7.5, 1 mM EDTA pH 7.5,
0.01 % NIKKOL, 10 mM DTT, 10 % Glycerol. The heterodimer were quantified by
spectrophotometry at 280 nm using a specific molar extinction coefficient of 15130 M-1cm-1.
1.2 øSRP19 purification
Human øSRP19 was overexpressed in BL21 E. coli cells using the plasmid pEø19. The
bacterial pellet was lysed in a French® pressure cell press (Sim Amincon®) and the protein was
purified first on a Hi-Trap Heparin Sepharose column (Amersham Biosciences) and then on a
CarboxyMethyl Sepharose column (BioRad Biosciences) as previously described (Thomas et
al., 1997). The purified protein was quantified by spectrophotometry at 280 nm using a specific
molar extinction coefficient of 12570 M-1cm-1.
1.3 SRP54 purification
Canine SRP54 was purified as described in Huck et al., 2004. Briefly, canine SRP54 was
expressed using the baculovirus system as described in Hauser et al., 1995. SF21 cells were
used to amplify the virus and Tn5 cells were used to express the protein. After the lysis of the
cells in a homogeniser, the protein was purified first on a CarboxyMethyl Sepharose column
(BioRad Laboratories) and then on a Hi-Trap Heparin Sepharose column (Amersham
Biosciences). The purified protein was quantified by spectrophotometry at 280 nm using a
specific molar extinction coefficient of 22220 M-1cm-1.
1.4 SRP68/72 purification
Canine SRP68/72 was purified from canine SRP as previously described (Siegel and Walter,
1985). SRP68/72 was quantified by comparing the SRP68 signal to known concentrations of
BSA in a coomassie-stained SDS-polyacrylamide gel. Based on this, 2 ?l of the purified
protein were used for each SRP reconstitution.
- 89 -
1.5 SP6 and T7 RNA polymerases purification
His-tagged SP6 RNA polymerase (plasmid pBH176) was expressed and purified as described
in He et al., 1997 with some modifications.
His-tagged T7 RNA polymerase (plasmid pMR7wt) was expressed and purified as described in
Arnaud et al., 1997 with some modifications.
1.6  L12 purification
Full-length human L12 cDNA was PCR-amplified from a HeLa cDNA library and cloned into
pSP64 (Promega) as pSP6L12mut (Pascal M. and Strub K., unpublished results). The coding
sequence of human L12 was PCR-amplified using pSP6L12mut and sub-cloned into pEtBlue-1
(Novagen) as pEBL12mut (data not shown). This plasmid carried a mutation: Alanine 164 was
mutated to Threonine (GCC mutated to ACC). Human L12 was overexpressed in TunerÔ
(DE3) pLacI competent cells (Novagen) transformed with the plasmid pEB-L12mut. L12
bacterial pellets were lysed in a French® pressure cell press (Sim Amincon®). L12 was purified
sequentially by chromatography on HiTrap Heparin Sepharose (Amersham Biosciences) and
MonoS (Amersham Biosciences) Hydroxyapatite (BioRad Laboratories) columns. The purified
protein was concentrated and stored at –80 °C in 20 mM HEPES pH 7.5, 500 mM KOAc
pH 7.5, 0.1 mM EDTA pH 7.5, 0.01 % NIKKOL, 10 mM DTT, 10 % Glycerol. It was
quantified by spectrophotometry at 280 nm using a specific molar extinction coefficient of
7330 M-1cm-1.
1.7 Antibodies production
All anti-sera were from rabbit and purchased at Sigma Genosys (SG) or Gramsch Laboratories
(GL) as indicated. The synthetic peptides were always cross-linked to the immunological
carrier KLH (Keyhole Limpet Hemocyanin) with the cross-linker MBS. A cysteine was added
at the N-terminus of the peptide to allow cross-linking. For anti-L12 production (GL), rabbits
were injected with the human recombinant L12 ribosomal protein (Materials and Methods 1.6).
For anti-L23 production (GL), rabbits were injected with the synthetic peptide
CKRGRGGSSGAKFR. The bold residues correspond to residues 3 to 15 of the human L23
ribosomal protein. For anti-L9 production (SG), rabbits were injected with the synthetic
peptide CKNKDIRKFLDGIY. The bold residues correspond to residues 168 to 180 of the
human L9 ribosomal protein. For anti-L3 production (SG), rabbits were injected with the
synthetic peptide CKKLPRKTHRGLRK. The bold residues correspond to residues 237 to
249 of the human L23 ribosomal protein. For anti-S15 production (SG), rabbits were injected
with the synthetic peptide CKKKRTFRKFTYRG. The bold residues correspond to residues 6
to 18 of the human S15 ribosomal protein. Anti-SRP14 antibodies were described in Bovia et
al., 1995.
1.8 Antibodies purification
To affinity-purify anti-L3 and anti-L23 antibodies, their respective immunogenic peptides used
for the injection were coupled to 1 ml of CNBr-activated Sepharose 4B (Amersham
Biosciences) according to the supplier instructions. 2 ml of each anti-serum were precipitated
with 50% Ammonium Sulfate (Fluka) 30 minutes at 4°C. Precipitated proteins were recovered
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by centrifugation, solubilised in 10 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.5% Tween 20 and
dialysed overnight against the same buffer. The solubilised proteins were loaded on the peptide
column  equilibrated  with  the  same  buffer.  The  column  was  washed  with  30  ml  of  the  same
buffer. Finally, affinity-bound antibodies were eluted with 3 ml of 50-100 mM Glycine pH 2.2,
500 mM NaCl. Fractions of 300 ?l were collected. To determine the fractions containing the
eluted antibodies, 10 ?l of each fraction was spotted on nitrocellulose membrane. The
membrane was dried, then incubated 1 hour at room temperature in TBS 1X, Tween 20 0.2 %,
non-fat dried milk 5 %, 1 hour in the same buffer containing goat anti-rabbit, HRP-conjugated
antibodies (BioRad). Finally, the membrane was washed three times with 1X TBS, 0.02 %
Tween 20 at room temperature before antigens detection with SuperSignal (Pierce). Images
were captured using a CCD camera-based system (GeneGnome, Syngene). The fractions
containing the purified antibodies were pooled, neutralised with Tris pH 8 and stored at -20 °C.
To affinity-purify anti-SRP14 and anti-L12 antibodies, we followed the method described in
Bovia et al., 1995. For anti-L12 purification, the human L12 protein (Material and Methods
1.6) was used instead of the MBP-SRP14 fusion protein.
1.9 NEM treatment of SRP9/14
The indicated heterodimer SRP9/14 (600-860 pmoles in 40 µl of 20 mM HEPES pH 7.5,
500 mM KOAc pH 7.5, 1 mM EDTA pH 7.5, 0.01% NIKKOL, 10% Glycerol) were treated
with 10 µl of N-ethylmaleimide (NEM; Sigma) dissolved in the same buffer for 30 minutes at
26 °C. The reaction was quenched with 10 µl of 20 mM HEPES pH 7.5, 500 mM KOAc
pH 7.5, 1 mM EDTA pH 7.5, 0.01% NIKKOL, 10% Glycerol, 500 mM DTT and the
NEM-treated SRP9/14 (SRP9/14-NEM) stored at -80 °C.
1.10 SDS-PAGE
SDS-PAGE was performed as described in Laemmli, 1970. The percentage of acrylamide is
indicated in the figure legend. Electrophoresis was performed at 25 mA per gel. The percentage
of acrylamide in the stacking gel was 4 %.
1.11 Western blotting
Protein samples separated by SDS-PAGE were transferred onto nitrocellulose membrane
(Protran BA83, Schleicher and Schuell Bioscience) in CAPS 10 mM, Methanol 20% at 90V,
4 °C for 1 hour. Membranes were stained with Ponceau S for 5 minutes at room temperature,
blocked for 1 hour at room temperature in blocking buffer (TBS 1X, Tween 20 0.2 %, non-fat
dried milk 5 %) and incubated overnight at 4 °C with the primary antibody/anti-serum diluted
in blocking buffer. Membranes were washed 3 x 10 minutes at room temperature with TBST
(TBS 1X, Tween 0.2 %) and incubated 1 hour at room temperature in blocking buffer
containing goat anti-rabbit, HRP-conjugated antibodies (BioRad). Finally, membranes were
washed 3 x 10 minutes at room temperature with TBST before antigens detection with
SuperSignal (Pierce). Images were captured using a CCD camera-based system (GeneGnome,
Syngene). Signals were quantified with GeneTools (Syngene). If the membrane had to be
tested  with  several  antibodies,  it  was  washed  with  5  M urea,  10  mM dithiothreitol  (DTT)  for
several hours at 37°C, blocked in TBST + milk and re-used as before.
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1.12 Slot blotting
Slot blotting was performed as described in Schaffner and Weissmann, 1973. Proteins in 90
mM Tris-HCl pH 7.5, 0.1% SDS were precipitated with 10% TCA in a final volume of 360 µl
for more than 5 minutes at room temperature. Precipitated proteins were spotted onto a
nitrocellulose membrane (Protran BA83) using the MilliBlot-S system (Millipore) following
the instructions. Equilibration of the membrane before and washes after sample loading were
done with TCA 6%. The membrane was stained with Ponceau S before immunodetection as
described in Material and Methods 1.11.
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2 Production, purification, modification and analysis of RNAs
2.1 RNA transcription with SP6 RNA polymerase
For the transcription of the truncated mRNA encoding the first 86 amino acids of preprolactin,
the plasmid pSP-BP4 (Sasavage et al., 1982) was linearized with PvuII (MBI Fermentas). For
the transcription of the truncated mRNA encoding the first 130 amino acids of cyclin, the
plasmid pcyclin (CYCD90 in Murray et al., 1989) was linearized with PstI (Invitrogen). For the
transcription of the mRNA encoding the full-length preprolactin, the plasmid pSP-BP4
(Sasavage et al., 1982) was linearized with EcoRI (Invitrogen). For the transcription of the
truncated mRNA encoding the first 130 amino acids of cyclin, the plasmid pcyclin (CYCD90
in Murray et al., 1989) was linearized with EcoRI (Invitrogen). In vitro transcription with the
SP6 RNA polymerase (Material and Methods 1.5) were performed as described (Strub and
Walter, 1990), except that the dinucleotide G(5’)ppp(5’)G was absent and that the
concentration  of  each  nucleotide  was  1  mM.  After  phenol-dichloromethane  extraction  and
ethanol precipitation, the RNA were quantified by spectrophotometry and checked by
Urea-PAGE and ethidium bromide staining.
2.2 RNA transcription with T7 RNA polymerase
For  the  transcription  of  the  LGAR  RNA,  the  plasmid  pSPLGAR  was  linearized  with SmaI
(Promega). pSPLGAR contains sequences 1923-2015 of human 28S rRNA (Gonzalez et al.,
1985) obtained by amplification from a HeLA cDNA library and cloned into pSP64 under the
control of the T7 promoter. For the transcription of 4.5S RNA, the plasmid pS4.5S (Bovia et
al., 1997) was linearized with DraI (Fermentas).For the transcription of Alu151 RNA, the
plasmid pSAlu151 (Strub K., unpublished data) was linearized with XbaI. The SRL RNA was
ordered from Xeragon. It was biotinylated at its 3’ end. In vitro transcription with the T7 RNA
polymerase (Material and Methods 1.5) and RNA purification were performed as described
elsewhere (Weichenrieder et al., 1997). The RNA concentration was determined by
spectrophotometry at 260 nm (assuming that 1 A260 nm = 50 ng/µl of RNA) and confirmed by
Urea-PAGE.
2.3 SRP RNA purification
Canine SRP RNA was purified as described in Siegel and Walter, 1985.
2.4 Alu151 RNA biotinylation
In vitro transcribed Alu151 RNA (500 pmoles) was precipitated and dissolved in 100 mM
NaOAc pH 7.5 (100 µl). NaIO4 was added at 10 mM (final concentration) to oxidize the RNA
for 2 hours at room temperature in the dark. After removal of NaIO4 by gel filtration on G50
(Amersham biosciences), NaOAc pH 5 was added at 100 mM (final concentration) before
addition of Biotin-hydrazide (400 nmoles; around 1000 fold the amount of RNA; Uptima
UP36466B) and incubation for 21 hours at 4°C. Finally, the biotinylated RNA was purified by
gel filtration on G50, precipitated and dissolve in water. Its concentration was determined by
spectrophotometry at 260 nm (1 A260 nm = 50 ng/µl of RNA).
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2.5 5’ and 3’ ends-labelling of RNA with 32P
For 5’ end-labelling of RNA, the KinaseMax™ kit (Ambion) was used. Twenty-five pmoles of
RNA were used per reaction. The 32P-labelled RNA was purified as described in
Weichenrieder  et  al.,  1997  and  stored  in  50  µl  of  water.  Its  concentration  was  less  than
0.5 pmoles/µl. The specific activity of the 5’ end-labelled RNA was determined by scintillation
counting in Ultima Gold Scintillation Reagent (Packard) using a scintillation counter
(Beckman). The specific activity was higher than 80000 cpm/pmoles. For 3’ end-labelling of
RNA, 32pCp was synthesized in a reaction of 20 µl containing 2 mM CMP, 1.8 µM of ATP ?-
32P (10 µCi/µl, Amersham Pharmacia Biotech), 0.5 u/µl T4 Polynucleotide Kinase (Promega)
in  T4  Polynucleotide  Kinase  1X  (Promega).  Synthesis  was  done  at  37  °C  for  1  hour.  The
kinase was inactivated at 65 °C for 10 minutes. 14 µl of 32pCp (about 25 pmoles) were used in
a ligation reaction (20 µl) containing 25 pmoles of RNA produced by run-off in vitro
transcription with T7 RNA polymerase, 2 u/µl of RNAse inhibitor (Promega) and 2 u/µl of T4
RNA ligase (Fermentas) in T4 RNA ligase buffer 1X. Ligation was done at 4 °C for 14-16
hours. Nucleotides were removed on two G-50 Sephadex column of 1 ml (Amersham
Pharmacia Biotech). The purified RNA was extracted twice with phenol-dichloromethane in
0.3 M NaOAc pH 7.5 and precipitated with ethanol overnight at 4 °C. The precipitated RNA
was suspended in 20 µl of bi-distillated, autoclaved water and stored at -20 °C. The
concentration of the 3’ end-labelled RNA was determined using the NanoDrop ND-1000
Spectrophotometer (Witec AG; 1 A260 nm = 50 ng/ µl of RNA) and the RNA was diluted to 0.4
µM in bi-distillated, autoclaved water. It was further analysed by denaturing PAGE and
ethidium bromide staining. The gel was fixed with 20% methanol, 7.5% acetic acid and
subjected to autoradiography. The specific activity of the 3’ end-labelled RNA was determined
by scintillation counting in Ultima Gold Scintillation Reagent (Packard) using a scintillation
counter (Beckman). The specific activity was higher than 106 cpm/moles.
2.6 RNA reannealing
In vitro transcribed RNAs were re-annealed in the following conditions:
LGAR RNA: 20 mM HEPES pH 7.5, 100 mM KOAc pH 7.5, 5 mM Mg(OAc)2 pH 7.5.
4.5S RNA: 20 mM HEPES pH7.5, 500 mM KOAc pH 7.5, 5 mM Mg(OAc)2 pH 7.5.
Alu151 RNA: 20 mM HEPES pH 7.5, 500 mM KOAc pH 7.5, 5 mM Mg(OAc)2 pH 7.5.
SRL RNA was not reannealed since it was cleaved during this procedure (data not shown).
Reannealing was performed as described in Weichenrieder et al., 1997.
2.7 Urea-PAGE
RNA samples were diluted (1:2) in FBJ (80% (v/v) deionized formamide, 1 mM EDTA
pH 8.0, 0.25% (w/v) Bromophenol Blue, 0.25% (w/v) Xylene Cyanol), heated 3 minutes at
65°C, transferred immediately for 3 minutes on ice before loading on a preheated (50°C)
acrylamide, TBE 1X, urea 8 M gel. Electrophoresis was performed at 12 W. The percentage of
acrylamide is indicated in the figure legend. TBE 1X: 89 mM Tris, 89 mM boric acid, 2 mM
EDTA pH 8.0.
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3 Production and purification of ribonucleoprotein complexes
3.1 Alu151 RNP reconstitution
The Alu151  RNA  (16  pmoles)  was  reannealed  in  the  presence  of  0.5  pmoles  of 32P-labelled
RNA (tracer; more than 1*105 cpm) in a final volume of 3 µl as described (Material and
Methods 2.6). The Alu151  RNP  was  reconstituted  in  the  presence  of  12.5  pmoles  of
recombinant human SRP9/14 in 5 µl of 20 mM HEPES pH 7.5, 500 mM KOAc pH 7.5, 5 mM
Mg(OAc)2 pH 7.5, 0.01% NIKKOL, 1 mM DTT for 10 minutes on ice and 10 minutes
at  37  °C.  An  excess  of  RNA  over  the  protein  was  used  to  ensure  that  no  free  proteins  are
present at the end of the reconstitution. The indicated amount of the RNP was directly used in
the assays. The concentration of the Alu151 RNP indicated in the figure legends is based on the
concentration of SRP9/14. The Alu151 RNA used in the ribosome-binding assay was prepared
with the same procedure, but the heterodimer SRP9/14 was replaced by its storage buffer
(Material and Methods 1.1).
3.2 SRP purification
Canine SRP was purified under native conditions as described previously (Walter and Blobel,
1983).
3.3 SRP reconstitution
Canine SRP54 (4 pmoles), SRP68/72 (1 ?l) and SRP RNA (2 ?l) and human øSRP19
(4 pmoles) and SRP9/14 (1 pmole) were incubated all together 10 minutes on ice and 10
minutes at 37 °C in a final volume of 8 ?l containing 20 mM HEPES pH 7.5, 500 mM KOAc
pH 7.5, 5 mM Mg(OAc)2 pH  7.5,  0.01%  NIKKOL  and  1  mM  DTT.  Reconstitutions  were
directly  used  in  cross-linking  assays.  The  SRP  proteins  and  the  SRP  RNA  were  purified  as
described in Material and Methods 1.1 to 1.4 and 2.3.
3.4 RNC purification
RNCs were produced in 100 µl translations with nuclease-treated rabbit reticulocyte lysate
(Promega) programmed individually with optimised amounts of truncated Cyc130 and pPl86
mRNAs (see below) in the presence of 40 µM cold methionine. No mRNA was added to the
mock  translations.  After  translation  for  30  min  at  30ºC,  synthesis  was  stopped  with
cycloheximide (final concentration, 0.5 mM) and the salt concentrations of the samples
adjusted to 500 mM potassium acetate (KOAc) and 5 mM magnesium acetate (Mg(OAc)2) in a
final volume of 200 µl. After 15 min on ice, reactions were centrifuged 5 min at 15000 rpm to
pellet aggregates. Aliquots of 100 µl of the supernatants were loaded on 2 ml sucrose cushions
(20 mM HEPES pH 7.5, 500 mM KOAc pH 7.5, 5 mM Mg(OAc)2 pH 7.5, 500 mM sucrose,
2 mM DTT, 0.01% Nikkol, 0.5 mM cycloheximide) and centrifuged in a TFT80.4 rotor
(Kontron) for 1 hour at 50,000 rpm at 4ºC. Ribosomal pellets were resuspended in 20 µl of
HKMND50-2.5-1 (20 mM HEPES pH 7.5, 50 mM KOAc pH 7.5, 2.5 mM Mg(OAc)2 pH 7.5,
0.01% Nikkol, 1 mM DTT). The concentrations of ribosomes were determined as described
Neuhof  et  al.,  1998.  RNC  yields  were  optimised  by  titrating  the  synthetic  mRNAs  into
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translation reactions containing [35S]-methionine (> 37Tbq/mmol, Amersham Pharmacia
Biotech). Ribosomal pellets were obtained as above and analysed by 5-20% SDS-PAGE and
autoradiography. Cyc130 and pPl86 nascent chains were quantified with a phosphorescence
imaging system (BioRad) and their relative yields calculated taking into account that pPl86 and
Cyc130 nascent chains contain four and six methionines residues, respectively. Maximal yields
of Cyc130 and pPl86 were obtained with a 6-fold and 16-fold excess of mRNA over
ribosomes, respectively. RNCs were also produced in 100 µl translations with wheat germ
extract at 26ºC and purified as described above. However, under optimised translation
conditions, the yields of RNCs formation were always lower with the wheat germ lysate (about
5 fold) when compared to the rabbit reticulocyte lysate (results not shown). SRP could
therefore not be saturated with pPl86 ribosomes as described for rabbit SRP-RNC cross-linking
(Results 3.3).
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4 In vitro assays
4.1 Cross-linking assay with purified RNC
SRP-RNC complexes were formed individually by incubating 2 pmoles of ribosomes,
pPl86 RNCs or Cyc130 RNCs with 1 pmole of canine SRP purified under native conditions in
a  final  volume  of  30  µl  of  HKMND50-2.5-1 (20 mM HEPES pH 7.5, 50 mM KOAc pH 7.5,
2.5 mM Mg(OAc)2 pH 7.5, 0.01 % NIKKOL, 1 mM DTT) at 26°C for 10 min. SRP9/14-RNC
complexes were formed individually by incubating 10 pmoles of pPl86 RNC with 3 pmoles of
human recombinant SRP9/14 in a final volume of 30 µl of HKMND50-2.5-1 at 26°C for 10 min.
When a component was omitted from the sample, it was replaced with its corresponding buffer.
Prior to incubating with DSS (suberic acid bis(N-hydroxy-succinimide ester) supplied from
Sigma, 40 mM fresh stock solution in DMSO diluted to a final concentration of 800 µM for the
SRP-RNC complexes and 100 µM for the SRP9/14-RNC complexes) at 26°C for 30 min, the
volume  was  increased  to  100  µl  with  HKMND50-2.5-1. The reactions were quenched with
100 mM Tris pH 7.5 for 15 min on ice, TCA-precipitated (10%, final concentration) and
analysed by western blotting with affinity-purified anti-SRP14 antibodies. For the assays with
the SRP-RNC complexes, the signals for 14-X45, 14-X31 and 14-X20 were quantified. The
relative intensities of each cross-link product in the reactions with mock ribosomes and pPl86
RNCs were calculated by comparison to the intensity of the same cross-link product in the
reactions with Cyc130 RNCs, which was set at 100 %. Cross-linking reactions under high salt
conditions were performed and analysed as described above but, prior to incubating with DSS,
cycloheximide (final concentration, 0.5 mM) was added to all reactions and salt concentrations
were increased to 500 mM KOAc and 5 mM Mg(OAc)2 where indicated. The intensities of the
cross-link products were similarly calculated. In addition, we had to take into account the lower
efficiency of cross-linking under high salt conditions. We calculated a ratio of efficiency for a
given reaction by dividing the relative intensity of 14-X20 in the Cyc130 reaction at 50 mM
KOAc by the relative intensity of 14-X20 in the given reaction. The relative intensity of each
cross-link product in the given reaction was corrected with this ratio.
4.2 Ribosomal subunit separation
Complexes were formed with 21 pmoles of pPl86 RNC purified from the rabbit reticulocyte
lysate and 17.5 pmoles of canine SRP and incubated for 10 min at 26°C in a final volume of
100 µl (final salt concentration, 60 and 2.5 mM KOAc and Mg(OAc)2, respectively). Cross-
linking was done as before but with 100 µM DSS. To separate the ribosomal subunits,
reactions were adjusted to 500 mM KOAc, 10 mM Mg(OAc)2, 1 mM puromycin and 1 mM
GTP in a final volume of 150 µl and incubated 30 min at 37°C. Ribosomal subunits were
separated by centrifugation through 11.2 ml, 10-30% sucrose gradients (HKMND500-10-2) for
5.30 h in a TST41.14 rotor (Kontron) at 4°C and 41’000 rpm. Fractions of 200 µl were
collected using Auto Densi-Flow®II C (Buchler Instruments) and the absorbance monitored at
254  nm with  an  Econo UV-Monitor  EM-1 (BioRad).  On the  basis  of  the  A254 nm profile (see
below), the fractions were pooled to represent the 40S and 60S subunits, as well as the 80S
ribosomes (see below). Fractions of the top of the gradient were arbitrary split in four groups.
Pooled fractions were TCA-precipitated and analysed by 12% SDS-PAGE and immunoblotting
with anti-SRP14, anti-L9 and anti-S15 antibodies. The L9 and S15 signals confirmed the
correct  assignments  of  the  fractions.  The  signals  of  L9,  S15  and  the  cross-link  products
14-X45, 14-X31 and 14-X20 were quantified for each fraction. All measured signals for the
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same protein were summed and, for comparison, the signal in each fraction was expressed as a
percentage of this sum. Cyc130 RNC-SRP complexes were analysed the same way, but only
S15, L9 and 14-X20 were quantified. To clearly identify the subunit fractions on the basis of
the A254 nm profile, Cyc130 RNCs were reacted with DSS (100 µM) and the ribosomal subunits
separated as above. 20 fractions were collected with continuous monitoring of the absorbance
at 254 nm. Fractions were TCA-precipitated and analysed by 12% SDS-PAGE and
immunoblotting with anti-L9 and anti-S15 antibodies. The signals of L9 and S15 were
quantified for each fraction. All measured signals for the same protein were summed and, for
comparison, the signal in each fraction was expressed as a percentage of this sum. L9 and S15
distribution confirmed the identification of the 40S and 60S subunit, as well as 80S
cross-linked ribosomes, using the A254 nm profile. The INT fraction contained both 40S and 60S
subunits. Complexes between SRP9/14 and pPl86 RNC purified from the wheat germ extract
were analysed the same way. The SRP9/14-pPl86 RNC complexes were formed by incubating
3 pmoles of SRP9/14 with 10 pmoles of pPl86 RNC for 10 min at 26°C in a final volume of
30 µl (final salt concentration, 50 and 2.5 mM KOAc and Mg(OAc)2, respectively). The
gradient for the SRP9/14-pPl86 RNC complexes was split in 20 fractions of 600 µl. The
fractions were analysed by western blotting with affinity-purified anti-SRP14 antibodies.
4.3 Cross-linking assay in ongoing translation
Rabbit reticulocyte translation reactions (25 µl, 150 mM KOAc and 2 mM Mg(OAc)2) primed
individually with full-length cyclin and preprolactin synthetic mRNAs were incubated at 30°C
for 15 min in the presence or absence of 4 pmoles exogenous canine SRP. The amount of
mRNAs in the reactions was chosen to obtain the same translational efficiency of cyclin and
preprolactin (see below). Mock translations contained no synthetic mRNA. Prior to incubation
with DSS (800 µM final) at 30°C for 30 min, the volume was increased to 100 µl with
HKMND150-2-1. The reactions were quenched with 100 mM Tris pH 7.5 for 15 min on ice.
Cycloheximide (final concentration, 0.5 mM) was added and the salt concentration of the
samples adjusted to 500 mM KOAc and 5 mM Mg(OAc)2 in a final volume of 150 µl. After
15 min on ice, reactions were centrifuged 5 min at 15000 rpm to pellet aggregates. The
supernatants were loaded on 2 ml sucrose cushions and ribosomes pelleted as above. The
ribosomal pellets were directly analysed by 12% SDS-PAGE and by immunoblotting with
anti-SRP14 and anti-S15 antibodies. Translational efficiencies of cyclin and preprolactin were
compared by titrating the synthetic mRNAs into translation reactions containing
[35S]-methionine in the absence of exogenous canine SRP. Aliquots of 5 µl of the reactions
were directly analysed by 15% SDS-PAGE and autoradiography. Cyclin and preprolactin were
quantified with a phosphorescence imaging system (BioRad) and their relative yield calculated
taking into account that the preprolactin and cyclin chains contain eight and sixteen
methionines residues, respectively. Similar efficiencies of cyclin and preprolactin synthesis
were obtained with 2.5 µg and 6.8 µg of mRNA, respectively.
4.4 Size exclusion chromatography of SRP9/14 complexes
In vitro transcribed RNAs were re-annealed in the presence of 0.2 pmoles of 32P-labelled RNA
(tracer; more than 2*105 cpm) as described (Material and Methods 2.6). When RNAs were
detected by on-line spectrophotometry (see figures legend), the tracer was omitted. The LGAR-
L12 complex (LGAR RNP) was formed by incubating the indicated amount of LGAR RNA
with the indicated amount of recombinant L12 in 20 µl of 20 mM Tris pH 7.5, 300 mM KCl,
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5 mM MgCl2, 0.01% NIKKOL, 1 mM DTT for 10 minutes on ice and 10 minutes at 37°C. The
reannealed LGAR RNA alone was prepared similarly, but recombinant recombinant L12 was
omitted. The complexes with the various SRP9/14 proteins were formed by incubating the
indicated amount of the different RNA/RNP with the indicated amount of the SRP9/14 proteins
in 200 µl of 20 mM Tris pH 7.5, 100 mM KCl, 0.5 mM MgCl2, 0.01% NIKKOL, 1 mM DTT
for 10 minutes on ice and 10 minutes at 26°C.  At each step, if a component was omitted in the
reconstitution, it was replaced by its corresponding buffer. The samples were loaded on a
Superdex 200 HR 10/ 30 sizing column (24 ml, Amersham Biosciences) equilibrated with the
filtration buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 0.5 mM MgCl2, 0.1% NIKKOL and 1
mM DTT). Gel filtration was performed at 0.5 ml/minute. 35 fractions (800 µl; otherwise
indicated) were collected after 6 ml and stored at -80 °C before analysis. After each run, the
column was washed with filtration buffer containing 500 mM KCl (12 ml) and re-equilibrated
with 50 ml of filtration buffer containing 100 mM KCl. The proteins were detected by western
blotting or slot blotting and immunoblotting with affinity-purified antibodies as indicated. The
protein content in each fraction was given as a percentage of the sum of the signals in the
analysed fractions. The 32P-labelled RNA in each fraction was quantified by scintillation
counting using a scintillation counter (Beckman): 100 µl of each fraction were diluted in 3 ml
of  Ultima  Gold  Scintillation  Reagent  (Packard).  The  radioactive  intensity  (in  cpm)  of  each
fraction was summed and the percentage of the total radioactive intensity in each fraction
calculated. For graphic representation, the amount (in pmoles) of RNA (cold + 32P-labelled) in
each  fraction  was  calculated  from  the  amount  of  RNA  loaded  on  the  column  and  the
percentage of radioactive intensity for each fraction. The fractions after the fraction 20 never
contained measurable radioactivity. For on-line spectrophotometry, the OD 254 nm profiles
were recorded on paper at a speed of 0.5 cm/ml after 6 ml of elution (dead volume of the
column). The elutions were scanned. The small peak before 21 ml was used as an internal
control for alignment of the scans.
4.5 Binding assay with biotinylated RNA
The biotinylated, re-annealed Alu151 RNA (5 pmoles) was immobilized on streptavidin beads
(Dynabeads, Dynal). The immobilized RNA was incubated with 1 pmoles of the indicated
SRP9/14 heterodimer in 20 µl of 20 mM HEPES pH 7.5, 500 mM KOAc pH 7.5, 5 mM
Mg(OAc)2 pH 7.5, 0.1% NIKKOL, 10 mM DTT for 10 minutes on ice and 10 minutes at
37 °C. The supernatant was collected and the beads were washed several times with the same
buffer. The bound proteins were eluted with SDS-PAGE loading buffer and detected by
western blotting with affinity-purified anti-SRP14 antibodies. The supernatant was analysed in
parallel to detect the unbound proteins. An input (1 pmoles of SRP9/14) was also analysed by
western blotting on the same gel.
4.6 Ribosome-binding assays
The mock ribosomes, purified from the wheat germ extract or the rabbit reticulocyte lysate,
were incubated with the Alu151 RNP, the Alu151 RNA or the SRP9/14 heterodimers in 30 µl
of binding buffer (20 mM HEPES pH 7.5, 50 mM KOAc pH 7.5, 2.5 mM Mg(OAc)2 pH 7.5,
0.01% NIKKOL, 1 mM DTT) for 10 minutes on ice and 10 minutes at 26 °C. The amounts
used in this incubation step are indicated in the figure legends, as well as the components used.
For the analysis by sedimentation through a sucrose cushion, the samples were laid on a 150 µl
sucrose cushion (binding buffer supplemented with 500 mM of sucrose) and centrifuged for 30
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minutes at 30 psig (148000 g), 4 °C in the A-100/18 rotor of the airfuge™ (Beckman
Coulter®). The cushions (180 µl; “S” fraction) were removed and kept for analysis and the
ribosomal pellets (“P” fraction) were solubilised in 180 µl of sucrose cushion buffer. When the
Alu151 RNP or the Alu151 RNA were assayed, 1/6e of the “S” and “P” fractions were analysed
by scintillation counting in Ultima Gold Scintillation Reagent (Packard) using a scintillation
counter (Beckman Coulter®) to detect the 32P-labelled Alu151 RNA (Material and Methods
3.1). 1/6e of the “S” and “P” fractions were analysed by western blotting with anti-L9
antibodies to detect the ribosome (ribosomal protein L9). 1/6e of the “S” and “P” fractions
were analysed by western blotting with affinity-purified anti-SRP14 antibodies to detect the
heterodimer SRP9/14 (SRP14). An input (“I”), corresponding to 1/6e of the amount of the
components used in each sample, was analysed in parallel. For the Alu151 RNA detection, the
signal for the input was made equal to 100 % and the signals for the “S” and “P” fractions were
expressed as a percentage of the input. When the SRP9/14 heterodimers were assayed, 100 %
of the “S” and “P” fractions were analysed by western blotting, first with affinity-purified
anti-SRP14 antibodies, then with anti-L9 antibodies. For the analysis by size exclusion
chromatography,  the  volume of  the  samples  was  increased  to  50  µl  with  binding  buffer.  The
samples were loaded at 4 °C on a Superdex 200 HR 10/30 column (Amersham Biosciences)
equilibrated with binding buffer containing 0.1 % NIKKOL. The filtration was performed at
0.5 ml/minute. After 6 ml of filtration, 10 fractions (1.6 ml) were collected. 25 % of each
fraction was analysed by western blotting, first with affinity-purified anti-SRP14 antibodies,
then with anti-L9 antibodies.
4.7 Hydroxyl radical footprinting
LGAR RNA was labelled at its 5’ end with 32P (Materials and Methods 2.5). Less than 1 pmole
at more than 80000cpm/pmole was reannealed as described in Materials and Methods 2.6.
Complex formation with recombinant, purified L12 (3 or 15 pmoles) was performed in 4 µl of
20 mM Tris pH 7.5, 300 mM KCl, 5 mM MgCl2, 0.01 % NIKKOL, 1 mM DTT. For control,
L12 was replaced with its buffer or 15 pmoles of BSA. The complexes were incubated 10
minutes on ice and 10 minutes at 37 °C. For the cleavage reaction, the complexes were diluted
to 40 µl in 20 mM Tris pH 7.5, 100 mM KCl, 0.5 mM MgCl2, 0.01 % NIKKOL, 5 mM DTT
and incubated 10 minutes on ice and 10 minutes at 26 °C prior to the sequential addition of
2 µl of 50 mM Fe(II)(NH4)2(SO4)2, 2 µl of 100 mM EDTA pH 8.0, 2 µl of 250 mM Sodium
Ascorbate and 2 µl of 5 % H2O2 on the wall  of the tube.  The drop (8 µl) was mixed with the
complexes and the hydroxyl radical cleavage reaction performed for 5 minutes at 4 °C. The
reaction was quenched with 48 µl of 100 mM Thiourea. The RNA was precipitated and
analysed by Urea-PAGE on a sequencing gel. The gel was fixed with 20 % Methanol and
7.5 % Acetic acid and dried. The RNA fragments were detected by autoradiography. The
LGAR RNA ladder was obtained by the treatment of 40000 cpm of 5’ end-labelled LGAR
RNA (less than 0.5 pmoles) with 60 mM of NaHCO3 pH 9.5 in the presence of 5 µg of tRNA
at  95  °C for  3  minutes.  The  ladder  (40  % of  the  reaction)  was  directly  used  for  Urea-PAGE.
For  LGAR RNA sequencing  with  RNAses,  40000 cpm of  5’  end-labelled  LGAR RNA (less
than 0.5 pmoles) were treated with T1, U2, PhyM and B. cereus RNAses as recommended by
the supplier (Industrial Research Limites). The RNAses reactions (30 %) were directly used for
Urea-PAGE analysis.
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5 Materials
The products were purchased from Acros Organics: KOAc / Applichem: Acrylamide (for SDS-
PAGE), HEPES, SDS, Urea / Boehringer Mannheim: tRNA / Eurobio: Agarose, DTT, IPTG /
Fluka: Ammonium Sulfate Boric acid, Dichloromethane, EDTA, Formamide, Glycerol,
Glycine, KCl, Methanol, Mg(OAc)2, NaIO4, NaOAc, Phenol, TCA, Tris / Interchim: Triton X-
100 / Merck: Acetic acid / National Diagnostics: Acrylamide (for Urea-PAGE) / Nikko
Chemicals Co: NIKKOL / Roche: Glycogen / Serva: MgCl2 /  Sigma:  BSA,  CAPS,  CMP,
Cycloheximide, Ethidium Bromide, GTP, Methionine, NaOAc, NEM, NH4Cl, Polymin,
Puromycin, Spermidine, Sucrose, Tween 20 / Uptima: Pefabloc (AEBSF).
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ABSTRACT: The eukaryotic signal recognition particle (SRP) is essential for cotranslational targeting of
proteins to the endoplasmic reticulum (ER). The SRP Alu domain is specifically required for delaying
nascent chain elongation upon signal sequence recognition by SRP and was therefore proposed to interact
directly with ribosomes. Using protein cross-linking, we provide experimental evidence that the Alu binding
protein SRP14 is in close physical proximity of several ribosomal proteins in functional complexes. Cross-
linking occurs even in the absence of a signal sequence in the nascent chain demonstrating that SRP can
bind to all translating ribosomes and that close contacts between the Alu domain and the ribosome are
independent of elongation arrest activity. Without a signal sequence, SRP14 cross-links predominantly to
a protein of the large subunit. Upon signal sequence recognition, certain cross-linked products become
detectable or more abundant revealing a change in the Alu domain-ribosome interface. At this stage, the
Alu domain of SRP is located at the ribosomal subunit interface since SRP14 can be cross-linked to
proteins from the large and small ribosomal subunits. Hence, these studies reveal differential modes of
SRP-ribosome interactions mediated by the Alu domain.
Ribosomes translating mRNAs coding for secretory and
membrane proteins are specifically targeted to the endoplas-
mic reticulum (ER) membrane by a cytosolic ribonucleopro-
tein particle, the signal recognition particle (SRP) (for review,
see ref 1). The specificity of this process is ensured by the
presence of a signal sequence in the growing peptide chain,
which is recognized by SRP when it emerges from the
ribosome. Signal sequence recognition by SRP causes a slow
down or an arrest in the elongation of the nascent chain (2,
3). The SRP-ribosome-nascent chain complex is then
targeted to the ER via the interaction of SRP with its
membrane receptor, the SRP receptor (SR), a heterodimeric
membrane protein (4, 5). SR coordinates the release of SRP
from the ribosome with the insertion of the nascent chain
into the Sec61 complex, the aqueous translocation pore in
the ER membrane (for reviews, see refs 6 and 7). Free SRP
can then engage in another targeting round, and membrane-
associated ribosomes resume translation at their regular
speed, leading to the cotranslational transfer of the nascent
chain across or into the ER membrane. As emphasized by
this model, SRP is proposed to play a critical role in the
precise accommodation of the translational machinery to the
translocation process. From this point of view, it appears
that the ability of SRP to interact with and to modulate the
activity of the translating ribosome is a major requirement
for its function.
Mammalian SRP is composed of a small RNA, SRP RNA,
and six polypeptides named according to their apparent
molecular mass (SRP9, 14, 19, 54, 68, and 72). SRP54
recognizes the signal sequence and mediates targeting to the
ER membrane by binding to SR in a GTP-controlled manner
(8, 9). SRP9/14 and the 5′ and 3′ ends of SRP RNA form
the Alu domain of SRP, which mediates elongation arrest
activity. Elongation arrest is detected in vitro as a complete
arrest or a transient delay in the elongation of the nascent
chain, and its absence decreases the translocation efficiency
(10-12). In vivo, it is required for the tight accommodation
of the translation and the translocation processes (13).
Removal of the Alu domain or the protein SRP9/14 abrogates
the elongation arrest activity of the particle (10, 14).
Many SRP activities appear to depend on interactions with
the ribosome. The ribosome may play an important role in
signal sequence recognition by SRP54 since SRP fails to
bind signal sequences of nascent chains that have been
released from the ribosome (15, 16). In addition, a ribosomal
component stimulates GTP binding of SRP54 for an interac-
tion with SR (17). Recently, two ribosomal proteins in
proximity to the nascent chain exit site have been shown to
interact in two distinct modes with SRP54 before and after
binding to SR (18). Together with the finding that the yeast
homologues of the two ribosomal proteins form major
contacts with the translocon complex Sec61p (19), these
† This work was supported by grants from the Swiss National Science
Foundation, the Canton of Geneva, and the MEDIC Foundation. B.D.
and K.S. wish to acknowledge long-term support from the European
Union Framework IV TMR program for SRPNET (FMRX-CT960035)
and Framework V Quality of Life program for MEMPROT-NET
(QLK3-CT200082). M.R.P. was a fellow of the TMR program
SRPNET.
* To whom correspondence should be addressed. Telephone: +41-
22-379 6724. Fax: +41-22-379 3221. E-mail: strub@cellbio.unige.ch.
‡ Universite´ de Gene`ve.
§ Zentrum fu¨r Molekularbiologie.
| Current address: University of Manchester, School of Biological
Sciences, 2.205 Stopford Building, Oxford Road, Manchester, M13 9PT,
UK.
107Biochemistry 2004, 43, 107-117
10.1021/bi0353777 CCC: $27.50 © 2004 American Chemical Society
Published on Web 12/09/2003
studies suggested that SR-regulated contacts of SRP54 with
the ribosome may control ribosome binding to the translocon.
Bacterial SRP can also be cross-linked to the same ribosomal
protein as well as to ribosomal RNA near the nascent chain
exit site (20, 21). On the basis of the observation that SRP
affects nascent chain elongation, it was proposed that the
Alu domain of SRP might bind in the ribosomal A-site (22,
23), possibly by mimicking tRNA. However, structural
studies failed to reveal a significant structural mimicry
between the Alu domain and tRNA (24). A mutational
analysis of SRP14 revealed that a short C-terminal region is
very critical for elongation arrest activity (12, 13), indicating
that direct contacts between the Alu domain, and possibly
more specifically, between SRP14 and the ribosome may
be essential for the delay in nascent chain elongation.
However, physical proximity and/or a direct contact between
the Alu domain and the ribosome have so far not been
experimentally documented, and the mechanism of the
elongation arrest function remains to be elucidated.
Here, we probe the molecular environment of SRP14 in
functional SRP-ribosome complexes of mammalian and
plant translation systems using a bifunctional cross-linker.
In both systems, SRP14 is in close proximity to several
ribosomal proteins. In addition, the four cross-linked products
have comparable sizes defining a conserved Alu domain-
binding site in the ribosome. With ribosomes bearing nascent
chains lacking a signal sequence and vacant ribosomes,
SRP14 cross-links predominantly to a protein of the large
ribosomal subunit. Upon signal sequence recognition, three
other cross-linked products become more abundant, revealing
a change in the Alu domain-ribosome interface. SRP14 is
now cross-linked to ribosomal proteins of the large and small
subunits in agreement with its location at the subunit interface
of the ribosome. Taking into account the complexity and
the apparent minimal sizes of the cross-linked products as
well as the location of the Alu domain at the ribosomal
subunit interface, we present a schematic model for the SRP
Alu domain-binding site.
MATERIAL AND METHODS
In Vitro Transcriptions. Cyc130 and pPl86 mRNAs,
encoding the first 130 and 86 amino acids of cyclin and
preprolactin, respectively, were synthesized with SP6 RNA
polymerase (Promega) from plasmids pCyclin and pSP-BP4
(12, 25) linearized with PstI and PVuII, respectively. Full-
length cyclin and preprolactin mRNAs were produced from
the same plasmids linearized with EcoRI.
Purification of Ribosome-Nascent Chain Complexes. RNCs
were produced in 100 íL translations with nuclease-treated
rabbit reticulocyte lysate (Promega) programmed individually
with optimized amounts of truncated Cyc130 and pPl86
mRNAs (see below) in the presence of 40 íM cold
methionine. No mRNA was added to the mock translations.
After translation for 30 min at 30 °C, synthesis was stopped
with cycloheximide (final concentration, 0.5 mM), and the
salt concentrations of the samples were adjusted to 500 mM
potassium acetate (KOAc) and 5 mM magnesium acetate
(Mg(OAc)2) in a final volume of 200 íL. After 15 min on
ice, reactions were centrifuged 5 min at 15 000 rpm to pellet
aggregates. Aliquots of 100 íL of the supernatants were
loaded on 2 mL sucrose cushions (20 mM HEPES pH 7.5,
500 mM KOAc pH 7.5, 5 mM Mg(OAc)2 pH 7.5, 500 mM
sucrose, 2 mM DTT, 0.01% Nikkol, 0.5 mM cycloheximide)
and centrifuged in a TFT80.4 rotor (Kontron) for 1 h at
50 000 rpm at 4 °C. Ribosomal pellets were resuspended in
20 íL of HKMND50-2.5-1 (20 mM HEPES pH 7.5, 50 mM
KOAc pH 7.5, 2.5 mM Mg(OAc)2 pH 7.5, 0.01% Nikkol, 1
mM DTT). The concentrations of ribosomes were determined
as described (26). RNC yields were optimized by titrating
the synthetic mRNAs into translation reactions containing
[35S]-methionine (>37 Tbq/mmol, Amersham Pharmacia
Biotech). Ribosomal pellets were obtained as stated previ-
ously and analyzed by 5-20% SDS-PAGE and autorad-
iography. Cyc130 and pPl86 nascent chains were quantified
with a phosphorescence imaging system (BioRad), and their
relative yields were calculated taking into account that the
pPl86 and Cyc130 nascent chains contain four and six
methionines residues, respectively. Maximal yields of Cyc130
and pPl86 were obtained with a 6- and 16-fold excess of
mRNA over ribosomes, respectively. RNCs were also
produced in 100 íL translations with wheat germ extract at
26 °C and purified as described previously. However, under
optimized translation conditions, the yields of RNC formation
were always lower with the wheat germ lysate (about 5-fold)
when compared to the rabbit reticulocyte lysate (results not
shown). SRP could therefore not be saturated with pPl86
ribosomes as described for rabbit SRP-RNC cross-linking
(see Results).
Antibody Purification and Immunoblotting. Anti-SRP14
antibodies were purified as described previously (27). Anti-
L9 and anti-S15 antibodies were raised in rabbits against
the peptides CKNKDIRKFLDGIY and KKKRTFRKFTY-
RGC, respectively (Sigma-Genosys). For immunoblotting,
proteins were separated by SDS-PAGE and transferred on
nitrocellulose membranes (Protran BA83). Membranes were
blocked 1 h at room temperature with TBS containing 0.2%
Tween 20 and 5% nonfat, dry milk (TBST + milk).
Incubation with primary antibodies was performed overnight
at 4 °C in TBST + milk. Washes were performed in TBST.
Membranes were incubated at room temperature with goat
anti-rabbit HRP-conjugated antibodies (BioRad) in TBST +
milk for 1 h. After washes with TBST, membranes were
incubated in Supersignal (Pierce). Images were taken with
a CCD camera-based system (GeneGnome, Syngene) and
quantified with GeneTools (Syngene). If the membrane had
to be tested with several antibodies, it was washed with 5
M urea, 10 mM dithiothreitol (DTT) for several hours at 37
°C, blocked in TBST + milk, and reused as before.
Cross-Linking Assays with Purified RNCs. SRP-RNC
complexes were formed individually by incubating 2 pmol
of ribosomes, pPl86 RNCs, or Cyc130 RNCs with 1 pmol
of canine SRP purified as described before (28) in a final
volume of 30 íL of HKMND50-2.5-1 at 26 °C for 10 min.
Prior to incubating with DSS (suberic acid (bis N-hydroxy-
succinimide ester) supplied from Sigma, 40 mM fresh stock
solution in DMSO diluted to a final concentration of 800
íM) at 26 °C for 30 min, the volume was increased to 100
íL with HKMND50-2.5-1. The reactions were quenched with
100 mM Tris pH 7.5 for 15 min on ice, TCA-precipitated
(10%), and analyzed by 12% SDS-PAGE and by immu-
noblotting with anti-SRP14 antibodies. Signals for 14-X45,
14-X31, and 14-X20 were quantified. The intensity of each
cross-linked product in the reaction with Cyc130 RNCs was
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arbitrarily set to 100% and used as a standard to calculate
the relative intensity of the equivalent cross-linked product
in reactions with ribosomes and pPl86 RNCs. To be able to
compare the 14-X45 and 14-X31 signals between different
reactions, we first had to normalize the intensities of all cross-
linked products in the pPl86 and in the ribosomes reactions
to equal intensities of 14-X20 in all reactions. This resulted
in only minor adjustments because the 14-X20 intensities
were nearly equal in all reactions. Cross-linking reactions
under high salt conditions were performed and analyzed as
described previously, but prior to incubating with DSS,
cycloheximide (final concentration, 0.5 mM) was added to
all reactions, and salt concentrations were increased to 500
mM KOAc and 5 mM Mg(OAc)2 where indicated.
Cross-Linking Assay in Ongoing Translations. Rabbit
reticulocyte translation reactions (25 íL, 150 mM KOAc,
and 2 mM Mg(OAc)2) primed individually with full-length
cyclin and preprolactin synthetic mRNAs were incubated at
30 °C for 15 min in the presence or absence of 4 pmol of
exogenous canine SRP. The amount of mRNAs in the
reactions was chosen to obtain the same translational
efficiency of cyclin and preprolactin (see below). Mock
translations contained no synthetic mRNA. Prior to incuba-
tion with DSS (800 íM final) at 30 °C for 30 min, the
volume was increased to 100 íL with HKMND150-2-1. The
reactions were quenched with 100 mM Tris pH 7.5 for 15
min on ice. Cycloheximide (final concentration, 0.5 mM)
was added, and the salt concentration of the samples was
adjusted to 500 mM KOAc and 5 mM Mg(OAc)2 in a final
volume of 150 íL. After 15 min on ice, reactions were
centrifuged 5 min at 15 000 rpm to pellet aggregates. The
supernatants were loaded on 2 mL sucrose cushions, and
ribosomes were pelleted as stated previously. The ribosomal
pellets were directly analyzed by 12% SDS-PAGE and by
immunoblotting with anti-SRP14 and anti-S15 antibodies.
Translational efficiencies of cyclin and preprolactin were
compared by titrating the synthetic mRNAs into translation
reactions containing [35S]-methionine in the absence of
exogenous canine SRP. Aliquots of 5 íL of the reactions
were directly analyzed by 15% SDS-PAGE and autorad-
iography. Cyclin and preprolactin were quantified with a
phosphorescence imaging system (BioRad), and their relative
yield was calculated by taking into account that the prepro-
lactin and cyclin chains contain eight and 16 methionines
residues, respectively. Similar efficiencies of cyclin and
preprolactin synthesis were obtained with 2.5 and 6.8 íg of
mRNA, respectively.
Ribosomal Subunit Separation. Complexes were formed
with 21 pmol of pPl86 RNC and 17.5 pmol of canine SRP
and incubated for 10 min at 26 °C in a final volume of 100
íL (final salt concentration, 60 and 2.5 mM KOAc and Mg-
(OAc)2, respectively). Cross-linking was done as before but
with 100 íM DSS. To separate the ribosomal subunits,
reactions were adjusted to 500 mM KOAc, 10 mM Mg-
(OAc)2, 1 mM puromycin, and 1 mM GTP in a final volume
of 150 íL and incubated for 30 min at 37 °C. Ribosomal
subunits were separated by centrifugation through 11.2 mL,
10-30% sucrose gradients (HKMND500-10-2) for 5.30 h in
a TST41.14 rotor (Kontron) at 4 °C and 41 000 rpm.
Fractions of 200 íL were collected using Auto Densi-FlowII
C (Buchler Instruments), and the absorbance was monitored
at 254 nm with an Econo UV-Monitor EM-1 (BioRad). On
the basis of the A254 profile, the fractions were pooled to
represent the 40S and 60S subunits, as well as the 80S
ribosomes (see below). Fractions of the top of the gradient
were arbitrarily split in four groups. Pooled fractions were
TCA-precipitated and analyzed by 12% SDS-PAGE and
immunoblotting with anti-SRP14, anti-L9, and anti-S15
antibodies. The L9 and S15 signals confirmed the correct
assignments of the fractions. The signals of L9, S15, and
the cross-linked products 14-X45, 14-X31, and 14-X20 were
quantified for each fraction. All measured signals for the
same protein were summed, and for comparison, the signal
in each fraction was expressed as a percentage of this sum.
Cyc130 RNC-SRP complexes were analyzed the same way,
but only S15, L9, and 14-X20 were quantified. To clearly
identify the subunit fractions on the basis of the A254 profile,
Cyc130 RNCs were reacted with DSS (100 íM), and the
ribosomal subunits were separated as stated previously.
Twenty fractions were collected with continuous monitoring
of the absorbance at 254 nm. Fractions were TCA-
precipitated and analyzed by 12% SDS-PAGE and immu-
noblotting with anti-L9 and anti-S15 antibodies. The signals
of L9 and S15 were quantified for each fraction. All
measured signals for the same protein were summed, and
for comparison, the signal in each fraction was expressed as
a percentage of this sum. L9 and S15 distribution confirmed
the identification of the 40S and 60S subunit, as well as 80S
cross-linked ribosomes, using the A254 profile. The INT
fraction contained both 40S and 60S subunits.
Data Collection of Ribosomal Proteins. Swiss-Prot Protein
Knowledgebase for ribosomal proteins: http://igweb.inte-
gratedgenomics.com/Bioinformatics/Nikos/Ribosome/rpro-
teins.html contains lists of ribosomal protein families
(@SWISS-PROT by Amos Bairoch).
RESULTS
The Alu Domain Has ConserVed Binding Sites on the
Ribosome. To examine the molecular environment of SRP14
in SRP bound to mammalian and plant ribosome-nascent
chain complexes (RNC), we used the homobifunctional
cross-linker DSS (Materials and Methods). DSS makes
covalent noncleavable bonds to neighboring proteins through
amino groups of lysyl side chains spanning a distance of at
most 12 Å. The results of the cross-linking experiments were
analyzed by SDS-PAGE followed by immunoblotting with
affinity-purified anti-SRP14 antibodies (Materials and Meth-
ods).
RNCs were formed in reticulocyte lysate using truncated
mRNAs encoding the N-terminal 86 and 130 amino acid
residues of preprolactin (pPl86) and cyclin (Cyc130), re-
spectively. RNCs were then purified by centrifugation
through a sucrose cushion at 500 mM salt to remove
translation factors, other cytoplasmic components, and in the
absence of a signal sequence in the nascent chain, also
endogenous SRP. Rabbit SRP has previously been shown
to be present and active in reticulocyte lysate (5, 11). After
purification, both nascent chains were detected as single
bands of the sizes expected for the truncated proteins (Figure
1A). The absence of shorter translation products demon-
strated that each translated mRNA molecule was associated
with only one ribosome. To minimize the amount of vacant
ribosomes in the RNC preparations (29), we saturated pPl86
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and Cyc130 synthesis by titrating the synthetic transcripts
into the translation reactions (results not shown, see Materials
and Methods). At optimized conditions, the ribosome oc-
cupancy with nascent chains in Cyc130 RNC samples was
reproducibly 1.6-fold higher as compared to pPl86 RNC
samples (Figure 1B). Hence, there were less vacant ribo-
somes in Cyc130 RNC than in pPl86 RNC samples.
Optimal cross-linking efficiencies with pPl86 RNCs were
obtained at a ribosome-SRP ratio of 2:1 as established in
experiments described below. Taking into account that SRP
binds preferentially to pPl86 RNCs as opposed to vacant
ribosomes (29), we deduced from this result that the pPl86
RNC preparation contained about 50% vacant ribosomes.
On the basis of the higher efficiency of Cyc130 synthesis,
the occupancy of ribosomes in Cyc130 RNC preparations
could be expected to be around 80%. The optimal DSS
concentration in the cross-linking experiments was 800 íM,
which is 20-fold higher than the one used in similar
experiments that identified ribosomal proteins cross-linked
to SRP54 (18). The requirement for a higher DSS concentra-
tion may be explained by the smaller size and/or lower
accessibility of the targets.
With pPl86 RNCs in the cross-linking reaction, the anti-
SRP14 antibodies specifically recognized five protein species
with higher apparent molecular weights than SRP14 (Figure
1C, lane 11), indicating that they represented SRP14 adducts.
With ribosomes from mock translations and with Cyc130
RNCs (Figure 1C, lanes 9 and 10), the antibodies revealed
four cross-linked products with the same apparent sizes
consistent with the interpretation that the covalent linkages
occurred to the same proteins. The cross-link 14-X17 was
undetectable. In all cases, the smallest cross-linked species
had the expected size of an SRP14-SRP9 adduct. Indeed, it
was also seen with SRP alone (Figure 1C, lane 2) and was
recognized by anti-SRP9 antibodies (result not shown). The
other cross-linked products presumably represented SRP14
covalently linked to ribosomal proteins. The size differences
between the apparent molecular weights of the cross-linked
products and of SRP14 were in the size range of 17-45 kDa
as expected for ribosomal proteins (Figure 1C). Notably, we
never observed smaller cross-linked products with different
RNC-SRP ratios and with different DSS concentrations,
making it unlikely that they represented cross-links between
more than two proteins (see also Figure 5).
The fact that SRP14 was cross-linked to ribosomal
components in all samples was consistent with the previous
observations that SRP could bind directly to ribosomes in a
signal sequence- and nascent chain-independent fashion (25,
29-31). Moreover, it demonstrated that the Alu domain was
already in close proximity to the ribosome in the absence of
elongation arrest. The 14-X20 product was present at equal
intensities in all reactions (Figure 1C), suggesting that it
might represent a cross-linked product specific to ribosomes
that do not expose a signal sequence. Later experiments
showed (see below) that 14-X20 also represented a signal
sequence-specific cross-linked product.
Interestingly, upon signal sequence recognition, the other
cross-linked products became more abundant. The 14-X45
and 14-X31 signals were reproducibly 2.5-fold higher with
pPl86 RNCs than with Cyc130 RNCs (Figure 1C,D and
Table 1). Similarly, 14-X17 was only detected with pPl86
RNCs. If this increase was specific for signal sequence
FIGURE 1: Cross-linking of the Alu domain-binding protein SRP14
to ribosomal components. (A) Analysis of [35S]-labeled Cyc130
and pPl86 nascent chains of purified RNCs by 5-20% SDS-
PAGE. (B) Relative yields of pPl86 and Cyc130 nascent chains at
maximized translation efficiencies. The [35S]-labeled polypeptides
were quantified with phosphorescence imaging, and their relative
yields were calculated taking into account that pPl86 and Cyc130
contain four and six methionine residues, respectively. (C) Immu-
noblot analysis of the cross-linking reactions with affinity-purified
anti-SRP14 antibodies. Complexes formed between SRP (1 pmol)
and RNCs (2 pmol) were treated with 800 íM DSS, and the proteins
of the different samples were separated by 12% SDS-PAGE. N:
ribosomes prepared from mock translations; C: Cyc130 RNCs; P:
pPl86 RNCs. Lanes 6-8: RNCs alone and lanes 9-11: RNCs
and canine SRP. Control lanes 3-5: RNCs alone without DSS
and lanes 1 and 2: canine SRP without and with DSS treatment,
respectively. The number following X in the labels indicates the
estimated minimal size of the cross-linked ribosomal components.
14-X9 marks the cross-link between SRP14 and SRP9. (D) The
relative abundances of the cross-linked products. The cross-linked
products in lanes 9-11 were quantified with a CCD camera-based
system. The intensities of each cross-linked product were compared
to the one in Cyc130 RNC reactions, which was set to 100%
(Materials and Methods). (E) Immunoblot analysis of the cross-
linking reactions with SRP and wheat germ RNCs using affinity-
purified anti-SRP14 antibodies. Cross-linking reactions were done
as in panel C. Lanes 1-3: RNCs without DSS; lanes: 4-6: RNCs
with DSS; and lanes 7-9: RNCs with SRP and DSS treatment. *:
wheat germ ribosomal protein of the small subunit recognized
fortuitously by the anti-SRP14 antibodies. MW: molecular weight
standards.
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recognition by SRP, it should reach a maximum, once all
SRP was bound to ribosomes bearing pPl86 nascent chains
(subsequently called pPl86 ribosomes to avoid confusion with
pPl86 RNC preparations, which also comprise vacant ribo-
somes). This hypothesis was tested experimentally by varying
the ratio between SRP and number of pPl86 ribosomes in
the cross-linking reactions. SRP is expected to bind prefer-
entially to pPl86 ribosomes because of its 2 orders of
magnitude higher affinity (29). To increase the number of
pPl86 ribosomes, we raised the total amount of ribosomes.
Specifically, cross-linking reactions with Cyc130 and pPl86
RNCs were done at ribosome-SRP ratios of 2:1 and 3:1.
We found that in both cases, 14-X45 and 14-X31 were 2.5-
fold more abundant in cross-linking reactions with pPl86
RNCs than with Cyc130 RNCs, confirming that the increase
was limited and that the maximum was already reached at
the lower ribosome-SRP ratio. To decrease the number of
pPl86 ribosomes, we lowered the ribosome occupancy by
adding less preprolactin and cyclin mRNAs while keeping
the ribosome-SRP ratio at 3:1. At 2.5-fold lower ribosome
occupancy as in the previous experiments, 14-X45 and 14-
X31 were only 1.6-fold more abundant (results not shown).
Presumably, pPl86 ribosomes now become limiting, and SRP
was also bound to vacant ribosomes, thereby reducing the
increase of 14-X45 and 14-X31. These findings were
consistent with the interpretation that the observed changes
were specific for pPl86 ribosomes and therefore revealed a
noticeable change in the environment of SRP14 upon signal
sequence recognition.
As indicated by the strong signal of SRP14 in the control
lanes with pPl86 RNCs (Figure 1C, lanes 5 and 8),
endogenous rabbit SRP present in the lysate copurified with
the RNCs exposing a signal sequence. Hence, the weak
signals observed for some adducts in the absence of canine
SRP were likely to result from covalent links between rabbit
SRP14 and ribosome (Figure 1C, lane 8).
We repeated the cross-linking experiments with wheat
germ ribosomes. At maximal translation efficiencies and at
a ribosome-SRP ratio of 2:1, we observed cross-linked
products of similar sizes (Figure 1E). The 14-X20 adduct
was weaker and the 14-X17 adduct stronger than with the
mammalian system, which may be explained by structural
differences between the systems. However, the proteins,
which were in proximity to the Alu domain, appeared to be
conserved between mammalian and plant ribosomes since
both RNC-SRP complexes produced the same number of
cross-linked products, and the cross-linked products were
of comparable sizes. Note, that even under optimized
translation conditions the yield of nascent chains for the same
amount of ribosome was significantly lower with wheat germ
lysate than with reticulocyte lysate (Materials and Methods).
Hence, the observed cross-links might predominantly reflect
binding of SRP to vacant ribosomes. It was therefore not
surprising that under the experimental conditions used, we
failed to observe a difference in the relative intensities of
the cross-linked products in the presence of preprolactin
nascent chains. In the subsequent experiments, we concen-
trated our efforts on the characterization of the homologous
system.
Cross-Linked Products Reflect Two Functional States of
SRP-Ribosome-Nascent Chain Complexes. If the cross-
linked species observed with purified RNCs, which were
artificially arrested in translation, reflected functional SRP-
ribosome complexes, we should be able to detect them in
ongoing translation. Reticulocyte lysate translation reactions
alone or programmed individually with full-length prepro-
lactin and cyclin synthetic mRNAs were reacted with DSS
after 15 min of translation. Both cyclin and preprolactin can
be detected at this time point, and the synthetic mRNA
concentrations chosen for the cross-linking experiments
yielded comparable translation efficiencies for both proteins
(Figure 2A,B). After cross-linking, the ribosomes were
purified through a high-salt sucrose cushion and analyzed
for the presence of SRP14 adducts as before (Figure 2C,
upper panel). To confirm that the same amount of ribosomes
was analyzed in each sample, we performed immunoblots
with anti-S15 antibodies on the same reactions (Figure 2C,
lower panel). The lower SRP concentrations in the cyclin
and mock translations samples, as reflected by the SRP9-
SRP14 signals, were explained by the fact that SRP-
ribosome complexes are only stable to high salt treatment
in the presence of a signal sequence in the nascent chain
(25). SRP was therefore removed from ribosome bearing
nascent chains lacking a signal sequence and from vacant
ribosomes in the high salt purification step, unless it was
covalently linked to a ribosomal protein (Figure 2C, lanes
1, 2, 4, and 5).
In one series of translation reactions, cross-linking occurred
to the endogenous rabbit SRP (Figure 2C, lanes 1-3).
However, since some of the signals were rather weak in these
samples, we repeated the same experiments in the presence
of additional canine SRP (Figure 2C, lanes 4-6). Cross-
linked products of identical sizes as those observed with
purified RNCs were unambiguously identified. During pre-
prolactin synthesis, three of the four ribosome-specific
adducts were clearly detectable with rabbit SRP alone (Figure
2C, lane 3), whereas based on the abundances of the other
adducts, 14-X17 was presumably too faint to be detected.
However, it became just detectable after the addition of
canine SRP (Figure 2C, lane 6). Hence, rabbit and canine
SRP yielded the same adducts during preprolactin synthesis
as observed with artificially arrested pPl86 RNCs. This
finding confirmed that these cross-linked products defined
the environment of SRP14 in functional SRP-ribosome
complexes.
During the translation of nascent chains lacking a signal
sequence, only 14-X20 was detected (Figure 2C, lane 2).
However, it was weaker than in preprolactin translation and
was even absent in mock translation (Figure 2C, lane 1).
Table 1: Formation and Ribosomal Subunit Association of SRP14
Cross-Linked Products
cross-linked
products
with
Cyc130
RNCa
with
pPl86
RNCa
in prepro-
laction
translationb
in cyclin
translationb
subunit
association
14-X45 + +++ D ND 60S
14-X31 + +++ D ND 40S
14-X20 + + + ++ 60S
14-X17 ND D D ND NA
a The intensities of the same cross-linked product formed either with
Cyc130 RNCs or with pPl86 RNCs were compared, as presented in
Figure 1D. b The intensities of the same cross-linked product formed
during synthesis of either cyclin or preprolactin were compared, as
presented in Figure 2C. The cyclin translation was supplemented with
canine SRP. D, detected; ND, not detected; NA, not assigned.
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Thus, in contrast to the experiments with artificially arrested
RNCs, the abundance of 14-X20 changed markedly in the
different samples. Indeed, the changes in the 14-X20 signals
appeared to parallel the expected relative affinities of SR
for the different ribosomes as characterized for wheat germ
ribosomes and canine SRP (29). This observation is plausibly
rationalized by assuming that other translation factors and/
or chaperones may compete with SRP binding to ribosomes
(25, 32) in ongoing translation but not in the experiments
with artificially arrested, purified RNCs.
In the experiments with artificially arrested RNCs, we
observed a signal sequence-specific increase in the relative
abundances of several SRP14 adducts. Similarly, the 14-
X31 and 14-X45 products were only detected during pre-
prolactin synthesis (Figure 2C, lane 3) in ongoing translation
confirming that signal sequence-specific changes occurred
at the Alu domain-ribosome interface. To exclude the
possibility that the 14-X31 and 14-X45 products escaped
detection, we increased the cross-linking signals by the
addition of canine SRP. Despite the 2-fold increase in 14-
X20 during cyclin synthesis (Figure 2C, lane 5) as compared
to preprolactin synthesis (Figure 2C, lane 3), 14-X31 and
14-X45 remained undetectable. Hence, unlike with Cyc130
RNCs, their formation was strictly dependent on signal
sequence recognition. The presence of small amounts of 14-
X45 and 14-X31 in the cross-linking reactions with
Cyc130RNCs might be explained by the artificial stabiliza-
tion of the normally transient interaction of SRP with
ribosomes synthesising cytosolic proteins as already dis-
cussed.
As mentioned before, SRP does not bind to ribosomes at
high salt concentrations (500 mM potassium acetate) in the
absence of a signal sequence in the nascent chain. Hence,
repeating the cross-linking experiments with pPl86 RNCs
at high salt concentrations should allow us to identify the
cross-linked products that were specific for the elongation-
arrested state of SRP. In these experiments (Figure 3A,B,
lanes 3 and 6), we detected four cross-linked products of
identical sizes with the same relative abundances at 50 and
500 mM salt. As expected, in the negative controls with
Cyc130 RNCs and ribosomes, we failed to detect cross-
linked products (Figure 3A, lanes 4 and 5). These results
were quite striking and proved that the observed cross-linked
products were specific for pPl86 ribosome-SRP complexes.
Most importantly, they demonstrated that the interactions
between the Alu domain and the ribosome were unchanged,
suggesting that upon signal sequence recognition the overall
position of complete SRP is the same at high salt concentra-
tions.
SRP14 Is CoValently Linked to Proteins of the Small and
Large Ribosomal Subunits. To address the question whether
SRP14 was cross-linked to bona fide ribosomal proteins that
belong to one or both subunits, we dissociated the RNCs
after the cross-linking reaction with puromycin and high salt
treatments. The subunits were separated by sedimentation
through a sucrose gradient. Fractions were collected with
continuous monitoring of the absorbance at 254 nm and
analyzed by SDS-PAGE followed by immunoblotting with
antibodies against SRP14, S15, and L9 (Materials and
Methods). Monitoring S15, L9, and the ribosomal RNA
allowed us to examine the efficiency of the subunit separation
and to identify the fractions comprising the subunits. Without
adding DSS to Cyc130 RNCs, all RNCs were separated into
subunits (Figure 4A). In contrast, after treatment with DSS
at the usual concentration (800 íM), almost all ribosomes
were found in the 80S peak, presumably because most of
the ribosomal subunits became covalently linked through
ribosomal proteins (results not shown). To alleviate this
problem, we determined the minimal DSS concentration,
which still allowed us to detect the SRP14-adducts (100 íM).
Even at the reduced DSS concentration, a significant fraction
of the ribosomal subunits were cross-linked (Figure 4B, 80S).
As evaluated from the S15 and L9 contents of the 80S
fractions, the cross-linked ribosomes represented about 75%
(see also Figure 5B,C). Importantly, based on the RNA and
FIGURE 2: Cross-linking of SRP14 to ribosomal components in
ongoing translation. (A) Cyclin and preprolactin synthesis analyzed
by 5-20% SDS-PAGE and autoradiography. Synthetic cyclin and
preprolactin mRNAs were titrated individually into reticulocyte
translation reactions in the presence of [35S]-methionine, and the
translation products were analyzed after 15 min. (B) Quantification
of cyclin and preprolactin by phosphorescence imaging. The relative
yields were calculated taking into account that cyclin and prepro-
lactin contain 16 and eight methionine residues, respectively. In
lanes 1 and 7, equivalent molar amounts of the full-length proteins
were present in the reactions, and these conditions were used for
the cross-linking experiments. (C) Immunoblot analysis of the cross-
linked products formed between SRP14 and ribosomal components
during cyclin and preprolactin synthesis. The ribosomes were
purified through high-salt sucrose cushions after cross-linking, and
the samples were analyzed by 12% SDS-PAGE (upper panel). N:
mock translations; C: cyclin synthesis; and P: preprolactin
synthesis. Lanes 4-6 contained additional canine SRP (4 pmol).
The same experiment was also analyzed by immunoblotting against
anti-S15 antibodies (lower panel). MW: molecular weight stan-
dards.
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protein profiles, we could clearly identify the regions in the
gradient that comprised the subunits (Figure 4B, upper and
lower panel).
To assign the cross-linked products observed with pPl86
RNC-SRP complexes, fractions were collected from a
gradient run in parallel. On the basis of the analysis presented
in Figure 4, the fractions were pooled to represent the 80S,
60S, and 40S subunits. This was necessary to detect the
cross-linked products associated with the subunits with the
anti-SRP14 antibodies. The intermediate region (INT) was
separated from the subunits because it contained small
amounts of L9 and S15 (Figure 4B). The fractions from the
top of the gradient were pooled into four equal parts (Figure
5A, fractions 1-4). The S15 and L9 contents of all fractions
were determined to verify the assignments (Figure 5A).
SRP14 was quantified from a picture taken at a much shorter
exposure to monitor the presence of SRP in the different
fractions (not shown). About 72% of SRP was not cross-
linked to ribosomes and was therefore found on top of the
gradient (Figure 5A, lanes 1-3, the presence of SRP was
also revealed by the SRP9-SRP14 cross-link). About 16%
of the SRP was found in the 80S fractions, whereas only 8
and 4% SRP was present in the 60S and 40S fractions,
respectively. Notably, in the experiments with pPl86 RNCs,
all four SRP14 adducts were present in the 80S fraction, and
none was found at the top of the gradient (Figure 5A,B),
confirming unambiguously that SRP14 was cross-linked to
bona fide ribosomal proteins.
Of the four cross-linked products, 14-X31 was clearly
detected in the 40S fraction (Figure 5A,B and Table 1). In
addition, it was more enriched in the 40S fraction as
compared to the adjacent fractions further corroborating its
association with the small subunit. Note, the 60S fraction
was contaminated with the 80S fraction (Figure 4B) and
therefore also contained S15 and 14-X31 (Figure 5B). The
cross-linked products 14-X20 and 14-X45 were present in
the 60S fraction and completely absent in the 40S fraction
consistent with the interpretation that both cross-links oc-
curred to the large subunit (Figure 5C,D and Table 1). The
weakest cross-linked species, 14-X17, was just detectable
in the 60S fraction. However, its abundance was lower as
FIGURE 3: Salt-dependent cross-linking of SRP14 to ribosomal
components. (A) Immunoblot analysis of the cross-linking reactions
with affinity-purified anti-SRP14 antibodies. Complexes formed
between SRP (1 pmol) and rabbit RNCs (2 pmol) were treated with
800 íM DSS, and the proteins were displayed by 12% SDS-
PAGE. N: ribosomes prepared from mock translations; C: Cyc130
RNCs; and P: pPl86 RNCs. Lanes 1-3 and 4-6: cross-linking
reactions at 50 and 500 mM KOAc, respectively. MW: molecular
weight standards. (B) Quantification of the cross-linked products
in the pPl86 reactions. The cross-linked products in lanes 2, 3, and
6 were quantified with a CCD camera-based system. The intensities
of each cross-linked product were compared to the one in Cyc130
RNC reactions at 50 mM salt, which was set to 100% (Materials
and Methods).
FIGURE 4: Ribosomal subunit separation with and without DSS
treatment. (A) RNA, S15, and L9 profiles without DSS treatment.
Cyc130 RNCs were treated with puromycin/high salt, and the
ribosomal subunits were resolved on a 10-30% sucrose gradient.
The absorbance at 254 nm was monitored continuously during
fractionation (upper panel). The L9 and S15 contents of all fractions
were determined by 12% SDS-PAGE followed by immunoblotting
with anti-S15 and anti-L9 antibodies. The signals were quantified
with a CCD camera-based system (lower panel). (B) RNA, S15,
and L9 profiles with DSS treatment (100 íM). Data were collected
as described in panel A. The asterisk denotes free GPT (see Material
and Methods).
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compared to 14-X20 and 14-X45, and in the 40S fraction it
could not be detected because of a significant background
in this region (Figure 5A). Hence, its subunit association
could not be determined unambiguously.
We repeated the same experiments with Cyc130 RNCs.
At the reduced DSS concentration, the 14-X20, 14-X31, and
14-X45 adducts were detectable in the 80S fraction. How-
ever, the latter two were rather weak and therefore almost
undetectable in the subunit fractions. We therefore only
quantified the 14-X20 adduct. Like with pPl86 RNCs, 14-
X20 was completely absent in the 40S fraction but was found
in the 60S fraction (Figure 5E) and therefore also represents
a covalent link between SRP14 and a protein from the large
subunit. Its assignment to the same subunit in experiments
with pPl86 and Cyc130 RNCs further supported the inter-
pretation that the 14-X20 cross-linked product was the same
in all samples. The fact that SRP14 could be covalently
linked to ribosomal proteins of the small and large subunits
provides the first experimental evidence that the Alu domain
of SRP is located in the subunit interface of ribosomes.
DISCUSSION
We have examined the environment of the SRP Alu
domain bound to ribosomes as a function of signal sequence
recognition by SRP in ongoing translation and with artifi-
cially arrested RNCs. These studies revealed new mechanistic
insights into SRP-ribosome interactions (summarized in
Table 1). They provided experimental evidence that the
protein SRP14 is in close physical proximity of ribosomal
proteins, which could explain the observed delay in nascent
chain elongation. In addition, these cross-linked products
define binding sites of the SRP Alu domain in functional
SRP-ribosome complexes comprising conserved ribosomal
components as deduced from the comparative analysis of
two translation systems. SRP14 cross-linking to ribosomes
is independent of signal sequence recognition. However,
three of the four cross-linked products become only detect-
able after signal sequence recognition in ongoing translation.
With artificially arrested RNCs, the same cross-linked
products were more abundant after signal sequence recogni-
tion consistent with a change in the interface of the SRP
Alu domain and the ribosome. Furthermore, upon signal
sequence recognition, the Alu domain is located in the
ribosomal subunit interface since SRP14 is cross-linked to
ribosomal proteins of the small and large subunit. Taken
together, these findings indicate that the SRP Alu domain
can bind to ribosomes in the absence of a signal sequence
and changes its environment after signal sequence recogni-
tion.
The fact that SRP14 could be cross-linked to ribosomes
synthesizing a cytoplasmic protein in a functional translation
system confirmed the notion that SRP binds transiently to
all actively translating ribosomes (33). Furthermore, it
demonstrated that the Alu domain is already in close contact
with the ribosome without signal sequence recognition by
SRP. Signal sequence-independent binding of SRP to ribo-
somes is thought to facilitate the identification of ribosome-
nascent chain complexes that need to be targeted to the ER.
It has previously been noticed that SRP subunits lacking the
Alu domain or Alu domain components have a strongly
reduced capacity to bind ribosomes directly in a signal
sequence-independent way (25, 31). On the basis of these
previous observations, our finding that the Alu domain is
already in contact with the ribosome in the absence of a
signal sequence argues in favor of an active role of the Alu
domain in direct ribosome binding of SRP. Without a signal
sequence, SRP14 is predominantly cross-linked to the large
ribosomal subunit. The cross-linked product 14-X20 therefore
defines binding of SRP to actively translating ribosomes in
the absence of a signal sequence.
Upon signal recognition, the Alu domain of SRP delays
elongation of the nascent chain and is therefore expected to
be located in a position in which it can interfere with the
ribosomal elongation cycle. This could be achieved by
preventing the entry and the exit of tRNAs at the E- and
A-sites, respectively. The four cross-linked products observed
at this stage reflect this position since they are specific for
FIGURE 5: Cross-linking of SRP14 to ribosomal subunits. (A)
Immunoblot analysis of the gradient after ribosomal subunit
separation. pPl86 RNCs (21 pmol) were incubated with canine SRP
(17.5 pmol) and treated with DSS (100 íM final concentration) at
low salt concentration (50 mM potassium acetate and 2.5 mM Mg-
(OAc)2). Subsequently, ribosomes were dissociated into subunits
by puromycin/high salt treatment, and the subunits were separated
on a 10-30% sucrose gradient. Fractions were collected and pooled
to represent 40S (lane 5), Int (lane 6), 60S (lane 7), and 80S (lanes
8 and 9) as established in Figure 4. The top fractions were combined
into four equal parts (fractions 1-4). All fractions were analyzed
by 12% SDS-PAGE and by immunoblotting with anti-SRP14
(upper panel), anti-L9 (medium panel), and anti-S15 (lower panel)
antibodies. MW: molecular weight standards. (B-D) Relative
amounts of 14-X31 (B), 14-X20 (C), and 14-X45 (D) as compared
to the amounts of S15 and L9 present in each fraction. (E)
Quantification of a gradient immunoblot analysis of Cyc130 RNCs
cross-linked to SRP. Same experimental conditions as in panel A,
but the cross-linking reaction was done with Cyc130 RNCs. At
DSS concentrations of 100 íM, only 14-X20 could be quantified
and was compared to S15 and L9.
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pPl86 ribosomes as indicated by their presence at high salt
concentrations, by their formation during preprolactin syn-
thesis, and by the results of the titration experiments with
artificially arrested RNCs. This position is undoubtedly
located at the subunit interface of the ribosome as proven
by the association of the cross-linked products with both
ribosomal subunits. To be linked covalently to ribosomal
proteins of both subunits, SRP14 would have to span the
intersubunit space. On the basis of the crystal structure of
the SA50 Alu RNP (24), the two most distant, solvent-
accessible lysine residues (K74 and K95) are separated by
about 47 Å. Adding twice the size of the cross-linker
increases the maximal distance between two proteins cross-
linked to SRP14 to about 74 Å, which is sufficient to bridge
the intersubunit space, with each extremity of SRP14 pointing
toward one of the ribosomal subunits. Moreover, to position
the Alu domain at the subunit interface, SRP has to span the
distance between the interface and the nascent chain exit site,
where SRP54 is located in proximity to L23a and L35 (18).
According to its size (23-24 nm), SRP is sufficiently
extended to contact the two positions simultaneously as
previously described (34).
Elongation arrest is strictly dependent on the presence of
a signal sequence at the nascent chain exit site. Our
observations reveal that, upon signal sequence recognition,
the interface between the Alu domain and the ribosome
changes. Hence, a signal has to be sent out from the SRP S
domain close to the nascent chain exit site, triggering
conformational changes at the Alu domain-ribosome inter-
face. The SRP RNA might be involved, as it supports
multiple conformations during the SRP cycle (35). The signal
might act directly on the conformation of the Alu domain,
which has been suggested to exist in two conformations (36).
Alternatively, or in addition, flexible domains of the ribosome
might be rearranged by long-range interactions within the
ribosomal structure (37, 38). Once in the elongation-arrested
state, the SRP Alu domain is likely to make additional
contacts with the ribosome. The changes in the environment
of SRP14 and the gain of high salt-resistant cross-linking of
SRP14 to ribosomes argue in favor of additional contacts
between the Alu domain and the ribosome. The components
in SRP that mediate these additional contacts remain to be
determined. The C-terminal region of SRP14, which is
essential for elongation arrest activity (12), may contribute
to mediating these contacts.
As judged by the sizes of the two largest cross-linked
products, the Alu domain may be located in proximity to
the ribosomal A-site. Since the apparent molecular size of a
cross-linked product defines the minimal size of the cross-
linked protein, only two proteins, L3 and L4, of all
mammalian ribosomal proteins may account for the X45
protein having a size larger than 36 kDa (ref 39, for a
compilation of all ribosomal protein sequences, see the
Swiss-Prot Protein Knowledgebase). Alternatively, 14-X45
may represent a cross-link between SRP14 and two ribosomal
proteins. We cannot completely exclude this possibility, but
it seems rather unlikely for at least two reasons. Since the
cross-linking efficiency is very low in our experiments,
simultaneous linkage of three proteins is statistically a very
rare event, and the 14-X45 cross-linked product would
therefore be expected to be much less abundant. In addition,
we never observed different cross-linked products of smaller
sizes by changing the experimental conditions (e.g., DSS
concentration, salt concentration, RNC-SRP ratio). On the
basis of structural and biochemical studies on archaeal and
eukaryotic ribosomes (40-43), only L3 is located at the
subunit interface, designating it as a strong candidate for the
X45 protein since it may account for both the size of the
cross-linked product as well as the location of the Alu domain
at the subunit interface of ribosomes. Hence, cross-links
between SRP14 and L3 place the Alu domain in the subunit
interface close to the A-site (Figure 6). On the basis of their
sizes and on their location with respect to L3, plausible
candidates for the other cross-linked ribosomal proteins are
L23, L12, and L9 in the large subunit as well as S2, S3, S9,
and S23 in the small subunit. S2 and S3 may account for
the size of the X31 protein. Although portions of S2 and S3
are exposed at the outer surface of the ribosome, both
proteins also reach into the interface, as they can be cross-
linked to 28S rRNA (43), and S2 is also cross-linked to P0
(a stalk protein) in the large subunit (44). Hence, they are
strong candidates for the X31 protein. The other possible
candidates, L23, L12, L9, S9, and S23, have molecular sizes
in the range of 15-22 kDa and are therefore plausible
candidates for the X20 and X17 proteins.
Multiple attempts to identify the cross-linked ribosomal
proteins using antibodies against several putative candidates
for the cross-linked proteins failed to yield irrefutable
evidence for their identity. This may be explained by the
accumulation of several aggravating factors, including the
lack of sensitivity and specificity of the antibodies against
ribosomal proteins. We are therefore convinced that the
unambiguous identification will require the use of in vitro
reconstituted SRP including a labeled or tagged SRP14
protein. However, we have not yet succeeded in obtaining
ribosomal cross-links by using SRP reconstituted in vitro
from recombinant proteins. In addition, cross-linking experi-
ments with SRP9/14 protein alone and with purified Alu
RNPs gave apparently different cross-linked products than
FIGURE 6: Schematic representation of a model for the SRP Alu
domain location within ribosomes. Complete ribosomes are rep-
resented schematically as viewed from the solvent side of the 40S
subunit. Ribosomal proteins are positioned in agreement with the
cryo-EM reconstructions of yeast ribosomes (42). The Alu domain
is represented at scale by the SA50 Alu RNP structure (36). Its
orientation was chosen randomly. The asterisk represents the two
lysine residues at the most distant locations. Gray arrow indicates
a possible pathway for the SRP RNA stem linking the Alu and S
domain.
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did authentic SRP (L. Terzi, and K. Strub, unpublished
results). Hence, the cross-linked products could not be
identified using labeled SRP9/14 protein alone or purified
Alu RNPs. Such an approach has been successfully used to
identify the ribosomal proteins covalently linked to SRP54
(18).
Our studies provide experimental evidence for a long-
standing notion that the Alu domain may bind at the
ribosomal interface, possibly in proximity to the ribosomal
A-site. In the future, they will guide us in finding its binding
partners in the ribosome to understand the mechanistic
implications of the interactions between the SRP Alu domain
and the ribosomes.
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ABSTRACT
Proper folding of the RNA is an essential step in the
assembly of functional ribonucleoprotein complexes.
We examined the role of conserved base pairs
formed between two distant loops in the Alu portion
of the mammalian signal recognition particle
RNA (SRP RNA) in SRP assembly and functions.
Mutations disrupting base pairing interfere with fold-
ing of the Alu portion of the SRP RNA as monitored by
probing the RNA structure and the binding of the
protein SRP9/14. Complementary mutations rescue
the defect establishing a role of the tertiary loop–
loop interaction in RNA folding. The same mutations
in the Alu domain have no major effect on binding of
proteins to the S domain suggesting that the S domain
can fold independently. Once assembled into a
complete SRP, even particles that contain mu-
tant RNA are active in arresting nascent chain
elongation and translocation into microsomes, and,
therefore, tertiary base pairing does not appear
to be essential for these activities. Our results
suggest a model in which the loop–loop inter-
action and binding of the protein SRP9/14 play an
important role in the early steps of SRP RNA folding
and assembly.
INTRODUCTION
The assembly of ribonucleoprotein particles (RNPs) is a com-
plex process that includes multiple steps such as proper folding
of the RNA moiety and the ordered concomitant or sequential
association of the proteins at specific subcellular locations.
Folding of RNAs with sizes >300 nt is rather slow and
may be assisted by proteins with RNA chaperone activities
and by specific RNA binding proteins, which may remain part
of the RNP. Reasons for the slow folding of RNA molecules
include their highly complex tertiary structure as well as their
intrinsic propensity to become kinetically trapped in inactive
structures [for review see (1,2) and references therein].
The goal of this study was to examine the specific role of an
RNA tertiary structure in the Alu domain of the mammalian
signal recognition particle (SRP). SRP is probably one of the
best-characterized ribonucleoprotein complexes, since it can
be assembled and studied in vitro. SRP plays an essential role
in targeting proteins to the endoplasmic reticulum (ER) [for
review see (3)], which is the first step in routing proteins into
the secretory pathway. SRP specifically recognizes signal
sequences, a common hallmark of ER-targeted proteins, in
nascent polypeptide chains as they exit from the ribosome
and subsequently delays elongation of the nascent chain.
SRP then targets the ribosome-nascent chain complex to the
translocon, a specific structure in the ER membrane that pro-
motes the transfer of the nascent chain across or into the ER
membrane [for review see (4)].
SRP has a two-domain structure in most but not all organ-
isms [for review see (5)]. The S domain of mammalian SRP
comprises the central part of SRP RNA (or 7SL RNA) and the
proteins SRP68/72, SRP54 and SRP19 (Figure 1). The
conserved RNA helix VIII and SRP54 harbour the signal
recognition and the targeting functions of SRP (6,7). The
Alu domain, which comprises the 50 and 30 ends of SRP
RNA and the protein SRP9/14, retards or arrests the elongation
of the nascent chain and thereby increases the translocation
efficiency in vitro (6,8,9). Over the last few years, a vast body
of atomic structure information was obtained [for review see
(10–12)] and the positioning of SRP on the ribosome was
reconstructed from cryo-electron microscopy (cryo-EM)
images (13). This information has yielded new insights into
the mechanism of SRP functions and has facilitated a more
specific biochemical analysis.
SRP is thought to assemble in nucleoli, because SRP RNA
and SRP proteins, except SRP54, can be observed in this
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structure (14–16). The localization of SRP RNA to the nucle-
olus is dependent on the Alu sequences and on the RNA helix
VIII (17). In addition, import of SRP proteins into nucleoli and
export of SRP RNA are mediated by specific receptors
(18–20). Till date, nothing is known about the specific events
that couple RNA synthesis and folding to the ordered assembly
of SRP proteins.
An Alu domain-like structure is present in all eukaryotic and
archaeal and in few eubacterial SRP RNAs. The common
signature of this domain is a three-way junction of stems
and a highly conserved single-stranded region (21,22). Of
the SRP RNAs including an Alu domain, the yeast and
protozoan RNAs are missing one or both hairpins. In trypano-
somes, the absence of one hairpin in the Alu domain may have
been compensated for by the acquisition of an additional
transfer RNA (tRNA)-like RNA in the SRP particle (23,24).
As revealed by crystallography, the Alu domain contains a
compactly folded three-way junction of stems. A stack of two
stems (H1.1 and H1.2) and a third stem (H2) are connected by
a single-stranded U-turn at this junction [Figure 1; (25)].
Note that we use the topological nomenclature in which
helix H2 and loop L2 represent stem–loop III and helix
H1.2 and loop L1.2 stem–loop IV in the helix diagram of
Figure 1A [according to the nomenclature in (26)]. The
single-stranded connecting region is highly conserved in
primary sequence and represents the major protein-binding
site [Figure 1B, U-turn motif; (22,25)]. The U-turn determines
the relative orientation of the two helical stems. The RNA fold
is further stabilized by a tertiary structure consisting of three
G-C base pairs, which are formed between the two distant
loops L1.2 and L2 (Figure 1D, G13-C37, G14-C34 and
C15-G33). The three base pairs form an extended stack
together with two purines from the loops L2 and L1.2 (G16
and A36). The existence of loop–loop interactions had pre-
viously been suggested based on sequence complementarities
observed between the two loops (27).
The protein SRP9/14 also makes contacts to the central stem
connecting the Alu and the S domains (Figure 1B). Further
biochemical and structural data support a model in which the
central stem would fold back by up to 180 to align alongside
the 50 domain allowing contacts to the SRP9 moiety of the
protein (25,28). The model is consistent with the requirement
that the 30 and the 50 domains have to be flexibly linked for
fully efficient binding of SRP9/14 (29).
After the existence of loop–loop interactions had been
confirmed and their identity revealed by crystal structure,
we decided to examine their role in SRP assembly and
function. Base pairs were disrupted by specific individual
mutations in both loops and restored with a different primary
sequence by simultaneous complementary mutations. The
mutated RNAs were analysed by native gel electrophoresis
and by limited V1 ribonuclease digestion experiments and
assayed for SRP9/14 binding. The mutated SRP RNAs
were also reconstituted into SRP and their activities compared
to the activities of SRP comprising wild-type (WT) RNA. Our
results demonstrate that base pairing between the loops is
Figure 1. Structure of SRP and the SRP Alu domain. (A) Schematic representation of SRP, (B) secondary structure of the minimal Alu RNA that still binds 9/14
efficiently. Stems and loops are named according to the topological nomenclature. Bases in the loops that form tertiary base pairs are highlighted in red. Protein
footprints are shown in boldface. U-turns are marked with asterisks and stretches of 10 nt are marked in blue. The U-turn motif marks a highly conserved sequence that
represents the major protein-binding site. (C) Structure of the SRP Alu 50 domain. SRP9 and SRP14 are displayed as dark and light grey ribbons, respectively. The
RNA is shown as a yellow ribbon with the loop sequences and the U-turn motif shown in orange. Nucleotides from loops L2 and L1.2 that are involved in tertiary
interactions between the loops are shown as wireframe. (D) Detailed view of the tertiary base pairing between loops. Bases G13, G14 and C15 form hydrogen bonds
with C37, C34 and G33, respectively (dotted green lines). One base from each loop, G16 and A36, are positioned to extend the stack formed by the three base pairs.
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important for proper folding of the SRP RNA Alu domain. The
mutations in the Alu domain had no significant impact on the
binding of the S domain proteins, suggesting that it can fold
independently. Despite the folding defects, all but one mutant
RNA could be assembled into SRPs with intact elongation
arrest and translocation activities, indicating that base pairing
is not essential for these activities.
MATERIALS AND METHODS
Materials
Sources of materials were as follows: urea, AppliChem;
4-(2-hydroxyethyl)-1-piperazine-1-ethane sulfonic acid
(HEPES), AppliChem; potassium and magnesium acetate
[KOAc and Mg(OAc)2], Fluka; Nikkol–BL-85Y, Nikko
Chemical Co.; Triton X-100, Interchim; [35S]methionine
(1500 mCi/mmol), Amersham Biosciences; Aquaphenol,
QbioGene; DTT, Eurobio; spermidine, Tris[hydroxymethyl]
aminomethane (Tris), BSA and ribonucleotides, Sigma. The
T7 RNA polymerase expression plasmid was a kind gift of
Dr Mallet (30). The T7 RNA polymerase was kindly prepared
by Viviane Simonet, Julien Hasler and L. Terzi.
Mutation and expression of the SRP RNA gene
Mutations at specific sites in the SRP RNA gene were intro-
duced by PCR using the QuickChangeTM method (Stratagene).
The primer oligonucleotides contained the desired mutations
flanked by 15 nt (Microsynth). The template for PCR was the
plasmid p7Sswt (22). Two sequential rounds of mutations
yielded the clones with complementary mutations. All clones
were verified by automatic sequencing. Plasmids were linear-
ized with XbaI (Gibco BRL) before synthesis of the RNA with
T7 RNA polymerase in 100 ml reactions containing 40 mM
Tris-HCl, pH 8.1, 7 mM MgCl2, 1 mM spermidine, 5 mM DTT,
1 mM of each rNTPs, 1 mg/ml BSA, 100 ng/ml DNA template
and 0.1mg /ml T7 RNA polymerase. After transcription, the
DNA was digested with RQ1 RNAse-free DNAse (Promega)
and the samples extracted with phenol and purified on 1 ml
Sephadex G50 (fine, Pharmacia) or on Nucleobond (Machery
& Nagel) columns. The RNAs were precipitated and dissolved
in sterile water. To optimize protein binding with biotinylated
SRP RNAs, we tested different ratios of UTP/bio-11-UTP
(ENZO Life Sciences) in the transcription reactions. Protein
binding was optimal when using equal ratios of both nucleo-
tides. RNA concentrations were determined by OD260 and the
quality of the RNA samples analysed by denaturing 6%
PAGE. The concentrations of biotinylated RNAs were
determined by comparing three dilutions of each sample to
a dilution series of an RNA standard of unmodified WT RNA
with ethidium-bromide-stained denaturing PAGE. Canine
SRP RNA was extracted from the DEAE resin used to dis-
assemble SRP into RNA and protein subunits (6).
RNA analysis
Native gels (acrylamide–bisacryamide ratio of 40:1) were run
in 50 mM Tris, pH 7.5 and 10 mM Mg(OAc)2 in the cold room
at 0.22 W/cm3 for 4 h. The samples were loaded in 20 mM
KOAc and 3 mM Mg(OAc)2 neutralized to pH 7.5 and 40%
glycerol. Native RNA was stained with GelStar1 (Cambrex).
One microgram of RNA was digested with V1 RNAse (Pierce,
0.05 U per reaction) in 20 ml of 300 mM KOAc, 3 mM
Mg(OAc)2 and 10 mM HEPES, pH 7.5 for 20 min on ice.
The reactions were stopped and the RNAs purified with
phenol/dichloromethane extractions. The precipitated RNA
was dissolved in formamide loading buffer and displayed
by 10% PAGE. The RNA was revealed by ethidium bromide
staining of the gel and visualized on an ultraviolet light box.
RNA binding assays
Synthetic mRNAs for human SRP14, human SRP19 and
canine SRP54 were prepared as described previously in
(31–33), respectively. The [35S]methionine-labelled h14 was
synthesized in wheat germ translation reactions in the presence
of 3 pmol of recombinant h9 (34) and 6 pmol of recombinant
h9/14 in 10 ml translation reaction. For the binding reactions,
an aliquot of 3.3 ml was combined with the desired amounts of
biotinylated RNA in a final volume of 50 ml of binding buffer
(50 mM HEPES–KOH, pH 7.5, 500 mM KOAc, pH 7.5, 5 mM
Mg(OAc)2 and 0.01% Nikkol). The complex was allowed to
form for 10 min on ice and then for 10 min at 37C. The
magnetic streptavidin beads (Dynabeads M-280, Dynal
Biotech ASA) were prepared as indicated by the manufacturer
and equilibrated with binding buffer. The beads (60 ml) were
combined with the protein–RNA samples and incubated for
another hour at 4C. The bound samples were washed three
times for 10 min with binding buffer including 0.1% Triton
X-100. Bound proteins were analysed by 15% SDS–PAGE,
visualized by autoradiography and quantified with the
PhosphoImager (Bio-Rad). We confirmed by denaturing
PAGE and ethidium bromide staining that no detectable
amounts of SRP RNA were present in the unbound fractions
at the highest RNA concentrations used (detection limit 25 ng).
In addition, the protein contents of the supernatant fractions
were also quantified in the initial experiments. The bound and
free proteins together accounted for the total protein input
(100 – 10%) confirming that dissociation of the complex
was negligible during the wash. A negative control RNA,
rat 4.5S RNA (34), showed no detectable protein-binding
activity (data not shown). For the binding reactions with
h19 and c54, the translation reactions contained 6 pmol of
recombinant h19 and 6 pmol of recombinant h19 and c54,
respectively.
SRP proteins
The proteins h9, h14 and h19 were expressed in Escherichia coli
from the plasmid pEh9, pEh14 and pE19 (8,34) using the T7
RNA polymerase expression system (35). Cells were lysed in a
FrenchPressTM andtheextractsofh9andh14werecombinedfor
the purification of the complex. Hi-Trap Heparin (Amersham
Biosciences), hydroxyl apatite (Bio-Rad) and Superdex-200
(Amersham Biosciences) chromatography was used to purify
h9/14. Hi-Trap Heparin, CM and Superdex-200 (Amersham
Biosciences) chromatography was used to purify hf19. c54 was
expressedininsectcellsusingthebaculovirusexpressionsystem
(7). Following lyses of the cells in the homogenizer, the
protein was purified by CM and Hi-Trap Heparin chromato-
graphy. The purified proteins were quantified by spectrophoto-
metry at 280 nm. Molar extinction coefficient eh9/14,
15 130 M1 cm1; eh19, 12 570 M1 cm1; and e54,
Nucleic Acids Research, 2004, Vol. 32, No. 16 4917
22 220 M1 cm1. Canine SRP68/72 was purified from canine
SRP as described previously (6). SRP68/72 was quantified by
comparing the SRP68 signal to known concentrations of BSA
in a Coomassie-stained SDS–PAGE.
Particle reconstitutions and activity assays
Particles were reconstituted as described previously (36) in 50 ml
reactions at 2 mM protein concentrations and 4 mM RNA con-
centrations for WT and 2Comp RNAs. 2L2 and 3L2 RNAs were
used at final concentrations of 16 and 24mM, respectively. Fifty
microliters DEAE Sephacel (Pharmacia) columns were eluted
twice with 50 ml of 20 mM HEPES–KOH, pH 7.5, 500 mM
KOAc, pH 7.5, 5 mM Mg(OAc)2, 0.01% Nikkol and 1 mM
DTT. Active SRP is eluted in the first fraction. In the reactions
with 2L2 and 3L2 RNAs, we first eluted with 30 ml followed
by two fractions of 50ml to optimize the yield of active SRP. On-
tenth of the total fraction was analysed by 5–20% SDS–PAGE
and visualized by silver staining. c54 samples containing 50,
100, 150 and 200 ng of protein were run on the same gel and used
to estimate the particle concentrations. For the direct assays,
reconstitutions were done in 8 ml at 0.5 and 1 mM final concen-
trations of canine SRP68/72, recombinant h9/14, h19 and c54
and in vitro synthesized SRP RNAs, respectively. Activity
assays were done as described previously (8) at final particle
and membrane concentrations of 100 nM and 0.15 eq/ml, respec-
tively. Preprolactin, prolactin and cyclin D were quantified by
the use of a phosphorescence imaging system (Bio-Rad). Elon-
gation arrest and translocation efficiencies were calculated as
follows:
EA = 1  Ps=Cs
Po=Co
 
· 100,
where EA is the percentage elongation arrest activity, Ps and
Cs are the amounts of preprolactin and cyclin quantified in the
sample and Po and Co the amounts of preprolactin and cyclin
present in the negative control (SRP buffer or SRP reconstit-
uted without h9/14). T = 100 · [P/(pP + P)], where T is the
percentage translocation, P is the amount of prolactin and pP
the amount of preprolactin quantified in each sample. All SRPs
were tested in at least two independent experiments.
Computer programs and data bases
For the sequence comparison of SRP RNAs, we used the SRP
database (21). Molecular graphics images were produced
using the UCSF Chimera package from the Computer
Graphics Laboratory, University of California, San Francisco
(supported by NIH P41 RR-01081) and the Swiss PDB viewer
using Pov-RayTM (http://www.expasy.org/spdbv/).
RESULTS
Tertiary base pairing and structural determinants
in loop L2 are conserved in evolution
To examine the conservation of structural determinants in the
loops L1.2 and L2, we created a new structure-based align-
ment of the loop sequences. In mammalian SRP RNA, loop L2
is well defined by the sheared G-G base pair and has a rather
stiff character determined by another U-turn (U12, Figure 1B,
asterisk). In contrast, loop L1.2 lacks internal stabilizing
elements and is, therefore, presumed to be flexible. Its most
important structural feature is its capacity to form base pairs
with loop L2 (25). For the analysis, we included SRP RNAs
[SRPDB; (21)] containing the three-way junction of stems
forming the specific fold of the mammalian SRP Alu domain
(Figure 2). As illustrated by the helix diagrams, the lengths of
the stems and the sizes of the loops are remarkably different.
Figure 2. Structure-based alignment of loop L1.2 and L2 sequences in SRP RNAs of animal metazoans, of plants and of eubacterial and archaeal species.
(A) Nucleotides proposed to base pair are shown in red, sheared G-G pairs in blue and U-turns in green. First nucleotides in stems are shown in italic. Black bars
delineate the loop sequences. For each species, only one representative is shown. Sequences were obtained from SRPDB. (B) Helix diagrams of mammalian, plant
and archaeal Alu RNA 50 domains. Asterisks highlight a conserved nucleotide in the archaeal RNAs. The helix diagram of a eubacterial SRP RNA resembles most
closely the one of archaeal SRP RNAs.
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The G-G base pair and the adjacent U-turn are well
conserved in loop L2 of all but archaeal SRP RNAs
(Figure 2, blue and green). In these organisms, the boundaries
of the loop L2 are well defined by these structural elements.
Since the G-G base pair is absent in archaeal RNAs,
the boundaries of loop L2 remain uncertain and the putative
U-turn motif may, therefore, precede the one shown. In a few
species, the uridine is replaced by a cytidine, which may also
introduce U-turn-like bends as revealed by the pseudoknot
structure of beet western yellow virus RNA (37). In four
Arabidopsis species, the G-G base pair is replaced by a
G-A base pair.
The potential to form base pairs is conserved in all SRP
RNAs with a remarkable bias for G-C pairs (Figure 2, red
nucleotides). More strikingly, in animal metazoans even the
primary sequences of the nucleotides are conserved. In plants,
only 2 bp may form between the loops because of the smaller
size of loop L1.2. In contrast, in Archaea and Eubacteria the
increased size of loop L2 expands the predicted base comple-
mentarities between the loops. In these organisms, helix H1.2
is not well defined, since the loop-adjacent strands are purine-
rich on both sides and it remains uncertain to which degree
they may form non-canonical base pairs to extend the four
Watson–Crick base pairs.
In summary, the high conservation of loop–loop base
pairing and of structural determinants in loop L2 points
towards a role of these structures in SRP assembly and
function. However, apart from base pairing, the shape and
size of the tertiary structure is expected to vary considerably,
since the number of base pairs and the sizes of the loops are not
conserved between different RNAs.
Mutations in loop L2 induce conformational changes
in the RNA Alu domain
To examine the functions of the tertiary base pairs in human SRP
RNA, we changed bases in single loops to disrupt base pairing
andinboth loops torestorebasepairingwithadifferent sequence
(see Table 1). Guanidine was replaced by cytidine and vice
versa. The RNAs were synthesized in vitro. They were never
denatured and were purified under native conditions to avoid
refolding artefacts. The mutated and wild-type synthetic RNAs
migrated as a single band at the position expected of their size
in denaturing gel electrophoresis (Figure 3A, lower panel).
To examine the conformation of the synthetic RNA var-
iants, they were displayed in parallel with native canine SRP
RNA by native PAGE (Figure 3A). Native canine SRP RNA
migrated as a single band. In vitro synthesized RNAs are more
heterogeneous, containing RNA aggregates and RNAs with
Table 1. Mutations in SRP RNA
Wild type
WT Loop L2 50-G13 — G14-C15-30
Loop L1.2 30-C37-(A36-U35)-C34-G33-50
Mutations in a single loop
2L2 Loop L2 50-C13 — C14-C15-30
Loop L1.2 30-C37-(A36-U35)-C34-G33-50
3L2 Loop L2 50-C13 — C14-G15-30
Loop L1.2 30-C37-(A36-U35)-C34-G33-50
2L1.2 Loop L2 50-G13 — G14-C15-30
Loop L1.2 30-G37-(A36-U35)-G34-G33-50
3L1.2 Loop L2 50-G13 — G14-C15-30
Loop L1.2 30-G37-(A36-U35)-G34-C33-50
Compensatory mutations in both loops
2Comp Loop L2 50-C13 — C14-C15-30
Loop L1.2 30-G37-(A36-U35)-G34-G33-50
3Comp Loop L2 50-C13 — C14-G15-30
Loop L1.2 30-G37-(A36-U35)-G34-C33-50
Figure 3. Analysis of wild-type and mutated synthetic SRP RNAs. (A) Native
(upper panel) and denaturing (lower panel) 6% PAGE. Equal amounts of RNA
were loaded on both gels. The RNAs were visualized by staining with Gelstar1.
SRP RNA was extracted from purified canine SRP. The synthetic RNAs are
labelled as shown in Table 1. (B) Limited V1 ribonuclease digestion
experiments. The digestion products were displayed by 10% denaturing
PAGE and the RNA fragments visualized with ethidium bromide staining.
The bracket highlights the region that contains RNAs obtained by single
cleavages in the Alu portion of SRP RNA. In, 50% of the RNA used in the
experiments.
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non-native structures most likely formed during synthesis
and precipitation. Nevertheless, synthetic WT SRP RNA
and RNAs with mutations in loop L1.2 (WT, 2L1.2 and
3L1.2) each have a major RNA band co-migrating with canine
SRP RNA. This suggested that they might contain a large
fraction of RNA with an active conformation. In contrast,
2L2 and 3L2 RNAs showed a dramatic change in their
migration pattern consistent with major changes in RNA
conformation.
To confirm that the different migration of 2L2 and 3L2 RNAs
could be explained by conformational changes in a significant
fraction of the RNAs, we used the double-strand-specific ribo-
nuclease V1 under conditions which allow only one cleavage
per RNA molecule. This allows the detection of the most
sensitive sites in the RNA, some of which are known to be
located in the Alu domain [(29); Materials and Methods].
Single cleavages within the Alu domain, which encompasses the
100 and 50 nt at the 50 and 30 ends, respectively, are predicted
to produce RNAs with sizes >200 nt. It was obvious that the
patterns of the major bands seen with WT and 2L2 and 3L2
RNAs were significantly different within the Alu domain-
specific region (Figure 3B) consistent with RNA folding
defects.
These results indicated that disrupting base pairing with
mutations in loop L2 strongly diminished proper folding of
the mutated RNAs leading to a large fraction of non-native
conformations that migrate fast in native gels. Importantly,
compensatory changes in loop L1.2 appeared to rescue proper
folding of the RNA (2Comp RNA), suggesting a role of the
tertiary structure in folding of the RNA. The 3Comp RNA
failed to migrate as a defined band but instead migrated
slightly slower than canine SRP RNA in a large band, as if
it was in a native-like but more ‘loosely’ folded state.
Base pairing is important for proper folding of the RNA
To assess the folding defects in the Alu domain of the SRP RNA
variants, we decided to set up a quantitative SRP9/14 binding
assay. Based on the crystal structure of the complex, local
changes in the loops are not expected to reduce the affinity of
SRP9/14 for SRP RNA, since they are quite distant from the
protein-binding site (Figure 1C). However, effects of the
mutations on RNA folding are expected to increase the frac-
tion of non-native RNA conformations that cannot bind SRP9/
14. We used recombinant human SRP9/14 (h9/14) and biotiny-
lated SRP RNA for complex formation and the free protein and
the complex were separated by immobilized streptavidin. To
ensure stoichiometric binding, the RNA–protein complexes
were formed at concentrations far above the dissociation
constant of the wild-type complex (50- to 100-fold), which
is in the subnanomolar range (34,38). To monitor binding,
in vitro-synthesized [35S]methionine-labelled h14 protein
bound to recombinant h9 was used as a tracer in the reactions.
The bound fractions were analysed with SDS–PAGE and
quantified by phosphorescence imaging (Materials and
Methods).
We optimized the binding conditions for WT RNA in
titration experiments. We monitored the protein-binding effi-
ciency as a function of the RNA concentration (10–200 nM)
while keeping the protein concentration constant at 40 nM. As
expected for stoichiometric binding, there was a linear
relationship between RNA concentrations and the protein-
binding efficiencies (Figure 4). We found that 27% of the
RNA and 62% of the protein could form a ribonucleoprotein
complex. The finding that not all of the in vitro synthesized
Figure 4. Binding of human SRP9/14 to mutated SRP RNAs. (A) Titration
experiments with synthetic WT; 2L2 and 3L2 biotinylated RNAs. The
binding reactions contained 40 nM h9/14 and tracer amounts of 35S-labelled
h14 in complex with recombinant h9. WT RNA concentrations in lanes 1–8: 10,
20, 30, 40, 50, 100, 150 and 200 nM. 2L2 and 3L2 RNA concentrations in lanes
1–4: 60, 120, 240 and 480 nM. In, 50% of total protein used in the experiment.
The bound protein was displayed by SDS–PAGE followed by autoradiography.
(B) Quantitative analysis of the titration experiments. WT (diamonds), 2L1.2
(triangles), 2L2 (squares) and 3L2 (dots) RNAs. (C) Protein binding with the
mutated synthetic SRP RNAs. The protein and RNA concentrations were 40 and
160 nM, respectively, in the binding reactions. The binding reactions of c54 also
contained 40 nM recombinant h19. The quantification of the results is shown in
Table 2.
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RNA was active was expected from the previous results
(native gel, Figure 3). An additional fraction of the RNA
might have been inactivated because of the presence of a
biotinylated uridine instead of a regular uridine at critical
positions in the RNA (Figure 1). In subsequent experiments
we determined the relative activities of mutated RNAs as
compared with WT RNA. Since the number and location of
the U residues are identical in all the RNA variants analysed,
biotinylation was not expected to interfere with the compara-
tive analysis. In addition, it was not necessary to take into
account the activity of the protein. Further control experiments
indicated that the RNA–protein complexes were stable during
the wash and that a negative control RNA gave no detectable
signal (see Materials and Methods). We chose to use a 4-fold
excess of RNA over the protein (dashed line in Figure 4B) and
binding of WT RNA was set to 100% (Figure 4C, upper panel
and Table 2).
The activities of 2L2 and 3L2 RNAs were very low as
expected if a major fraction of the RNA was misfolded.
The activities of RNAs with mutations in loop L1.2 (2L1.2
and 3L1.2 RNAs) was reduced 3-fold compared with WT
RNA, suggesting that these RNAs were also misfolded, albeit
to a lesser extent. The fact that they could bind h9/14 to a
significant extent is consistent with the presence of an
SRP-RNA-specific band in the native gel. Complementary
mutations in both loops (2Comp, 3Comp) restored binding,
establishing a role of base pairing in RNA folding. This is
surprising for 3Comp RNA, because this RNA migrates in an
odd native-like manner in native gels. It might, therefore, still
harbour minor conformational defects that are only partially
detected by SRP9/14 binding.
To corroborate that reduced binding was explained by mis-
folding and not by a reduced affinity of the protein for the
RNA, we repeated the titration experiment with 2L1.2, 2L2
and 3L2 RNAs (Figure 4A and B). There was a linear
relationship between RNA concentration and protein binding
as was expected, if a fraction of the RNA was misfolded while
the affinity of the protein to the active fraction of the RNA
remained the same. Hence, these results confirmed that protein
binding was a valuable way to determine the folding
efficiencies of mutated SRP RNAs. The activities of the
RNAs were calculated from the slope of the straight lines
(Figure 4B, inset). The effects of the mutations were the
same as previously seen in the comparative protein-binding
assays (Table 2).
We also tested whether the presence of all the other SRP
proteins in the binding reactions (recombinant h19 and c54,
canine SRP68/72, Materials and Methods) and re-annealing of
SRP RNA might improve the binding efficiencies of the
mutated RNAs. We had shown previously that the minimal
Alu RNA that still binds h9/14 with full efficiency (SA86)
could be folded in vitro (29). With SRP RNA, however,
there were no significant improvements of the h9/14 binding
capacities of the RNAs (Table 2). Even worse, we noticed that
re-annealing abrogated SRP54 binding (Table 2) indicating
that the S domain became misfolded.
In summary, disrupting the tertiary structure with mutations
in either loop result in a negative asymmetric effect on RNA
folding during its synthesis. Complementary mutations
significantly rescue proper folding of the RNA. These results
establish that base pairing takes place in complete SRP RNA
and that it is important for the efficient assembly of the SRP
Alu domain.
Protein binding to the S domain is not significantly
affected by the mutations in the Alu domain
We repeated the comparative protein-binding experiments
with human SRP19 (h19) and h19 together with canine
SRP54 (c54). SRP54 binding to SRP RNA is dependent on
the presence of SRP19 (39). Binding was monitored by the
addition of trace amounts of [35S]methionine-labelled h19 or
c54 synthesized in wheat germ extract in the presence of
recombinant proteins. The binding reactions were done as
before at final concentrations of 40 and 160 nM of protein
and RNA, respectively. In general, there was no major effect
on binding of c54 and h19 to the mutated RNAs, suggesting
that the S domain was capable of folding independently
(Figure 4C and Table 2). However, 2L2, 3L2 and 3L1.2
RNAs had slightly reduced protein-binding activities,
consistent with the presence of small fractions of completely
misfolded SRP RNAs. As with h9/14 binding, the small
defects in h19 and c54 binding were restored to WT levels
in the RNAs with compensatory mutations, consistent with the
interpretation that misfolding of the Alu domain interfered
with S domain folding to a low extent.
Mutations do not interfere with SRP activities
To assess whether the mutated SRP RNAs were capable of
conferring elongation arrest and targeting activities to SRP,
it was necessary to reconstitute particles from the in vitro-
synthesizedRNAsandallSRPproteins(8,36).Thereconstituted
particleswere thenadded to invitro translationreactions toassay
their activities. The relative inhibition of preprolactin synthesis
(a secreted protein) as compared with cyclin D synthesis
Table 2. Effects of mutations in loops L1.2 and L2 of SRP RNA on protein-
binding efficiencies and on functional activities of reconstituted particles
RNAs Protein-binding
efficiencies (%)
Activities of
particles (%)
9/14 9/14a 19 54 EA T
WT 100 100 100 100 100 100
2L2 8 9 90 78 — —
3L2 4 4 80 79 — —
2L1.2 30 31 104 94 93 100
3L1.2 30 29 95 81 64 71
2Comp 86 85 119 96 93 125
3Comp 44 50 101 96 86 101
WT refold. 103 112 — 20 — —
2L2 refold. 5 9 — — — —
Buffer — — — — 0 23
The RNA and protein concentrations in the binding reactions were 160 and 40
nM, respectively. Binding efficiencies were normalized to WT SRP RNA,
which was set to 100%. Average standard deviations for protein binding (%):
4.3 (9/14), 3.8 (19) and 4.6 (54). EA, elongation arrest activity; T, translocation
efficiency. EA and T were set to 100% for WTSRP. Translocation in the absence
of SRP is due to microsome-bound SRP. Average standard deviations were 7%
for EA and T.
a9/14 binding was assayed in the presence of all other SRP proteins. C54 binding
was assayed in the presence of 40 nM h19. Particles were reconstituted using a
2-fold excess of SRP RNAs together with all SRP proteins and the activities of
the reconstitution reactions were assayed directly.
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(a cytoplasmic protein) was monitored to determine
elongation arrest activities. To examine the signal recognition
and targeting activities of the particles, we assayed their ability
to promote translocation of preprolactin into salt-washed canine
microsomes as revealed by the processing of preprolactin to
prolactin.
Since 2L2 and 3L2 RNAs had only a very low ability to bind
h9/14 and, therefore, to assemble into complete SRP, it was
necessary to do the reconstitution reactions in the presence of
excess of RNA over protein to obtain detectable amounts of
SRP. Because translation of preprolactin and cyclin was
severely inhibited by the addition of high levels of RNA,
we enriched completely reconstituted mutant SRP by anion
exchange chromatography (Materials and Methods). It is
known that functional canine SRP elutes at 600 mM potassium
acetate from a DEAE column (36,39). At the same time, we
also reconstituted WT and 2Comp particles. The fractions
containing all SRP proteins were assayed for activities (Figure
5A and B). The maximal concentrations of potentially active
SRP that might be present in these fractions were estimated
from the intensities of the c54 signal. The 2L2 and 2Comp
fractions showed concentration-dependent elongation arrest
and translocation activities comparable to the one of the
WT fraction (Figure 5C and D). Hence, the mutations in
2L2 and 2Comp RNAs did not interfere with the elongation
arrest and translocation activities of reconstituted particles.
Similar experiments with 3L2 RNA failed to yield detect-
able amounts of active SRP in the fractions eluting from the
anion exchange columns, even when using higher amounts of
RNA in the reconstitution reactions probably because the
presence of too much RNA eventually abolishes assembly
of functional SRP.
To test the other RNAs that had lower assembly defects, we
assayed directly the reconstitution reactions for elongation
arrest and translocation activities (Materials and Methods).
The activities of particles containing mutated RNAs were
normalized to the activities of fully reconstituted particles
containing WT RNA (Table 2). SRPs comprising 2L1.2,
2Comp and 3Comp RNAs had elongation arrest and translo-
cation activities comparable to WT SRP whereas 3L1.2 SRP
had slightly diminished activities. The latter was most likely
explained by its reduced c54 binding activity.
Five of the six mutated SRP RNAs could be assembled into
fully functional particles, thereby demonstrating that the
mutations had no direct impact on the elongation arrest
activity.
DISCUSSION
An important step in the assembly of functional ribonucleo-
protein complexes is the proper folding of the RNA subunit.
Folding is not a trivial problem, especially for larger RNAs,
since once trapped in non-native conformations, RNA second-
ary structures cannot be easily converted into native structures
because of the high stability of even small helical stems. Our
results underscore the primary importance of a tertiary
structure for proper folding of SRP RNA and they therefore
define the loop–loop base pairs as a key architectural element
for the assembly of functional SRP.
Figure 5. Elongation arrest and translocation activities of particles
reconstituted with mutated SRP RNAs. (A) Fractions enriched in complete
SRP that was reconstituted in vitro with all SRP proteins and WT, 2L2 and
2Comp synthetic RNAs. (B) Elongation arrest (upper panel) and translocation
(lower panel) assays with 2, 1, 0.5 and 0 ml (B, Buffer) of the fractions shown in
(A). Translocation assays contain SRP-depleted microsomes. B, buffer.
(C and D) Quantification of the elongation arrest and translocation assays.
The ratio of preprolactin to cyclin in the buffer sample was taken as 0%
inhibition in the elongation arrest assay. In the absence of exogenous SRP,
the membranes have a residual translocation activity of about 20%. Values
represent the average of at least two independent experiments. WT SRP
(diamonds), 2L2 SRP (triangles) and 2Comp SRP (dots).
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Co-transcriptional folding is a vectorial process, and local
secondary and tertiary structures might form as soon as the
RNA exits the transcription complex [for review see (2,40)].
As yet, we can only speculate on the folding pathway of
the Alu domain. However, the results presented highlight
two important events that might control the early steps of
SRP RNA folding. First, the formation of the first hairpin
structure including loop L2 sequences appears to be very
critical and, second, the recruitment of SRP9/14, which is
required for SRP function, depends strongly on proper folding,
and hence, on the tertiary structure of SRP RNA. These find-
ings suggest a series of sequential events that might control
folding of the SRP RNA Alu domain (Figure 6).
The first rigid element to emerge from the transcription
complex is the conserved U-turn in loop L2. Together with
the other loop L2 sequences and the stable G-C-rich helix H2,
it might ensure efficient and the fast formation of the first
hairpin (Figure 6, step 1). The next rigid element to emerge
is the U-turn of the conserved protein-binding site. It will
determine the orientation of the emerging strand facilitating
loop–loop interactions (step 2). Base pairing between the loops
(step 3) further stabilizes the central U-turn, which can now be
recognized by the protein SRP9/14. At this point, SRP9/14
may act as an early checkpoint for proper folding of the RNA
as it can distinguish between native and non-native conforma-
tions (step 4). In addition, it may assist proper folding of
certain native-like conformations at this point or possibly
already in the earlier step (steps 3 and 4). Protein binding
locks the stem alignment and the base pairs into place and
thereby facilitates the formation and stacking of stems H1.2
and H1.1 (step 5).
Once the Alu 50 domain is properly assembled, folding and
assembly of the S domain will ensue. The final step of SRP
assembly is the formation of the 30 half of the central stem
(Figure 1). Based on earlier studies, formation of the central
stem will allow the Alu 50 domain to flip by 180 to align
besides the central stem. The central stem (Figure 1, Alu 30
domain) can then bind to the protein SRP9/14 (25,28). The last
step might represent a final checkpoint for SRP assembly
before its export to the cytoplasm.
According to this model, SRP9/14 would have a pivotal role
in SRP assembly in vivo. It may act as a sensor of properly
folded RNA and of properly assembled SRP in the assembly
pathway. SRP14 has been found in nucleoli of mammalian and
yeast cells (16,20) and it might, therefore, be present during
synthesis of the RNA, although the transcription sites of the
SRP RNA gene have not yet been identified. As yet, it is
unclear whether archaeal and eubacterial organisms contain
9/14-like proteins. It is possible that the extended interactions
between the loops may compensate for its absence in the early
folding events.
The fact that mutations in loop L2 have a more dramatic
effect on folding indicates that these mutations not only inter-
fere with base pairing but possibly also with the formation of
the crucial first hairpin structure. Based on a strictly sequential
mode of events, it is difficult to understand how compensatory
changes in loop L1.2 can rescue proper folding of the mutated
first hairpin. However, it is possible that pairing rearrange-
ments may be mediated by the tertiary structure. Formation of
secondary structures as a function of native tertiary structures
has been observed previously in folding studies (41–43). Our
results also indicate that 1 bp is not sufficient to ensure proper
folding. In the loop alignments, there is a strong bias for G-C
base pairs and, with the exception of plants, at least three G-C
pairs have been conserved in all SRP RNAs (Figure 2),
consistent with the requirement of a minimal free energy
for base pairing to occur.
The primary importance of the tertiary structure is its role in
the assembly of functional SRP. It is conceivable that it might
also play a role in the elongation arrest function. However,
based on the results presented here, this function would not
include sequence- or structure-specific interactions between
the tertiary structure and the ribosome. This conclusion is
also supported by the phylogenetic analysis, which predicts
considerable changes in the specific structure of the base
pairing loops between RNAs from different organisms. Yet,
structures interacting directly with the ribosome are likely to
be conserved. In the absence of a structure that is strikingly
conserved between RNAs of all organisms, it is at this point
impossible to predict whether there is a functionally decisive
element in the RNA moiety. The RNA is likely to determine
the position of the Alu domain in the elongation factor binding
site (13,44) and might, therefore, put the protein SRP9/14
into the right place to exert its essential function in
delaying nascent chain elongation by mammalian and yeast
SRPs (8,9).
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Figure 6. Model for the early steps of SRP RNA folding. Step (1) formation of
the first very stable hairpin structure; step (2) the central U-turn ensures
orientation of the emerging strand to allow base pairing with loop L2 [step (3)];
SRP9/14 recognizes the correctly folded central U-turn region and by binding to
it stabilizes the fold [step (4)]; formation and alignment of H1.2 and H1.2 ensues
[step (5)]. It is possible that the protein may bind the U-turn before base pairing
occurs.
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